10-Q

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 1-8923

HEALTH CARE REIT, INC.

(Exact name of registrant as specified in its charter) 

Delaware	34-1096634
(State or other jurisdiction of  incorporation or organization)	(I.R.S. Employer  Identification No.)
4500 Dorr Street, Toledo, Ohio	43615
(Address of principal executive offices)	(Zip Code)

(419) 247-2800

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☑  No  o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑  No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☑ Accelerated filer o Non-accelerated filer   o  (Do not check if a smaller reporting company) Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  ☑

As of May 1, 2015, the registrant had 350,626,627 shares of common stock outstanding.

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets — March 31, 2015 and December 31, 2014	3
Consolidated Statements of Comprehensive Income — Three months ended March 31, 2015 and 2014	4
Consolidated Statements of Equity — Three months ended March 31, 2015 and 2014	6
Consolidated Statements of Cash Flows — Three months ended March 31, 2015 and 2014	7
Notes to Unaudited Consolidated Financial Statements	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3. Quantitative and Qualitative Disclosures About Market Risk	50
Item 4. Controls and Procedures	51
PART II. OTHER INFORMATION
Item 1. Legal Proceedings Item 1A. Risk Factors	51 52
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	52
Item 5. Other Information	52
Item 6. Exhibits	52
Signatures	53

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

CONSOLIDATED BALANCE SHEETS

HEALTH CARE REIT, INC. AND SUBSIDIARIES

(In thousands)

				March 31, 2015		December 31, 2014
				(Unaudited)		(Note)
Assets:
Real estate investments:
	Real property owned:
		Land and land improvements		$	2,160,886	$	2,046,541
		Buildings and improvements			23,192,154		21,799,313
		Acquired lease intangibles			1,187,094		1,135,936
		Real property held for sale, net of accumulated depreciation			234,829		323,818
		Construction in progress			211,941		186,327
			Gross real property owned		26,986,904		25,491,935
		Less accumulated depreciation and amortization			(3,186,424)		(3,020,908)
			Net real property owned		23,800,480		22,471,027
	Real estate loans receivable				745,267		380,169
	Net real estate investments				24,545,747		22,851,196
Other assets:
		Investments in unconsolidated entities			715,468		744,151
		Goodwill			68,321		68,321
		Deferred loan expenses			63,378		69,282
		Cash and cash equivalents			202,273		473,726
		Restricted cash			85,177		79,697
		Straight-line rent receivable			307,050		279,806
		Receivables and other assets			641,981		448,117
			Total other assets		2,083,648		2,163,100
Total assets				$	26,629,395	$	25,014,296
Liabilities and equity
Liabilities:
		Borrowings under primary unsecured credit facility		$	410,000	$	-
		Senior unsecured notes			7,518,196		7,766,251
		Secured debt			3,010,971		2,977,713
		Capital lease obligations			75,622		84,049
		Accrued expenses and other liabilities			604,149		626,825
Total liabilities					11,618,938		11,454,838
Redeemable noncontrolling interests					92,508		86,409
Equity:
		Preferred stock			1,006,250		1,006,250
		Common stock			350,434		328,835
		Capital in excess of par value			16,218,794		14,740,712
		Treasury stock			(41,373)		(35,241)
		Cumulative net income			3,049,173		2,842,022
		Cumulative dividends			(5,924,844)		(5,635,923)
		Accumulated other comprehensive income (loss)			(107,496)		(77,009)
		Other equity			4,449		5,507
			Total Health Care REIT, Inc. stockholders’ equity		14,555,387		13,175,153
		Noncontrolling interests			362,562		297,896
Total equity					14,917,949		13,473,049
Total liabilities and equity				$	26,629,395	$	25,014,296

NOTE: The consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

See notes to unaudited consolidated financial statements

3

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

HEALTH CARE REIT, INC. AND SUBSIDIARIES

(In thousands, except per share data)

			Three Months Ended
			March 31,
			2015		2014
Revenues:
	Rental income		$	379,587	$	336,455
	Resident fees and services			492,510		456,265
	Interest income			16,994		8,594
	Other income			5,086		493
		Total revenues		894,177		801,807
Expenses:
	Interest expense			121,080		120,833
	Property operating expenses			376,461		341,431
	Depreciation and amortization			188,829		233,318
	General and administrative			35,138		32,865
	Transaction costs			48,554		952
	Loss (gain) on derivatives, net			(58,427)		-
	Loss (gain) on extinguishment of debt, net			15,401		(148)
	Impairment of assets			2,220		-
		Total expenses		729,256		729,251
Income (loss) from continuing operations before income taxes
	and income from unconsolidated entities			164,921		72,556
Income tax (expense) benefit				304		(2,260)
Income (loss) from unconsolidated entities				(12,648)		(5,556)
Income (loss) from continuing operations				152,577		64,740
Income (loss) from discontinued operations, net				-		460
Gain (loss) on real estate dispositions, net				56,845		-
Net income				209,422		65,200
Less:		Preferred stock dividends		16,352		16,353
Less:		Net income (loss) attributable to noncontrolling interests(1)		2,271		(1,175)
Net income (loss) attributable to common stockholders			$	190,799	$	50,022
Average number of common shares outstanding:
	Basic			336,754		289,606
	Diluted			337,812		290,917
Earnings per share:
	Basic:
	Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions		$	0.57	$	0.17
	Net income (loss) attributable to common stockholders*		$	0.57	$	0.17
	Diluted:
	Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions		$	0.56	$	0.17
	Net income (loss) attributable to common stockholders*		$	0.56	$	0.17
Dividends declared and paid per common share			$	0.825	$	0.795

* Amounts may not sum due to rounding

(1) Includes amounts attributable to redeemable noncontrolling interests.

See notes to unaudited consolidated financial statements

4

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

HEALTH CARE REIT, INC. AND SUBSIDIARIES

(In thousands)

		Three Months Ended March 31,
		2015		2014
Net income		$	209,422	$	65,200
Other comprehensive income (loss):
	Unrecognized gain (loss) on available for sale securities		(11,687)		549
	Unrealized gains (losses) on cash flow hedges		(2,159)		440
	Foreign currency translation gain (loss)		(29,197)		(9,889)
Total other comprehensive income (loss)			(43,043)		(8,900)
Total comprehensive income (loss)			166,379		56,300
Less: Total comprehensive income (loss) attributable to noncontrolling interests(1)			(10,285)		(9,187)
Total comprehensive income (loss) attributable to common stockholders		$	176,664	$	65,487
(1) Includes amounts attributable to redeemable noncontrolling interests.

See notes to unaudited consolidated financial statements

5

CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)

HEALTH CARE REIT, INC. AND SUBSIDIARIES

(In thousands)

		Three Months Ended March 31, 2015
														Accumulated
						Capital in								Other
		Preferred		Common		Excess of		Treasury		Cumulative		Cumulative		Comprehensive		Other		Noncontrolling
		Stock		Stock		Par Value		Stock		Net Income		Dividends		Income (Loss)		Equity		Interests		Total
Balances at beginning of period		$	1,006,250	$	328,835	$	14,740,712	$	(35,241)	$	2,842,022	$	(5,635,923)	$	(77,009)	$	5,507	$	297,896	$	13,473,049
Comprehensive income:
	Net income (loss)										207,151								1,925		209,076
	Other comprehensive income														(30,487)				(12,556)		(43,043)
Total comprehensive income																					166,033
Net change in noncontrolling interests							(4,540)												75,297		70,757
Amounts related to issuance of common stock from dividend reinvestment and stock incentive plans, net of forfeitures					1,001		73,642		(6,132)								(1,275)				67,236
Proceeds from issuance of common stock					19,550		1,404,385														1,423,935
Equity component of convertible debt					1,048		4,595														5,643
Option compensation expense																	217				217
Cash dividends paid:
	Common stock cash dividends												(272,569)								(272,569)
	Preferred stock cash dividends												(16,352)								(16,352)
Balances at end of period		$	1,006,250	$	350,434	$	16,218,794	$	(41,373)	$	3,049,173	$	(5,924,844)	$	(107,496)	$	4,449	$	362,562	$	14,917,949
		Three Months Ended March 31, 2014
														Accumulated
						Capital in								Other
		Preferred		Common		Excess of		Treasury		Cumulative		Cumulative		Comprehensive		Other		Noncontrolling
		Stock		Stock		Par Value		Stock		Net Income		Dividends		Income (Loss)		Equity		Interests		Total
Balances at beginning of period		$	1,017,361	$	289,461	$	12,418,520	$	(21,263)	$	2,329,869	$	(4,600,854)	$	(24,531)	$	6,020	$	341,748	$	11,756,331
Comprehensive income:
	Net income (loss)										66,375								(982)		65,393
	Other comprehensive income														(888)				(8,012)		(8,900)
Total comprehensive income																					56,493
Net change in noncontrolling interests							(2,713)												(4,383)		(7,096)
Amounts related to issuance of common stock from dividend reinvestment and stock incentive plans, net of forfeitures					1,397		67,725		(5,191)								(12)				63,919
Conversion of preferred stock			(11,111)		233		10,878														-
Option compensation expense																	233				233
Cash dividends paid:
	Common stock cash dividends												(230,801)								(230,801)
	Preferred stock cash dividends												(16,353)								(16,353)
Balances at end of period		$	1,006,250	$	291,091	$	12,494,410	$	(26,454)	$	2,396,244	$	(4,848,008)	$	(25,419)	$	6,241	$	328,371	$	11,622,726

See notes to unaudited consolidated financial statements

6

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

HEALTH CARE REIT, INC. AND SUBSIDIARIES

(In thousands)

			Three Months Ended
			March 31,
			2015		2014
Operating activities:
Net income			$	209,422	$	65,200
Adjustments to reconcile net income to
	net cash provided from (used in) operating activities:
		Depreciation and amortization		188,829		233,318
		Other amortization expenses		1,320		1,672
		Impairment of assets		2,220		-
		Stock-based compensation expense		9,054		7,667
		Loss (gain) on derivatives, net		(58,427)		-
		Loss (gain) on extinguishment of debt, net		15,401		(148)
		Loss (income) from unconsolidated entities		12,648		5,556
		Rental income in excess of cash received		(27,244)		(15,323)
		Amortization related to above (below) market leases, net		113		266
		Loss (gain) on sales of properties, net		(56,845)		-
		Distributions by unconsolidated entities		172		4,560
		Increase (decrease) in accrued expenses and other liabilities		(47,489)		(25,532)
		Decrease (increase) in receivables and other assets		(22,992)		(18,575)
Net cash provided from (used in) operating activities				226,182		258,661
Investing activities:
	Cash disbursed for acquisitions			(1,500,994)		(55,041)
	Cash disbursed for capital improvements to existing properties			(29,828)		(27,406)
	Cash disbursed for construction in progress			(59,552)		(52,717)
	Capitalized interest			(2,387)		(1,605)
	Investment in real estate loans receivable			(384,695)		(29,709)
	Other investments, net of payments			(102,126)		1,787
	Principal collected on real estate loans receivable			16,501		10,646
	Contributions to unconsolidated entities			(83,964)		(214,832)
	Distributions by unconsolidated entities			89,195		12,462
	Proceeds from (payments on) derivatives			72,477		-
	Decrease (increase) in restricted cash			(1,660)		5,024
	Proceeds from sales of real property			177,265		-
Net cash provided from (used in) investing activities				(1,809,768)		(351,391)
Financing activities:
	Net increase (decrease) under unsecured credit facilities			410,000		432,000
	Payments to extinguish senior unsecured notes			(154,654)		(1)
	Net proceeds from the issuance of secured debt			82,724		10,690
	Payments on secured debt			(208,057)		(129,539)
	Net proceeds from the issuance of common stock			1,489,547		63,755
	Decrease (increase) in deferred loan expenses			(4,485)		(2,284)
	Contributions by noncontrolling interests(1)			2,514		778
	Distributions to noncontrolling interests(1)			(7,417)		(7,386)
	Acquisitions of noncontrolling interests			-		(1,175)
	Cash distributions to stockholders			(288,921)		(247,154)
	Other financing activities			(8,428)		(87)
Net cash provided from (used in) financing activities				1,312,823		119,597
Effect of foreign currency translation on cash and cash equivalents				(690)		281
Increase (decrease) in cash and cash equivalents				(271,453)		27,148
Cash and cash equivalents at beginning of period				473,726		158,780
Cash and cash equivalents at end of period			$	202,273	$	185,928
Supplemental cash flow information:
	Interest paid		$	134,737	$	126,302
	Income taxes paid			2,942		10,064
(1) Includes amounts attributable to redeemable noncontrolling interests.

See notes to unaudited consolidated financial statements

7

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business

     Health Care REIT, Inc., an S&P 500 company with headquarters in Toledo, Ohio, is an equity real estate investment trust (“REIT”) that invests in seniors housing and health care real estate. Our full service platform offers property management and development services to our customers. As of March 31, 2015, our diversified portfolio consisted of 1,384 properties in 46 states, the United Kingdom, and Canada.  Founded in 1970, we were the first real estate investment trust to invest exclusively in health care facilities.

2. Accounting Policies and Related Matters

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2015 are not necessarily an indication of the results that may be expected for the year ending December 31, 2015. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.

New Accounting Standards

     In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). The standard is a comprehensive new revenue recognition model that requires revenue to be recognized in a manner to depict the transfer of goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016, and early adoption is not permitted.  In April 2015, the FASB proposed deferring the effective date by one year to December 15, 2017 for annual reporting periods beginning after that date, but early adoption is permitted.  We are currently evaluating the impact that the standard will have on our consolidated financial statements and have not yet determined the method by which we will adopt the standard.

     In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis” (“ASU 2015-02”), which makes certain changes to both the variable interest model and the voting model, including changes to (1) the identification of variable interests (fees paid to a decision maker or service provider), (2) the variable interest entity characteristics for a limited partnership or similar entity and (3) the primary beneficiary determination.  ASU 2015-02 is effective beginning January 1, 2016.  We are continuing to evaluate this guidance; however, we do not expect its adoption to have a significant impact on our consolidated financial statements.

     In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs”(“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability.  The recognition and measurement guidance for debt issuance costs are not affected.  Upon adoption, we will apply the new guidance on a retrospective basis and adjust the balance sheet of each individual period presented to reflect the period-specific effects of applying the new guidance.  The guidance is effective beginning January 1, 2016.  We are continuing to evaluate this guidance; however, we do not expect its adoption to have a significant impact on our consolidated financial statements.

3. Real Property Acquisitions and Development

     The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets, liabilities and noncontrolling interests based upon their respective fair values in accordance with our accounting policies. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments.  Transaction costs primarily represent costs incurred with property acquisitions, including due diligence costs, fees for legal and valuation services and termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs.

8

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

    Triple-net Activity

		Three Months Ended
(In thousands)		March 31, 2015(1)			March 31, 2014
Land and land improvements			$	70,002		$	2,750
Buildings and improvements				537,014			30,693
Acquired lease intangibles				799			-
Receivables and other assets				7			-
	Total assets acquired			607,822			33,443
Accrued expenses and other liabilities				(732)			-
	Total liabilities assumed			(732)			-
Non-cash acquisition related activity				(357)			(657)
	Cash disbursed for acquisitions			606,733			32,786
Construction in progress additions				45,360			24,657
Less:	Capitalized interest			(1,756)			(1,170)
	Foreign currency translation			(642)			(14)
Cash disbursed for construction in progress				42,962			23,473
Capital improvements to existing properties				11,557			5,877
	Total cash invested in real property, net of cash acquired		$	661,252		$	62,136
(1) Includes acquisitions with an aggregate purchase price of $571,586,000 for which the allocation of the purchase price consideration is preliminary and subject to change.

Seniors Housing Operating Activity

     Acquisitions of seniors housing operating properties are structured under RIDEA, which is described in Note 18.  This structure results in the inclusion of all resident revenues and related property operating expenses from the operation of these qualified health care properties in our Consolidated Statements of Comprehensive Income.  Certain of our subsidiaries’ functional currencies are the local currencies of their respective countries. See Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014 for information regarding our foreign currency policies.

		Three Months Ended
(In thousands)		March 31, 2015(1)			March 31, 2014
Land and land improvements			$	86,184		$	2,100
Building and improvements				1,016,426			19,069
Acquired lease intangibles				62,838			1,331
Restricted cash				3,820			-
Receivables and other assets				23,014			-
	Total assets acquired(2)			1,192,282			22,500
Secured debt				(208,960)			-
Accrued expenses and other liabilities				(16,164)			(245)
	Total liabilities assumed			(225,124)			(245)
Noncontrolling interests				(83,194)			-
	Cash disbursed for acquisitions			883,964			22,255
Construction in progress additions				4,193			1,026
Less:	Capitalized interest			(394)			(50)
	Foreign currency translation			(1,472)			-
Cash disbursed for construction in progress				2,327			976
Capital improvements to existing properties				11,632			13,998
	Total cash invested in real property, net of cash acquired		$	897,923		$	37,229
(1) Includes acquisitions with an aggregate purchase price of $885,642,000 for which the allocation of the purchase price consideration is preliminary and subject to change.
(2) Excludes $1,677,000 and $245,000 of cash acquired during the three months ended March 31, 2015 and 2014, respectively.

9

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Outpatient Medical Activity

		Three Months Ended
(In thousands)		March 31, 2015 (1)			March 31, 2014
Buildings and improvements			$	9,786	$	-
Acquired lease intangibles				511		-
	Total assets acquired			10,297		-
	Cash disbursed for acquisitions			10,297		-
Construction in progress additions				16,421		38,237
Less:	Capitalized interest			(237)		(385)
	Accruals(2)			(1,921)		(9,584)
Cash disbursed for construction in progress				14,263		28,268
Capital improvements to existing properties				6,639		7,531
	Total cash invested in real property		$	31,199	$	35,799
(1) Includes acquisitions with an aggregate purchase price of $10,297,000 for which the allocation of the purchase price consideration is preliminary and subject to change.
(2) Represents non-cash consideration accruals for amounts to be paid in future periods relating to properties that converted in the periods noted above.

Construction Activity

     The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):

			Three Months Ended
			March 31, 2015			March 31, 2014
	Development projects:
		Triple-net		$	-		$	8,481
		Outpatient medical			16,592			42,799
		Total development projects			16,592			51,280
	Expansion projects				19,541			9,209
Total construction in progress conversions				$	36,133		$	60,489

10

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

4. Real Estate Intangibles

     The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):

		March 31, 2015		December 31, 2014
Assets:
	In place lease intangibles	$	1,037,697	$	988,290
	Above market tenant leases		66,162		65,684
	Below market ground leases		62,426		62,426
	Lease commissions		20,809		19,536
	Gross historical cost		1,187,094		1,135,936
	Accumulated amortization		(789,546)		(776,501)
	Net book value	$	397,548	$	359,435
	Weighted-average amortization period in years		16.2		17.7
Liabilities:
	Below market tenant leases	$	91,365	$	91,168
	Above market ground leases		7,859		7,859
	Gross historical cost		99,224		99,027
	Accumulated amortization		(42,853)		(40,891)
	Net book value	$	56,371	$	58,136
	Weighted-average amortization period in years		14.4		14.4

     The following is a summary of real estate intangible amortization for the periods presented (in thousands):

	Three Months Ended
	March 31,
	2015		2014
Rental income related to above/below market tenant leases, net	$	206	$	(45)
Property operating expenses related to above/below market ground leases, net		(319)		(311)
Depreciation and amortization related to in place lease intangibles and lease commissions		(24,324)		(79,393)

     The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):

		Assets		Liabilities
2015	$	72,406	$	$3,323
2016		60,019		8,176
2017		37,369		8,594
2018		26,596		8,500
2019		23,289		6,819
Thereafter		177,869		20,959
Total	$	397,548	$	56,371

11

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

5. Dispositions, Assets Held for Sale and Discontinued Operations

We periodically sell properties for various reasons, including favorable market conditions or the exercise of tenant purchase options.  Of our total sales proceeds, $19,493,000 was deposited in an Internal Revenue Code Section 1031 exchange escrow account with a qualified intermediary.  The following is a summary of our real property disposition activity for the periods presented (in thousands):

		Three Months Ended
		March 31, 2015			March 31, 2014
Real property dispositions:
	Triple-net		$	110,998		$	-
	Outpatient medical			9,422			-
	Total dispositions			120,420			-
Gain (loss) on sales of real property, net				56,845			-
Proceeds from real property sales			$	177,265		$	-

Dispositions and Assets Held for Sale

     Pursuant to our adoption of ASU No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity” (“ASU 2014-08”), operating results attributable to properties sold subsequent to or classified as held for sale after January 1, 2014 and which do not meet the definition of discontinued operations are no longer reclassified on our Consolidated Statements of Comprehensive Income.  The following represents the activity related to these properties for the periods presented (in thousands):

			Three Months Ended
			March 31,
		2015		2014
Revenues:
	Rental income	$	4,517	$	28,243
Expenses:
	Interest expense		1,303		7,644
	Property operating expenses		14		673
	Provision for depreciation		133		8,236
	Total expenses		1,450		16,553
Income (loss) from real estate dispositions, net		$	3,067	$	11,690

Discontinued Operations

We have reclassified the income and expenses attributable to all properties sold prior to or held for sale at January 1, 2014 to discontinued operations in accordance with ASU 2014-08.  The following illustrates the reclassification impact as reported in our Consolidated Statements of Comprehensive Income as a result of classifying these properties as discontinued operations for the periods presented (in thousands):

			Three Months Ended
			March 31,
		2015		2014
Revenues:
	Rental income	$	-	$	583
Expenses:
	Interest expense		-		123
	Total expenses		-		123
Income (loss) from discontinued operations, net		$	-	$	460

12

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

6. Real Estate Loans Receivable

     The following is a summary of our real estate loan activity for the periods presented (in thousands):

		Three Months Ended
		March 31, 2015						March 31, 2014
				Outpatient						Outpatient
		Triple-net		Medical		Totals		Triple-net		Medical		Totals
Advances on real estate loans receivable:
	Investments in new loans	$	368,080	$	-	$	368,080	$	1,203	$	-	$	1,203
	Draws on existing loans		14,330		2,285		16,615		23,077		5,429		28,506
	Net cash advances on real estate loans		382,410		2,285		384,695		24,280		5,429		29,709
Receipts on real estate loans receivable:
	Loan payoffs		8,568		-		8,568		500		-		500
	Principal payments on loans		7,933		-		7,933		10,127		19		10,146
	Net cash receipts on real estate loans		16,501		-		16,501		10,627		19		10,646
Net cash advances (receipts) on real estate loans			365,909		2,285		368,194		13,653		5,410		19,063
Change in balance due to foreign currency translation			(3,096)		-		(3,096)		192		-		192
Net change in real estate loans receivable		$	362,813	$	2,285	$	365,098	$	13,845	$	5,410	$	19,255

We recorded no provision for loan losses during the three months ended March 31, 2015.  At March 31, 2015, we had real estate loans with outstanding balances of $21,000,000 on non-accrual status with an allowance for loan losses of $0.

7. Investments in Unconsolidated Entities

We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate.  The results of operations for these properties have been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities.  The following is a summary of our investments in unconsolidated entities (dollars in thousands):

	Percentage Ownership(1)	March 31, 2015		December 31, 2014
Triple-net	10% to 49%	$	31,276	$	31,511
Seniors housing operating	10% to 50%		509,743		539,147
Outpatient medical	36% to 49%		174,449		173,493
Total		$	715,468	$	744,151
(1) Excludes ownership of in-substance real estate.

     At March 31, 2015, the aggregate unamortized basis difference of our joint venture investments of $169,696,000 is primarily attributable to appreciation of the underlying properties and transaction costs.  This difference will be amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.

8. Credit Concentration

     We use net operating income from continuing operations (“NOI”) as our credit concentration metric.  See Note 17 for additional information and reconciliation. The following table summarizes certain information about our credit concentration as of March 31, 2015, excluding our share of NOI in unconsolidated entities (dollars in thousands):

13

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

		Number of	Total		Percent of
Concentration by relationship:(1)		Properties	NOI		NOI(2)
	Genesis Healthcare	180	$	87,277	17%
	Sunrise Senior Living(3)	143		71,268	14%
	Brookdale Senior Living	146		42,092	8%
	Benchmark Senior Living	49		21,726	4%
	Revera(3)	71		19,121	4%
	Remaining portfolio	727		276,232	53%
	Totals	1,316	$	517,716	100%

(1)Genesis Healthcare is in our triple-net segment.  Sunrise Senior Living and Revera are in our seniors housing operating segment.  Benchmark Senior Living and Brookdale Senior Living are in both our triple-net and seniors housing operating segments.

(2)NOI with our top five relationships comprised 49% of total NOI for the year ending December 31, 2014.

(3)Revera owns a controlling interest in Sunrise.

9. Borrowings Under Credit Facilities and Related Items

     At March 31, 2015, we had a primary unsecured credit facility with a consortium of 28 banks that includes a $2,500,000,000 unsecured revolving credit facility, a $500,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility.  We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $500,000,000 unsecured term credit facility by up to an additional $1,000,000,000 and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000.  The primary unsecured credit facility also allows us to borrow up to $500,000,000 in alternate currencies (none outstanding at March 31, 2015).  Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over LIBOR interest rate (1.103% at March 31, 2015). The applicable margin is based on certain of our debt ratings and was 0.925% at March 31, 2015.  In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount.  The facility fee depends on certain of our debt ratings and was 0.15% at March 31, 2015.  The primary unsecured credit facility is scheduled to expire October 31, 2018 and can be extended for an additional year at our option.

     The following information relates to aggregate borrowings under the unsecured revolving credit facility for the periods presented (dollars in thousands):

		Three Months Ended March 31,
		2015		2014
Balance outstanding at quarter end(1)		$	410,000	$	562,000
Maximum amount outstanding at any month end		$	430,000	$	562,000
Average amount outstanding (total of daily
	principal balances divided by days in period)	$	408,944	$	286,889
Weighted average interest rate (actual interest
	expense divided by average borrowings outstanding)		1.21%		1.34%
(1) As of March 31, 2015, letters of credit in the aggregate amount of $65,335,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

10. Senior Unsecured Notes and Secured Debt

     We may repurchase, redeem or refinance convertible and non-convertible senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms.   The non-convertible senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of (1) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (2) any “make-whole” amount due under the terms of the notes in connection with early redemptions.   Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.At March 31, 2015, the annual principal payments due on these debt

14

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

obligations were as follows (in thousands):

	Senior		Secured
	Unsecured Notes(1,2)		Debt (1,3)		Totals
2015	$	-	$	332,035	$	332,035
2016		700,000		493,223		1,193,223
2017		450,000		379,397		829,397
2018		450,000		444,394		894,394
2019(4,5)		1,297,150		371,800		1,668,950
Thereafter(6,7)		4,670,771		951,809		5,622,580
Totals	$	7,567,921	$	2,972,658	$	10,540,579
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(2) Annual interest rates range from 1.1% to 6.5%.
(3) Annual interest rates range from 1.0% to 7.9%.  Carrying value of the properties securing the debt totaled $5,349,988,000 at March 31, 2015.
(4) On July 25, 2014, we refinanced the funding on a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $197,150,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2015).  The loan matures on October 31, 2018 (with an option to extend for an additional year at our discretion) and bears interest at the Canadian Dealer Offered Rate plus 97.5 basis points (2.0% at March 31, 2015).
(5) On July 25, 2014, we refinanced the funding on a $500,000,000 unsecured term credit facility.  The loan matures on October 31, 2018 (with an option to extend for one additional year at our discretion) and bears interest at LIBOR plus 97.5 basis points (1.15% at March 31, 2015).
(6) On November 20, 2013, we completed the sale of £550,000,000 (approximately $816,860,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2015) of 4.8% senior unsecured notes due 2028.
(7) On November 25, 2014, we completed the sale of £500,000,000 (approximately $742,600,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2015) of 4.5% senior unsecured notes due 2034.

          The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):

	Three Months Ended
	March 31, 2015			March 31, 2014
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	7,817,154	4.385%	$	7,421,707	4.400%
Debt redeemed		(154,654)	3.000%		(1)	3.000%
Foreign currency		(94,579)	4.333%		(3,332)	3.486%
Ending balance	$	7,567,921	4.352%	$	7,418,374	4.400%

         The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands):

	Three Months Ended
		March 31, 2015		March 31, 2014
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	2,941,765	4.94%	$	3,010,711	5.10%
Debt issued		82,724	2.34%		10,690	3.54%
Debt assumed		205,897	3.98%		-	0.00%
Debt extinguished		(192,427)	4.02%		(114,084)	5.73%
Principal payments		(15,630)	5.01%		(15,455)	5.12%
Foreign currency		(49,672)	3.96%		(15,905)	3.86%
Ending balance	$	2,972,657	4.88%	$	2,875,957	5.08%

     Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2015, we were in compliance with all of the covenants under our debt agreements.

15

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

11. Derivative Instruments

We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates.  We may elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to manage the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates.  In addition, non-U.S. investments expose us to the potential losses associated with adverse changes in foreign currency to U.S. Dollar exchange rates.  We may elect to manage this risk through the use of forward contracts and issuing debt in foreign currencies.

I nterest Rate Swap Contracts and Foreign Currency Forward Contracts Designated as Cash Flow Hedges

     For instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”), and reclassified into earnings in the same period, or periods, during which the hedged transaction affects earnings.  Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings.  Approximately $5,363,000 of losses, which are included in accumulated other comprehensive income (“AOCI”), are expected to be reclassified into earnings in the next 12 months.

Foreign Currency Hedges

     For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI.  During the three months ended March 31, 2015, we settled certain net investment hedges generating cash proceeds of $72,477,000.  The balance of the cumulative translation adjustment will be reclassified to earnings when the hedged investment is sold or substantially liquidated. 

     The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands):    

		March 31, 2015		December 31, 2014
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	1,175,000	$	900,000
Denominated in Pounds Sterling	£	350,000	£	350,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges
Denominated in U.S. Dollars	$	57,000	$	57,000
Denominated in Canadian Dollars	$	55,000	$	58,000
Denominated in Pounds Sterling	£	42,000	£	40,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	3,000	$	12,000

     The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):

16

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

		Three Months Ended
		March 31,
	Location		2015		2014
Gain (loss) on interest rate swap recognized in OCI (effective portion)	OCI	$	-	$	(3)
Gain (loss) on interest rate swaps reclassified from AOCI into income (effective portion)	Interest expense		(466)		(443)
Gain (loss) on forward exchange contracts recognized in income	Interest expense		2,747		-
Loss (gain) on option exercise(1)	Loss (gain) on derivatives, net		(58,427)		-
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		184,051		18,489
(1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.

12. Commitments and Contingencies

     At March 31, 2015, we had seven outstanding letter of credit obligations totaling $77,057,000 and expiring between 2015 and 2018.  At March 31, 2015, we had outstanding construction in progress of $211,941,000 and were committed to providing additional funds of approximately $355,231,000 to complete construction.  Purchase obligations include contingent purchase obligations totaling $59,856,000. These contingent purchase obligations relate to unfunded capital improvement obligations and contingent obligations on acquisitions. Rents due from the tenant are increased to reflect the additional investment in the property. 

     We evaluate our leases for operating versus capital lease treatment in accordance with Accounting Standards Codification (“ASC”) Topic 840 “Leases.”  A lease is classified as a capital lease if it provides for transfer of ownership of the leased asset at the end of the lease term, contains a bargain purchase option, has a lease term greater than 75% of the economic life of the leased asset, or if the net present value of the future minimum lease payments are in excess of 90% of the fair value of the leased asset. Certain leases contain bargain purchase options and have been classified as capital leases.  At March 31, 2015, we had operating lease obligations of $948,535,000 relating to certain ground leases and company office space and capital lease obligations of $102,117,000 relating primarily to certain investment properties. Regarding ground leases, we have sublease agreements with certain of our operators that require the operators to reimburse us for our monthly operating lease obligations.  At March 31, 2015, aggregate future minimum rentals to be received under these noncancelable subleases totaled $28,834,000.

17

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

13. Stockholders’ Equity

     The following is a summary of our stockholders’ equity capital accounts as of the dates indicated:

	March 31, 2015	December 31, 2014
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	25,875,000	25,875,000
Outstanding shares	25,875,000	25,875,000
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	351,237,849	329,487,615
Outstanding shares	350,471,798	328,790,066

Preferred Stock. The following is a summary of our preferred stock activity during the periods indicated:

	Three Months Ended
	March 31, 2015		March 31, 2014
		Weighted Avg.		Weighted Avg.
	Shares	Dividend Rate	Shares	Dividend Rate
Beginning balance	25,875,000	6.500%	26,108,236	6.496%
Shares converted	-	0.000%	(233,236)	6.000%
Ending balance	25,875,000	6.500%	25,875,000	6.500%

Common Stock. The following is a summary of our common stock issuances during the three months ended March 31, 2015 and 2014 (dollars in thousands, except per share amounts):

	Shares Issued		Average Price		Gross Proceeds		Net Proceeds
2014 Dividend reinvestment plan issuances	1,143,397	$	55.71	$	63,703	$	63,703
2014 Option exercises	1,155		45.02		52		52
2014 Senior note conversions	1				-		-
2014 Preferred stock conversions	233,236				-		-
2014 Totals	1,377,789			$	63,755	$	63,755
February 2015 public issuance	19,550,000	$	75.50	$	1,476,025	$	1,423,935
2015 Dividend reinvestment plan issuances	766,488		76.38		58,547		58,547
2015 Option exercises	149,788		47.17		7,065		7,065
2015 Stock incentive plans, net of forfeitures	166,815				-		-
2015 Senior note conversions	1,048,641				-		-
2015 Totals	21,681,732			$	1,541,637	$	1,489,547

Dividends.  The increase in dividends is primarily attributable to increases in our common shares outstanding as described above and an increase in common dividends per share.  The following is a summary of our dividend payments (in thousands, except per share amounts):

18

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

	Three Months Ended
	March 31, 2015				March 31, 2014
	Per Share		Amount		Per Share		Amount
Common Stock	$	0.8250	$	272,569	$	0.7950	$	230,801
Series H Preferred Stock		-		-		0.0079		1
Series I Preferred Stock		0.8125		11,680		0.8125		11,680
Series J Preferred Stock		0.4064		4,672		0.4064		4,672
Totals			$	288,921			$	247,154

     Accumulated Other Comprehensive Income.  The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):

		Unrecognized gains (losses) related to:
		Foreign Currency Translation		Available for Sale Securities		Actuarial Losses		Cash Flow Hedges		Total
Balance at December 31, 2014	$	(74,770)	$	-	$	(1,589)	$	(650)	$	(77,009)
Other comprehensive income before reclassification adjustments		(16,641)		(11,687)		-		(2,625)		(30,953)
Reclassification amount to net income		-		-		-		466 (1)		466
Net current-period other comprehensive income		(16,641)		(11,687)		-		(2,159)		(30,487)
Balance at March 31, 2015	$	(91,411)	$	(11,687)	$	(1,589)	$	(2,809)	$	(107,496)
Balance at December 31, 2013	$	(17,631)	$	(389)	$	(1,452)	$	(5,059)	$	(24,531)
Other comprehensive income before reclassification adjustments		(1,877)		549		-		(3)		(1,331)
Reclassification amount to net income		-		-		-		443 (1)		443
Net current-period other comprehensive income		(1,877)		549		-		440		(888)
Balance at March 31, 2014	$	(19,508)	$	160	$	(1,452)	$	(4,619)	$	(25,419)
(1) Please see note 11 for additional information.

14. Stock Incentive Plans

     Our Amended and Restated 2005 Long-Term Incentive Plan (“2005 Plan”) authorizes up to 6,200,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. The 2005 Plan replaced the 1995 Stock Incentive Plan (“1995 Plan”) and the Stock Plan for Non-Employee Directors. The options granted to officers and key employees under the 1995 Plan vested through 2010 and expire ten years from the date of grant. Our non-employee directors, officers and key employees are eligible to participate in the 2005 Plan. The 2005 Plan allows for the issuance of, among other things, stock options, restricted stock, deferred stock units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years. Options expire ten years from the date of grant.  Stock-based compensation expense totaled $9,054,000 for the three months ended March 31, 2015 and $7,667,000 for the same period in 2014. 

19

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

15. Earnings Per Share

     The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

		Three Months Ended
		March 31,
		2015		2014
Numerator for basic and diluted earnings
	per share - net income (loss) attributable
	to common stockholders	$	190,799	$	50,022
Denominator for basic earnings per
	share - weighted average shares		336,754		289,606
Effect of dilutive securities:
	Employee stock options		200		148
	Non-vested restricted shares		416		540
	Convertible senior unsecured notes		442		623
Dilutive potential common shares			1,058		1,311
Denominator for diluted earnings per
	share - adjusted weighted average shares		337,812		290,917
Basic earnings per share		$	0.57	$	0.17
Diluted earnings per share		$	0.56	$	0.17

The Series I Cumulative Convertible Perpetual Preferred Stock was not included in the calculations as the effect of conversions into common stock was anti-dilutive.

16. Disclosure about Fair Value of Financial Instruments

U.S. GAAP provides authoritative guidance for measuring and disclosing fair value measurements of assets and liabilities.  The guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  The guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.  The guidance describes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014 for additional information.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.

Mortgage Loans and Other Real Estate Loans Receivable — The fair value of mortgage loans and other real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. 

Cash and Cash Equivalents — The carrying amount approximates fair value.

Available-for-sale Equity Investments — Available-for-sale equity investments are recorded at their fair value based on Level 1 publicly available trading prices.

20

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Borrowings Under Primary Unsecured Credit Facility — The carrying amount of the primary unsecured credit facility approximates fair value because the borrowings are interest rate adjustable.

Senior Unsecured Notes — The fair value of the fixed rate senior unsecured notes payable was estimated based on Level 1 publicly available trading prices. The carrying amount of variable rate senior unsecured notes payable approximates fair value because the borrowings are interest rate adjustable.

Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities.  The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable.

Foreign Currency Forward Contracts — Foreign currency forward contracts are recorded in other assets or other liabilities on the balance sheet at fair market value.  Fair market value is determined using Level 2 inputs by estimating the future value of the currency pair based on existing exchange rates, comprised of current spot and traded forward points, and calculating a present value of the net amount using a discount factor based on observable traded interest rates.

Redeemable OP Unitholder Interests — The fair value of our redeemable unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs.  The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances.

The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):

		March 31, 2015				December 31, 2014
		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
	Mortgage loans receivable	$	554,731	$	577,232	$	188,651	$	194,935
	Other real estate loans receivable		190,536		192,005		191,518		195,375
	Available-for-sale equity investments		46,740		46,740		-		-
	Cash and cash equivalents		202,273		202,273		473,726		473,726
	Foreign currency forward contracts		73,081		73,081		57,087		57,087
Financial liabilities:
	Borrowings under unsecured credit facilities	$	410,000	$	410,000	$	-	$	-
	Senior unsecured notes		7,518,196		8,378,885		7,766,251		8,613,702
	Secured debt		3,010,971		2,993,308		2,977,713		3,053,067
	Foreign currency forward contracts		410		410		1,495		1,495
Redeemable OP unitholder interests			47,147		47,147		46,722		46,722

Items Measured at Fair Value on a Recurring Basis

The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis.  The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):

21

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

	Fair Value Measurements as of March 31, 2015
	Total		Level 1		Level 2		Level 3
Available-for-sale equity investments(1)	$	46,740	$	46,740	$	-	$	-
Foreign currency forward contracts, net(2)		72,671		-		72,671		-
Redeemable OP unitholder interests		47,147		-		47,147		-
Totals	$	166,558		46,740	$	119,818	$	-
(1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.
(2) Please see Note 11 for additional information.

Items Measured at Fair Value on a Nonrecurring Basis

In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis.  As these assets and liabilities are not measured at fair value on a recurring basis, they are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired/assumed in business combinations (see Note 3) and asset impairments (if applicable, see Note 5 for impairments of real property and Note 6 for impairments of loans receivable). We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally reside within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates.  We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value.  We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above.  We estimate the fair value of secured debt assumed in business combinations using current interest rates at which similar borrowings could be obtained on the transaction date.

17. Segment Reporting

We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our four operating segments: triple-net, seniors housing operating, outpatient medical and life science.  During the quarter ended March 31, 2015, we changed the names of our seniors housing triple-net segment to triple-net and our medical facilities segment to outpatient medical.

     Our triple-net properties include long-term/post-acute care facilities, hospitals, assisted living facilities, independent living/continuing care retirement communities, care homes (United Kingdom), independent support living facilities (Canada), care homes with nursing (United Kingdom) and combinations thereof. Under the triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our seniors housing operating properties include the seniors housing communities referenced above that are owned and/or operated through RIDEA structures (see Notes 3 and 18).

     Our outpatient medical properties include medical office buildings and life science buildings which are aggregated into our outpatient medical reportable segment. Our medical office buildings are typically leased to multiple tenants and generally require a certain level of property management.  Our life science investment represents an investment in an unconsolidated entity (see Note 7). 

          We evaluate performance based upon NOI by segment. We define NOI as total revenues, including tenant reimbursements, less property level operating expenses. We believe NOI provides investors relevant and useful information because it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.    

     Non-segment revenue consists mainly of interest income on non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.

     The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and

22

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

are components of the appropriate segments.  There are no intersegment sales or transfers.

     Summary information for the reportable segments is as follows for the periods presented (in thousands):

Three Months Ended March 31, 2015:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	264,406	$	-	$	115,181	$	-	$	379,587
Resident fees and services		-		492,510		-		-		492,510
Interest income		14,699		1,031		1,264		-		16,994
Other income		3,883		1,020		161		22		5,086
Total revenues		282,988		494,561		116,606		22		894,177
Property operating expenses		-		338,507		37,954		-		376,461
Net operating income from continuing operations		282,988		156,054		78,652		22		517,716
Reconciling items:
Interest expense		10,027		34,458		7,625		68,970		121,080
Loss (gain) on derivatives, net		(58,427)		-		-		-		(58,427)
Depreciation and amortization		70,031		76,636		42,162		-		188,829
General and administrative		-		-		-		35,138		35,138
Transaction costs		36,172		12,042		341		-		48,555
Loss (gain) on extinguishment of debt, net		10,336		-		-		5,064		15,400
Impairment of assets		2,220		-		-		-		2,220
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		212,629		32,918		28,524		(109,150)		164,921
Income tax expense		418		(533)		466		(48)		303
(Loss) income from unconsolidated entities		1,393		(15,073)		1,032		-		(12,648)
Income (loss) from continuing operations		214,440		17,312		30,022		(109,198)		152,576
Gain (loss) on real estate dispositions, net		54,097		-		2,749		-		56,846
Net income (loss)	$	268,537	$	17,312	$	32,771	$	(109,198)	$	209,422
Total assets	$	11,916,636	$	10,208,763	$	4,444,058	$	59,938	$	26,629,395

23

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Three Months Ended March 31, 2014:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	237,716	$	-	$	98,739	$	-	$	336,455
Resident fees and services		-		456,265		-		-		456,265
Interest income		7,720		-		874		-		8,594
Other income		144		54		280		15		493
Total revenues		245,580		456,319		99,893		15		801,807
Property operating expenses		243		308,184		33,004		-		341,431
Net operating income from continuing operations		245,337		148,135		66,889		15		460,376
Reconciling items:
Interest expense		9,115		27,479		9,383		74,856		120,833
Depreciation and amortization		67,269		129,162		36,887		-		233,318
General and administrative		-		-		-		32,865		32,865
Transaction costs		275		630		47		-		952
Loss (gain) on extinguishment of debt, net		-		(148)		-		-		(148)
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		168,678		(8,988)		20,572		(107,706)		72,556
Income tax expense		(355)		(1,643)		(262)		-		(2,260)
(Loss) income from unconsolidated entities		1,382		(7,961)		1,023		-		(5,556)
Income (loss) from continuing operations		169,705		(18,592)		21,333		(107,706)		64,740
Income (loss) from discontinued operations		460		-		-		-		460
Net income (loss)	$	170,165	$	(18,592)	$	21,333	$	(107,706)	$	65,200

		Three Months Ended
		March 31, 2015			March 31, 2014
Revenues:		Amount	%		Amount	%
United States	$	745,136	83.3%	$	675,099	84.2%
International		149,041	16.7%		126,708	15.8%
Total	$	894,177	100.0%	$	801,807	100.0%
		As of
		March 31, 2015			December 31, 2014
Assets:		Amount	%		Amount	%
United States	$	21,880,931	82.2%	$	20,728,477	82.9%
International		4,748,464	17.8%		4,285,819	17.1%
Total	$	26,629,395	100.0%	$	25,014,296	100.0%

24

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

18. Income Taxes and Distributions

     We elected to be taxed as a REIT commencing with our first taxable year.  To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of current year taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes.

Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.”  A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years. 

     Income tax expense reflected in the financial statements primarily represents U.S. federal and state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S.  In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure.  The structure includes a property holding company that is tax resident in the United Kingdom.  No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and all of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes.  The company reflects current and deferred tax liabilities for any such withholding taxes incurred as a result of this holding company structure in its consolidated financial statements. 

      The income tax benefit for the three month periods ended March 31, 2015 and 2014 is due primarily to operating income or losses at our TRS entities.  Net deferred tax liabilities with respect to our TRS entities totaled $13,771,000 and $12,451,000 as of March 31, 2015 and December 31, 2014, respectively, and related primarily to differences between the financial reporting and tax bases of fixed and intangible assets.

     Generally, given current statutes of limitations, we are subject to audit by the Internal Revenue Service (“IRS”) for the year ended December 31, 2011 and subsequent years and by state taxing authorities for the year ended December 31, 2010 and subsequent years.  The company and its subsidiaries are also subject to audit by the Canada Revenue Agency and provincial authorities generally for periods subsequent to our initial investments in Canada made in May 2012, by HM Revenue & Customs for periods subsequent to our initial investments in the United Kingdom made in August 2012 and by Luxembourg taxing authorities generally for periods subsequent to our establishment of certain Luxembourg-based subsidiaries during 2014.

      The balance of our unrecognized tax benefits as of March 31, 2015 and December 31, 2014 was $857,000.  The unrecognized tax benefits and related penalties, as currently accrued for, have an immaterial impact on the effective tax rate to the extent that they would be recognized.

25

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

EXECUTIVE SUMMARY
Company Overview      Business Strategy      Capital Market Outlook      Key Transactions in 2015      Key Performance Indicators, Trends and Uncertainties      Corporate Governance	27 27 28 28 29 31
LIQUIDITY AND CAPITAL RESOURCES
Sources and Uses of Cash      Off-Balance Sheet Arrangements      Contractual Obligations      Capital Structure	32 32 33 33
RESULTS OF OPERATIONS
Summary      Triple-net      Seniors Housing Operating      Outpatient Medical      Non-Segment/Corporate	34 35 37 39 41
OTHER
Non-GAAP Financial Measures      Other Disclosures      Critical Accounting Policies	42 46 49
Cautionary Statement Regarding Forward-Looking Statements	49

26

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following discussion and analysis is based primarily on the unaudited consolidated financial statements of Health Care REIT, Inc. for the periods presented and should be read together with the notes thereto contained in this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2014, including factors identified under the headings “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”  References herein to “we,” “us,” “our,” or the “company” refer to Health Care REIT, Inc. and its subsidiaries unless specifically noted otherwise.

Executive Summary

Company Overview

     Health Care REIT, Inc. is a real estate investment trust (“REIT”) that has been at the forefront of seniors housing and health care real estate since the company was founded in 1970.  We are an S&P 500 company headquartered in Toledo, Ohio. Our portfolio spans the full spectrum of seniors housing and health care real estate, including seniors housing communities, long-term/post-acute care facilities, medical office buildings, inpatient and outpatient medical centers and life science facilities. Our capital programs, when combined with comprehensive planning, development and property management services, make us a single-source solution for acquiring, planning, developing, managing, repositioning and monetizing real estate assets. 

     The following table summarizes our consolidated portfolio as of March 31, 2015 (dollars in thousands):

			Percentage of	Number of
Type of Property	NOI(1)		NOI	Properties
Triple-net	$	282,988	54.7%	731
Seniors housing operating		156,054	30.1%	342
Outpatient medical		78,652	15.2%	243
Totals	$	517,694	100.0%	1,316
(1) Excludes our share of investments in unconsolidated entities. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount.

Business Strategy

     Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in net operating income and portfolio growth. To meet these objectives, we invest across the full spectrum of seniors housing and health care real estate and diversify our investment portfolio by property type, relationship and geographic location.

     Substantially all of our revenues are derived from operating lease rentals, resident fees and services, and interest earned on outstanding loans receivable. These items represent our primary sources of liquidity to fund distributions and depend upon the continued ability of our obligors to make contractual rent and interest payments to us and the profitability of our operating properties. To the extent that our customers/partners experience operating difficulties and become unable to generate sufficient cash to make payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property. Our proactive and comprehensive asset management process for seniors housing properties generally includes review of monthly financial statements and other operating data for each property, review of obligor/partner creditworthiness, property inspections, and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. Our internal property management division actively manages and monitors the outpatient medical portfolio with a comprehensive process including tenant relations, lease expirations, the mix of health service providers, hospital/health system relationships, property performance, capital improvement needs, and market conditions among other things. In monitoring our portfolio, our personnel use a proprietary database to collect and analyze property-specific data. Additionally, we conduct extensive research to ascertain industry trends.  We evaluate the operating environment in each property’s market to determine the likely trend in operating performance of the facility.  When we identify unacceptable trends, we seek to mitigate, eliminate or transfer the risk. Through these efforts, we are generally able to intervene at an early stage to address any negative trends, and in so doing, support both the collectability of revenue and the value of our investment.

     In addition to our asset management and research efforts, we also structure our investments to help mitigate payment risk. Operating leases and loans are normally credit enhanced by guaranties and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other real estate loans, operating leases or agreements between us and the obligor and its affiliates.

27

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     For the three months ended March 31, 2015, rental income and resident fees and services represented 42% and 55%, respectively, of total revenues.  Substantially all of our operating leases are designed with escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.

     Our primary sources of cash include rent and interest receipts, resident fees and services, borrowings under our primary unsecured credit facility, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses and general and administrative expenses.  Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash.

     We also continuously evaluate opportunities to finance future investments.  New investments are generally funded from temporary borrowings under our primary unsecured credit facility, internally generated cash and the proceeds from investment dispositions. Our investments generate cash from net operating income and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under our primary unsecured credit facility, has historically been provided through a combination of the issuance of public debt and equity securities and the incurrence or assumption of secured debt.

     Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. It is also possible that investment dispositions may occur in the future. To the extent that investment dispositions exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any investment dispositions in new investments. To the extent that new investment requirements exceed our available cash on-hand, we expect to borrow under our primary unsecured credit facility. At March 31, 2015, we had $202,273,000 of cash and cash equivalents, $85,177,000 of restricted cash and $2,024,665,000 of available borrowing capacity under our primary unsecured credit facility.

Capital Market Outlook

     We believe the capital markets remain supportive of our investment strategy.  In July 2014, we closed on a new primary unsecured credit facility that further enhances our access to efficient capital and financial flexibility.  For the 15 months ended March 31, 2015, we raised over $4.7 billion in aggregate gross proceeds through the issuance of common stock and unsecured debt. The capital raised, in combination with available cash and borrowing capacity under our primary unsecured credit facility, supported $3.6 billion in pro rata gross new investments during 2014 and $2.2 billion during the three months ended March 31, 2015.  We expect attractive investment opportunities to remain available in the future as we continue to leverage the benefits of our relationship investment strategy.

Key Transactions in 2015

Capital.  In February 2015, we completed the public issuance of 19,550,000 shares of common stock at a price of $75.50 per share for approximate gross proceeds of $1,476,025,000. This was the largest overnight common stock offering and the highest offering price in our history. Also, during the three months ended March 31, 2015, we raised $58,547,000 through our dividend reinvestment program.

Investments.  The following summarizes our acquisitions and joint venture investments completed during the three months ended March 31, 2015 (dollars in thousands):

28

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Properties		Investment Amount(1)	Capitalization Rates(2)		Book Amount(3)
Triple-net	17	$	612,504	6.8%	$	607,822
Seniors housing operating	38		1,022,004	6.1%		1,192,282
Outpatient medical	1		10,300	6.5%		10,297
Totals	56	$	1,644,808	6.4%	$	1,810,401
(1) Represents stated pro rata purchase price including cash and any assumed debt but excludes fair value adjustments pursuant to U.S. GAAP.
(2) Represents annualized contractual or projected income to be received in cash divided by investment amounts.
(3) Represents amounts recorded on our books including fair value adjustments pursuant to U.S. GAAP.  See Notes 3, 6 and 7 to our unaudited consolidated financial statements for additional information.

Dispositions.  The following summarizes our property dispositions completed during the three months ended March 31, 2015 (dollars in thousands):

	Properties		Proceeds(1)	Capitalization Rates(2)		Book Amount(3)
Triple-net	11	$	165,095	8.4%	$	110,998
Outpatient medical	1		10,549	7.3%		9,422
Totals	12	$	175,644	8.3%	$	120,420
(1) Represents pro rata proceeds received upon disposition including any seller financing.
(2) Represents annualized contractual income that was being received in cash at date of disposition divided by disposition proceeds.
(3) Represents carrying value of assets at time of disposition. See Notes 5 and 6 to our unaudited consolidated financial statements for additional information.

Dividends. Our Board of Directors increased the annual cash dividend to $3.30 per common share ($0.825 per share quarterly), as compared to $3.18 per common share for 2014, beginning in February 2015.  The dividend declared for the quarter ended March 31, 2015 represents the 176^th consecutive quarterly dividend payment.

Key Performance Indicators, Trends and Uncertainties

     We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, concentration risk and credit strength. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.

Operating Performance. We believe that net income attributable to common stockholders (“NICS”) is the most appropriate earnings measure. Other useful supplemental measures of our operating performance include funds from operations (“FFO”), net operating income from continuing operations (“NOI”) and same store cash NOI (“SSCNOI”); however, these supplemental measures are not defined by U.S. generally accepted accounting principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations of FFO, NOI and SSCNOI. These earnings measures and their relative per share amounts are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies. The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands, except per share amounts):

29

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

		Three Months Ended
		March 31,		June 30,		September 30,		December 31,		March 31,
		2014		2014		2014		2014			2015
Net income (loss) attributable to common stockholders		$	50,022	$	71,829	$	136,255	$	188,636	$	190,799
Funds from operations			288,803		284,245		316,512		284,516		344,250
Net operating income from continuing operations			460,376		482,692		492,366		504,754		517,716
Same store cash net operating income			411,867		424,197		428,268		425,669		419,110
Per share data (fully diluted):
	Net income (loss) attributable to common stockholders	$	0.17	$	0.24	$	0.44	$	0.58	$	0.57
	Funds from operations		0.99		0.95		1.01		0.86		1.02

Concentration Risk. We evaluate our concentration risk in terms of NOI by property mix, relationship mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our NOI could be at risk if certain sectors were to experience downturns.  Property mix measures the portion of our NOI that relates to our various property types. Relationship mix measures the portion of our NOI that relates to our top five relationships. Geographic mix measures the portion of our NOI that relates to our top five states (or international equivalents). The following table reflects our recent historical trends of concentration risk by NOI as of the date indicated below:

		March 31,	June 30,	September 30,	December 31,	March 31,
		2014	2014	2014	2014	2015
Property mix:(1)
	Triple-net	53%	53%	53%	53%	55%
	Seniors housing operating	32%	33%	33%	32%	30%
	Outpatient medical	15%	14%	14%	15%	15%
Relationship mix:(1)
	Genesis Healthcare	15%	16%	16%	16%	17%
	Sunrise Senior Living(2)	15%	15%	16%	15%	14%
	Brookdale Senior Living	9%	9%	8%	8%	8%
	Benchmark Senior Living	4%	4%	4%	4%	4%
	Revera(2)	4%	4%	5%	4%	4%
	Remaining relationships	53%	52%	51%	53%	53%
Geographic mix:(1)
	California	10%	10%	10%	10%	10%
	United Kingdom	7%	6%	7%	7%	8%
	New Jersey	8%	8%	9%	8%	8%
	Texas	7%	7%	7%	7%	7%
	Pennsylvania	5%	5%	5%	5%	6%
	Remaining geographic areas	63%	64%	62%	63%	61%
(1) Excludes our share of investments in unconsolidated entities.  Entities in which the company has a joint venture with a minority partner are shown at 100% of the joint venture amount.
(2) Revera owns a controlling interest in Sunrise.

     Credit Strength. We measure our credit strength both in terms of leverage ratios and coverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt. The coverage ratios indicate our ability to service interest and fixed charges (interest, secured debt principal amortization and preferred dividends). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain compliance with our debt covenants. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”) which is discussed in further detail, and reconciled to net income, below in

30

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

“Non-GAAP Financial Measures.” Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented:

		Three Months Ended
		March 31,	June 30,	September 30,	December 31,	March 31,
		2014	2014	2014	2014	2015
Debt to book capitalization ratio		48%	45%	43%	45%	42%
Debt to undepreciated book
	capitalization ratio	43%	40%	38%	40%	38%
Debt to market capitalization ratio		37%	33%	32%	29%	28%
Interest coverage ratio		3.45x	3.51x	3.86x	4.29x	4.21x
Fixed charge coverage ratio		2.74x	2.77x	3.07x	3.39x	3.34x

     Lease Expirations. The following table sets forth information regarding lease expirations for certain portions of our portfolio as of March 31, 2015 (dollars in thousands):

			Expiration Year
			2015		2016		2017		2018		2019		2020		2021		2022		2023		2024		Thereafter
Triple-net:
	Properties		13		-		33		51		3		12		26		41		14		21		485
	Base rent(1)	$	26,583	$	-	$	14,907	$	37,421	$	2,973	$	14,900	$	38,640	$	36,735	$	19,591	$	45,752	$	884,451
	% of base rent		2.4%		0.0%		1.3%		3.3%		0.3%		1.3%		3.4%		3.3%		1.7%		4.1%		78.8%
	Units/beds		1,143		-		1,467		3,151		235		1,076		3,805		5,144		1,464		2,254		53,165
	% of Units/beds		1.6%		0.0%		2.0%		4.3%		0.3%		1.5%		5.2%		7.1%		2.0%		3.1%		72.9%
Outpatient medical:
	Square feet		551,708		939,097		1,212,299		947,840		1,094,263		1,049,196		1,103,054		2,148,033		1,164,307		1,378,599		3,186,302
	Base rent(1)	$	12,868	$	19,915	$	28,346	$	23,178	$	27,879	$	23,496	$	26,484	$	45,323	$	24,441	$	38,147	$	74,625
	% of base rent		3.7%		5.8%		8.2%		6.7%		8.1%		6.8%		7.7%		13.1%		7.1%		11.1%		21.7%
	Leases		200		203		252		201		215		131		129		144		82		104		102
	% of Leases		11.3%		11.5%		14.3%		11.4%		12.2%		7.4%		7.3%		8.2%		4.7%		5.9%		5.8%
(1) The most recent monthly base rent including straight line for leases with fixed escalators or annual cash rents for leases with contingent escalators.  Base rent does not include tenant recoveries or amortization of above and below market lease intangibles.

     We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Cautionary Statement Regarding Forward-Looking Statements” and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2014, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of these risk factors.

Corporate Governance

     Maintaining investor confidence and trust is important in today’s business environment. Our Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on the Internet at www.hcreit.com/investor-relations/governance.  The information on our website is not incorporated by reference in this Quarterly Report on Form 10-Q, and our web address is included as an inactive textual reference only.

31

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Liquidity and Capital Resources

Sources and Uses of Cash

     Our primary sources of cash include rent and interest receipts, resident fees and services, borrowings under our primary unsecured credit facility, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, and general and administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below.  The following is a summary of our sources and uses of cash flows (dollars in thousands):

		Three Months Ended				Change
		March 31, 2015		March 31, 2014		$		%
Cash and cash equivalents at beginning of period		$	473,726	$	158,780	$	314,946	198%
Cash provided from (used in):
Operating activities			226,182		258,661		(32,479)	-13%
Investing activities			(1,809,768)		(351,391)		(1,458,377)	415%
Financing activities			1,312,823		119,597		1,193,226	998%
Effect of foreign currency translation on cash and cash equivalents			(690)		281		(971)	n/a
	Cash and cash equivalents at end of period	$	202,273	$	185,928	$	16,345	9%

Operating Activities. The change in net cash provided from operating activities is primarily attributable to increases in NOI, which is primarily due to acquisitions.  Please see “Results of Operations” for further discussion. For the three months ended March 31, 2015, cash distributions to stockholders exceeded cash flow provided from operations. The sources of funds for these excess distributions was available cash on hand, which was $473,726,000 at December 31, 2014 and $202,273,000 at March 31, 2015.  For the three months ended March 31, 2014, cash flow provided from operations exceeded cash distributions to stockholders.

Investing Activities.  The changes in net cash used in investing activities are primarily attributable to net changes in real property investments, real estate loans receivable and investments in unconsolidated entities, which are summarized above in “Key Transactions in 2015” and Notes 3, 6 and 7 of our unaudited consolidated financial statements.The following is a summary of cash used in non-acquisition capital improvement activities (dollars in thousands):

	Three Months Ended				Change
	March 31,		March 31,
	2015		2014		$		%
New development	$	59,552	$	52,717	$	6,835	13%
Recurring capital expenditures, tenant improvements and lease commissions		10,485		12,392		(1,907)	-15%
Renovations, redevelopments and other capital improvements		19,343		15,014		4,329	29%
Total	$	89,380	$	80,123	$	9,257	12%

    The change in new development is primarily due to the number and size of construction projects on-going during the relevant periods.  Renovations, redevelopments and other capital improvements include expenditures to maximize property value, increase net operating income, maintain a market-competitive position and/or achieve property stabilization.  Generally, these expenditures have increased as a result of acquisitions, primarily in our seniors housing operating segment.

      Financing Activities.  The changes in net cash provided from financing activities are primarily attributable to changes related to our long-term debt arrangements, the issuance/conversion of common and preferred stock and dividend payments. Please refer to Notes 9, 10 and 13 of our unaudited consolidated financial statements for additional information.

Off-Balance Sheet Arrangements

     At March 31, 2015, we had investments in unconsolidated entities with our ownership ranging from 10% to 50%. Please see Note 7 to our unaudited consolidated financial statements for additional information.  We use financial derivative instruments to hedge

32

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

interest rate and foreign currency exchange rate exposure. Please see Note 11 to our unaudited consolidated financial statements for additional information.  At March 31, 2015, we had seven outstanding letter of credit obligations. Please see Note 12 to our unaudited consolidated financial statements for additional information.

Contractual Obligations

     The following table summarizes our payment requirements under contractual obligations as of March 31, 2015 (in thousands):

	Payments Due by Period
Contractual Obligations	Total		2015		2016-2017		2018-2019		Thereafter
Unsecured revolving credit facility(1)	$	410,000	$	-	$	-	$	410,000	$	-
Senior unsecured notes and credit facilities:(2)
U.S. Dollar senior unsecured notes		5,311,311		-		1,150,000		1,050,000		3,111,311
Pounds Sterling senior unsecured notes(3)		1,559,460		-		-		-		1,559,460
U.S. Dollar term credit facility		500,000		-		-		500,000		-
Canadian Dollar term credit facility(3)		197,150		-		-		197,150		-
Secured debt:(2,3)
Consolidated		2,972,658		332,035		872,620		816,194		951,809
Unconsolidated		686,005		35,435		131,029		67,494		452,047
Contractual interest obligations:(4)
Unsecured revolving credit facility		4,522		-		-		4,522		-
Senior unsecured notes and term loans(3)		3,386,089		241,601		619,967		520,362		2,004,159
Consolidated secured debt(3)		659,921		107,417		217,280		123,208		212,016
Unconsolidated secured debt(3)		184,022		19,521		45,743		36,812		81,946
Capital lease obligations(5)		102,117		3,548		9,464		9,012		80,093
Operating lease obligations(5)		948,535		11,310		30,225		30,361		876,639
Purchase obligations(5)		415,087		77,363		329,627		6,666		1,431
Other long-term liabilities(6)		6,759		1,106		2,950		2,703		-
Total contractual obligations	$	17,343,636	$	829,336	$	3,408,905	$	3,774,484	$	9,330,911
(1) Relates to unsecured revolving credit facility with an aggregate commitment of $2,500,000,000. See Note 9 to our unaudited consolidated financial statements for additional information.
(2) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(3) Based on foreign currency exchange rates in effect as of balance sheet date.
(4) Based on variable interest rates in effect as of balance sheet date.
(5) See Note 12 to our unaudited consolidated financial statements for additional information.
(6) Primarily relates to payments to be made under our Supplemental Executive Retirement Plan.

Capital Structure

          Please refer to “Credit Strength” above for a discussion of our leverage and coverage ratio trends.  Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2015, we were in compliance with all of the covenants under our debt agreements. Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our primary unsecured credit facility, the ratings on our senior unsecured notes are used to determine the fees and interest charged.  A summary of certain covenants and our results as of March 31, 2015 is as follows:

33

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

	Per Agreement
	Primary Unsecured Credit Facility	Senior Unsecured Notes	Actual at
Covenant			March 31, 2015
Total Indebtedness to Book Capitalization Ratio maximum	60%	n/a	42%
Secured Indebtedness to Total Assets Ratio maximum	30%	40%	11%
Total Indebtedness to Total Assets maximum	n/a	60%	41%
Unsecured Debt to Unencumbered Assets maximum	60%	n/a	37%
Adjusted Interest Coverage Ratio minimum	n/a	1.50x	4.09x
Adjusted Fixed Charge Coverage minimum	1.50x	n/a	3.24x

     We plan to manage the company to maintain compliance with our debt covenants and with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the rating agencies could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.

     On May 1, 2015, we filed with the Securities and Exchange Commission (the “SEC”) (1) an open-ended automatic or “universal” shelf registration statement covering an indeterminate amount of future offerings of debt securities, common stock, preferred stock, depositary shares, warrants and units and (2) a registration statement in connection with our enhanced dividend reinvestment plan under which we may issue up to 15,000,000 shares of common stock. As of May 1, 2015, 15,000,000 shares of common stock remained available for issuance under this registration statement. We have entered into separate Equity Distribution Agreements with each of UBS Securities LLC, RBS Securities Inc., KeyBanc Capital Markets Inc. and Credit Agricole Securities (USA) Inc. relating to the offer and sale from time to time of up to $630,015,000 aggregate amount of our common stock (“Equity Shelf Program”). As of May 1, 2015, we had $457,112,000 of remaining capacity under the Equity Shelf Program. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our primary unsecured credit facility.

Results of Operations

Summary

Our primary sources of revenue include rent and resident fees and services. Our primary expenses include interest expense, depreciation and amortization, property operating expenses, transaction costs and general and administrative expenses. We evaluate our business and make resource allocations on our three business segments: triple-net, seniors housing operating and outpatient medical. The primary performance measures for our properties are NOI and SSCNOI, which are discussed below.  Please see Note 17 to our unaudited consolidated financial statements for additional information. The following is a summary of our results of operations (dollars in thousands, except per share amounts):

	Three Months Ended				Change
	March 31,		March 31,
	2015		2014		Amount		%
Net income (loss) attributable to common stockholders	$	190,799	$	50,022	$	140,777	281%
Funds from operations		344,250		288,803		55,447	19%
EBITDA		519,027		421,734		97,293	23%
Net operating income from continuing operations (NOI)		517,716		460,376		57,340	12%
Same store cash NOI		419,110		411,867		7,243	2%
Per share data (fully diluted):
Net income (loss) attributable to common stockholders	$	0.56	$	0.17	$	0.39	229%
Funds from operations	$	1.02	$	0.99	$	0.03	3%
Interest coverage ratio		4.21x		3.24x		0.97x	30%
Fixed charge coverage ratio		3.34x		2.56x		0.78x	30%

34

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Triple-net

     The following is a summary of our NOI for the triple-net segment (dollars in thousands):

	Three Months Ended					Change
		March 31,		March 31,
		2015		2014		$		%
SSCNOI(1)		$	207,224		200,740	$	6,484	3%
Non-cash NOI attributable to same store properties(1)			18,519		9,277		9,242	100%
NOI attributable to non same store properties(2)			57,244		35,320		21,924	62%
NOI		$	282,988	$	245,337	$	37,651	15%
(1) Change is due to increases in cash and non-cash NOI (described below) related to 586 same store properties.
(2) Change is primarily due to the acquisition of 118 properties and the conversion of 10 construction projects into revenue-generating properties subsequent to January 1, 2014.

     The following is a summary of our results of operations for the triple-net segment (dollars in thousands):

			Three Months Ended				Change
			March 31,		March 31,
			2015		2014		$		%
Revenues:
	Rental income		$	264,406	$	237,716	$	26,690	11%
	Interest income			14,699		7,720		6,979	90%
	Other income			3,883		144		3,739	2597%
				282,988		245,580		37,408	15%
Property operating expenses				-		243		(243)	-100%
		Net operating income from continuing operations (NOI)		282,988		245,337		37,651	15%
Other expenses:
	Interest expense			10,027		9,115		912	10%
	Loss (gain) on derivatives, net			(58,427)		-		(58,427)	n/a
	Depreciation and amortization			70,031		67,269		2,762	4%
	Transaction costs			36,172		275		35,897	13053%
	Loss (gain) on extinguishment of debt, net			10,336		-		10,336	n/a
	Impairment of assets			2,220		-		2,220	n/a
				70,359		76,659		(6,300)	-8%
Income from continuing operations before income taxes and income (loss) from unconsolidated entities				212,629		168,678		43,951	26%
Income tax benefit (expense)				418		(355)		773	n/a
Income (loss) from unconsolidated entities				1,393		1,382		11	1%
Income from continuing operations				214,440		169,705		44,735	26%
Discontinued operations, net(1)				-		460		(460)	-100%
Gain (loss) on real estate dispositions, net(1)				54,097		-		54,097	n/a
Net income				268,537		170,165		98,372	58%
Less: Net income (loss) attributable to noncontrolling interests				454		510		(56)	-11%
Net income attributable to common stockholders			$	268,083	$	169,655	$	98,428	58%
(1) See Note 5 to our unaudited consolidated financial statements.

     The increase in rental income is primarily attributable to the acquisitions of new properties, the conversion of newly constructed triple-net properties from which we receive rent and the modification of our lease with Genesis Healthcare to replace the CPI-based component of an annual increaser with a fixed annual increaser effective April 1, 2014. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties.  These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period.  If gross operating revenues at our facilities and/or the Consumer Price Index do

35

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

not increase, a portion of our revenues may not continue to increase.  Sales of real property would offset revenue increases and, to the extent that they exceed new acquisitions, could result in decreased revenues.  Our leases could renew above or below current rent rates, resulting in an increase or decrease in rental income.  For the three months ended March 31, 2015, we had no lease renewals but we had 35 leases with rental rate increasers ranging from 0.10% to 0.53% in our triple-net portfolio.

   The change in interest income is due to a higher loan volume in the current year, which includes a first mortgage loan to Genesis Healthcare to facilitate their merger with Skilled Healthcare Group.  The increase in other income over the prior year includes the receipt of an early prepayment fee related to a real estate loan receivable. 

    During the three months ended March 31, 2015, we completed triple-net expansion projects totaling $19,541,000.  The following is a summary of our triple-net construction projects, excluding expansions, pending as of March 31, 2015 (dollars in thousands):

Location	Units/Beds		Commitment		Balance	Est. Completion
Upper Providence, PA	96	$	29,367	$	26,325	2Q15
Mahwah, NJ	96		29,400		21,354	2Q15
Haddonfield, NJ	52		18,900		13,721	2Q15
Derby, UK	74		10,965		8,092	3Q15
Frederick, MD	130		19,000		13,370	3Q15
Carrollton, TX	104		18,900		3,219	1Q16
Tulsa, OK	145		25,800		2,457	1Q16
Bracknell, UK	64		14,941		6,153	2Q16
Edmond, OK	142		24,500		3,914	3Q16
Livingston, NJ	120		51,440		12,056	3Q16
Piscataway, NJ	124		30,600		16,042	3Q16
Raleigh, NC	225		93,000		20,605	4Q16
Total	1,372	$	366,813	$	147,308

     Interest expense for the three months ended March 31, 2015 and 2014 represents secured debt interest expense offset by interest allocated to discontinued operations.  The change in secured debt interest expense is due to the net effect and timing of assumptions, segment transitions, extinguishments and principal amortizations. The following is a summary of our triple-net property secured debt principal activity (dollars in thousands):

	Three Months Ended
	March 31, 2015			March 31, 2014
			Wtd. Avg.			Wtd. Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	670,769	5.337%	$	587,136	5.394%
Debt extinguished		(90,808)	4.089%		-	0.000%
Foreign Currency		(8,334)	5.316%		-	0.000%
Principal payments		(3,519)	5.621%		(2,773)	5.897%
Ending balance	$	568,108	5.562%	$	584,363	5.391%
Monthly averages	$	578,679	5.494%	$	585,355	5.391%

     In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare.  In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.  We elected to exercise our option during the three months ended March 31, 2015.

     Depreciation and amortization increased primarily as a result of new property acquisitions and the conversions of newly constructed investment properties. To the extent that we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly. 

36

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     Transaction costs represent costs incurred with property acquisitions including due diligence costs, fees for legal and valuation services, the termination of pre-existing relationships, lease termination expenses and other similar costs.  The increase in transaction costs over the prior year includes a charge related to the termination of pre-existing relationships, the termination of a lease obligation and overall higher transaction volume. The fluctuation in losses/gains on debt extinguishment is primarily attributable to the volume of extinguishments and the terms of the related secured debt. 

    Changes in the gain on sales of properties are related to property sales which totaled 11 and zero for the three months ended March 31, 2015 and 2014, respectively.  During the three months ended March 31, 2015, we recorded an impairment of $2,200,000 related to a land parcel that is considered held for sale.

Seniors Housing Operating

     The following is a summary of our NOI for the seniors housing operating segment (dollars in thousands):

	Three Months Ended					Change
		March 31,		March 31,
		2015		2014		$		%
SSCNOI(1)		$	147,271	$	148,284	$	(1,013)	-1%
Non-cash NOI attributable to same store properties			(251)		(266)		15	-6%
NOI attributable to non same store properties(2)			9,034		117		8,917	7621%
NOI		$	156,054	$	148,135	$	7,919	5%
(1) Relates to 279 same store properties. Decrease is primarily due to unfavorable changes in USD/CAD and GBP/USD rates.
(2) Change is primarily due to the acquisition of 63 properties subsequent to January 1, 2014.

The following is a summary of our seniors housing operating results of operations (dollars in thousands):

		Three Months Ended				Change
		March 31,		March 31,
		2015		2014		$		%
Revenues:
	Resident fees and services	$	492,510	$	456,265	$	36,245	8%
	Interest income		1,031		-		1,031	n/a
	Other income		1,020		54		966	1789%
			494,561		456,319		38,242	8%
Property operating expenses			338,507		308,184		30,323	10%
	Net operating income from continuing operations (NOI)		156,054		148,135		7,919	5%
Other expenses:								n/a
	Interest expense		34,458		27,479		6,979	25%
	Depreciation and amortization		76,636		129,162		(52,526)	-41%
	Transaction costs		12,042		630		11,412	1811%
	Loss (gain) on extinguishment of debt, net		-		(148)		148	-100%
			123,136		157,123		(33,987)	-22%
Income (loss) from continuing operations before income taxes and income (loss) from unconsolidated entities			32,918		(8,988)		41,906	n/a
Income tax benefit (expense)			(533)		(1,643)		1,110	-68%
Income (loss) from unconsolidated entities			(15,073)		(7,961)		(7,112)	89%
Net income (loss)			17,312		(18,592)		35,904	n/a
Less: Net income (loss) attributable to noncontrolling interests			1,273		(1,821)		3,094	n/a
Net income (loss) attributable to common stockholders		$	16,039	$	(16,771)	$	32,810	n/a

37

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     Fluctuations in revenues and property operating expenses are primarily a result of acquisitions subsequent to March 31, 2014 and the movement of U.S. and foreign currency exchange rates. The fluctuations in depreciation and amortization are due to acquisitions and variations in amortization of short-lived intangible assets. The decrease in depreciation and amortization for the three months ended March 31, 2015 as compared to the prior year is due primarily to a number of short lived intangible assets which were fully amortized recently. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. 

     The following is a summary of our seniors housing operating construction projects, excluding expansions, pending as of March 31, 2015 (dollars in thousands):

Location	Units/Beds		Commitment		Balance	Est. Completion
Edgbaston, UK	70	$	19,849	$	19,468	2Q15
Camberley, UK	102		20,606		11,926	4Q15
Total	172	$	40,455	$	31,394

Interest expense represents secured debt interest expense as well as interest expense related to our $250,000,000 Canadian-denominated unsecured term credit facility and Sterling-denominated senior unsecured notes. The increase in interest expense from the prior year is attributed primarily to the £500,000,000 Sterling-denominated senior unsecured notes issued in November 2014.  Please refer to Note 10 to our unaudited consolidated financial statements for additional information. The following is a summary of our seniors housing operating property secured debt principal activity (dollars in thousands):

	Three Months Ended
	March 31, 2015			March 31, 2014
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	1,654,531	4.422%	$	1,714,714	4.622%
Debt issued		82,724	2.336%		10,690	3.544%
Debt assumed		205,897	3.976%		-	0.000%
Debt extinguished		(82,961)	3.575%		(73,218)	5.883%
Foreign currency		(41,338)	3.686%		(15,905)	3.862%
Principal payments		(8,416)	4.327%		(8,513)	4.454%
Ending balance	$	1,810,437	4.356%	$	1,627,768	4.529%
Monthly averages	$	1,621,849	4.431%	$	1,687,910	4.596%

The increase in transaction costs in the current year is a result of increased acquisition and transaction volume in the current year.  The majority of our seniors housing operating properties are formed through partnership interests.  Net income attributable to noncontrolling interests for the three month periods ended March 31, 2015 and 2014 represents our partners’ share of net income (loss) related to joint ventures. The increased loss from unconsolidated entities is primarily due to depreciation and amortization of short-lived intangible assets and costs associated with new investments in unconsolidated entities subsequent to March 31, 2014. 

38

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Outpatient Medical

     The following is a summary of our NOI for the outpatient medical segment (dollars in thousands):

	Three Months Ended					Change
		March 31,		March 31,
		2015		2014		$		%
SSCNOI(1)		$	64,615	$	62,843	$	1,772	3%
Non-cash NOI attributable to same store properties(1)			1,287		2,188		(901)	-41%
NOI attributable to non same store properties(2)			12,750		1,858		10,892	586%
NOI		$	78,652	$	66,889	$	11,763	18%
(1) Change is due to increases in cash NOI and decreases in non-cash NOI related to 191 same store properties.
(2) Change is primarily due to acquisitions of 33 properties and conversions of construction projects into 10 revenue-generating properties subsequent to January 1, 2014.

     The following is a summary of our results of operations for the outpatient medical segment (dollars in thousands):

		Three Months Ended				Change
		March 31,		March 31,
		2015		2014		$		%
Revenues:
	Rental income	$	115,181	$	98,739	$	16,442	17%
	Interest income		1,264		874		390	45%
	Other income		161		280		(119)	-43%
			116,606		99,893		16,713	17%
Property operating expenses			37,954		33,004		4,950	15%
	Net operating income from continuing operations (NOI)		78,652		66,889		11,763	18%
Other expenses:
	Interest expense		7,625		9,383		(1,758)	-19%
	Depreciation and amortization		42,162		36,887		5,275	14%
	Transaction costs		341		47		294	626%
			50,128		46,317		3,811	8%
Income from continuing operations before income taxes and income from unconsolidated entities			28,524		20,572		7,952	39%
Income tax (expense) benefit			466		(262)		728	n/a
Income from unconsolidated entities			1,032		1,023		9	1%
Income from continuing operations			30,022		21,333		8,689	41%
Gain (loss) on real estate dispositions, net(1)			2,749		-		2,749	n/a
Net income (loss)			32,771		21,333		11,438	54%
Less: Net income (loss) attributable to noncontrolling interests			544		136		408	300%
Net income (loss) attributable to common stockholders		$	32,227	$	21,197	$	11,030	52%
(1) See Note 5 to our unaudited consolidated financial statements.

     The increase in rental income is primarily attributable to the acquisitions of new properties and the conversion of newly constructed outpatient medical properties from which we receive rent. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Sales of real property would offset revenue increases and, to the extent that they exceed new acquisitions, could result in decreased revenues. Our leases could renew above or below current rent rates, resulting in an increase or decrease in rental income.  For the three months ended March 31, 2015, our consolidated outpatient medical portfolio signed 80,975

39

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

square feet of new leases and 191,609 square feet of renewals.  The weighted-average term of these leases was five years, with a rate of $29.58 per square foot and tenant improvement and lease commission costs of $13.65 per square foot. Substantially all of these leases during the referenced quarter contain an annual fixed or contingent escalation rent structure ranging from the change in CPI to 5%. 

    During the three months ended March 31, 2015, we completed one outpatient medical construction project representing $16,592,000 or $325 per square foot. The following is a summary of the outpatient medical construction projects, excluding expansions, pending as of March 31, 2015 (dollars in thousands):

Location	Square Feet		Commitment		Balance	Est. Completion
Bel Air, MD	99,184	$	26,386	$	6,485	1Q16
Richmond, TX	36,475		11,670		2,100	1Q16
Brooklyn, NY	140,955		103,624		6,436	1Q17
Total	276,614	$	141,680	$	15,021

     Total interest expense represents secured debt interest expense. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. The following is a summary of our outpatient medical secured debt principal activity (dollars in thousands):

	Three Months Ended
	March 31, 2015			March 31, 2014
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	609,268	5.838%	$	700,427	5.999%
Debt extinguished		(18,658)	5.696%		(40,866)	5.463%
Principal payments		(3,375)	6.006%		(3,865)	5.976%
Ending balance	$	587,235	5.841%	$	655,696	6.036%
Monthly averages	$	597,895	5.839%	$	679,495	5.889%

     A portion of our outpatient medical properties were formed through partnerships. Net income attributable to noncontrolling interests represents our partners’ share of net income or loss relating to those partnerships where we are the controlling partner. The increase is primarily due to the earnings associated with investments made in the second half of 2014.

     The increase in property operating expenses and depreciation and amortization is primarily attributable to acquisitions and construction conversions of new outpatient medical facilities for which we incur certain property operating expenses.

     Transaction costs represent costs incurred with property acquisitions (including due diligence costs, fees for legal and valuation services and termination of pre-existing relationships computed based on the fair value of assets acquired), lease termination fees and other similar costs. The fluctuations in transaction costs are primarily due to acquisition volumes in the relevant periods.

   Income from unconsolidated entities represents our share of net income or losses related to our joint venture investment with Forest City Enterprises and certain unconsolidated property investments related to our strategic joint venture relationship with a national medical office building company.

40

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     Non-Segment/Corporate

     The following is a summary of our results of operations for the non-segment/corporate activities (dollars in thousands):

		Three Months Ended				Change
		March 31,		March 31,
		2015		2014		$		%
Revenues:
	Other income	$	22	$	15	$	7	47%
Expenses:
	Interest expense		68,970		74,856		(5,886)	-8%
	General and administrative		35,138		32,865		2,273	7%
	Loss on extinguishment of debt, net		5,064		-		5,064	n/a
			109,172		107,721		1,451	1%
Loss from continuing operations before income taxes			(109,150)		(107,706)		(1,444)	1%
Income tax (expense) benefit			(48)		-		(48)	n/a
Loss from continuing operations			(109,198)		(107,706)		(1,492)	1%
Less: Preferred stock dividends			16,352		16,353		(1)	0%
Net loss attributable to common stockholders		$	(125,550)	$	(124,059)	$	(1,491)	1%

     The following is a summary of our non-segment/corporate interest expense (dollars in thousands):

	Three Months Ended				Change
	March 31,		March 31,
	2015		2014		$		%
Senior unsecured notes	$	64,400	$	70,702	$	(6,302)	-9%
Secured debt		88		104		(16)	-15%
Primary unsecured credit facility		3,047		2,301		746	32%
Capitalized interest		(1,840)		(1,553)		(287)	18%
Swap loss (savings)		(4)		(4)		-	0%
Loan expense		3,279		3,306		(27)	-1%
Totals	$	68,970	$	74,856	$	(5,886)	-8%

The change in interest expense on senior unsecured notes is due to the net effect of issuances and extinguishments, excluding our Sterling-denominated senior unsecured notes, both of which are in our seniors housing operating segment.  Please refer to Note 10 to our unaudited consolidated financial statements for additional information.  We capitalize certain interest costs associated with funds used for the construction of properties owned directly by us. The amount capitalized is based upon the balances outstanding during the construction period using the rate of interest that approximates our cost of financing. Our interest expense is reduced by the amount capitalized.  Loan expense represents the amortization of deferred loan costs incurred in connection with the issuance and amendments of debt. Loan expense changes are due to amortization of charges for costs incurred in connection with senior unsecured note issuances.  The change in interest expense on the primary unsecured credit facility is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes.  Please refer to Note 9 of our unaudited consolidated financial statements for additional information regarding our primary unsecured credit facility.

     General and administrative expenses as a percentage of consolidated revenues for the three months ended March 31, 2015 and 2014 were 3.93% and 4.10%, respectively.  The increase in general and administrative expenses is primarily related to costs associated with our initiatives to attract and retain appropriate personnel to achieve our business objectives.  The loss on extinguishment of debt is due to the redemption of convertible senior notes. 

41

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Other

Non-GAAP Financial Measures

     We believe that net income, as defined by U.S. GAAP, is the most appropriate earnings measurement. However, we consider FFO, NOI and EBITDA to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means net income attributable to common stockholders, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.

     Net operating income from continuing operations (“NOI”) is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our seniors housing operating and medical facility properties.  These expenses include, but are not limited to, property-related payroll and benefits, property management fees, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance.  General and administrative expenses represent costs unrelated to property operations or transaction costs.  These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets.  Same store cash NOI (“SSCNOI”) is used to evaluate the cash-based operating performance of our properties under a consistent population which eliminates changes in the composition of our portfolio.  As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the reporting period subsequent to January 1, 2014.  Any properties acquired, developed, transitioned, sold or classified as held for sale during that period are excluded from the same store amounts.  We believe NOI and SSCNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOI and SSCNOI to make decisions about resource allocations and to assess the property level performance of our properties.

     EBITDA stands for earnings before interest, taxes, depreciation and amortization. We believe that EBITDA, along with net income and cash flow provided from operating activities, is an important supplemental measure because it provides additional information to assess and evaluate the performance of our operations. We primarily utilize EBITDA to measure our interest coverage ratio, which represents EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA divided by fixed charges. Fixed charges include total interest, secured debt principal amortization and preferred dividends. 

     A covenant in our primary unsecured credit facility contains a financial ratio based on a definition of EBITDA that is specific to that agreement. Failure to satisfy these covenants could result in an event of default that could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Due to the materiality of these debt agreements and the financial covenants, we have disclosed Adjusted EBITDA, which represents EBITDA as defined above and adjusted for stock-based compensation expense, provision for loan losses and gain/loss on extinguishment of debt. We use Adjusted EBITDA to measure our adjusted fixed charge coverage ratio, which represents Adjusted EBITDA divided by fixed charges on a trailing twelve months basis. Fixed charges include total interest (excluding capitalized interest and non-cash interest expenses), secured debt principal amortization and preferred dividends. Our covenant requires an adjusted fixed charge coverage ratio of at least 1.50 times.

     Other than Adjusted EBITDA, our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. Adjusted EBITDA is used solely to determine our compliance with a financial covenant in our primary unsecured credit facility and is not being presented for use by investors for any other purpose. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.

42

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The table below reflects the reconciliation of FFO to net income attributable to common stockholders, the most directly comparable U.S. GAAP measure, for the periods presented. Noncontrolling interest and unconsolidated entity amounts represent adjustments to reflect our share of depreciation and amortization.  Amounts are in thousands except for per share data.

		Three Months Ended
		March 31,		June 30,		September 30,		December 31,		March 31,
FFO Reconciliations:		2014		2014		2014		2014		2015
Net income (loss) attributable to common stockholders		$	50,022	$	71,829	$	136,255	$	188,636	$	190,799
Depreciation and amortization			233,318		214,449		200,970		195,393		188,829
Impairment of assets			-		-		-		-		2,220
Loss (gain) on sales of properties, net			-		(13,079)		(29,604)		(110,839)		(56,845)
Noncontrolling interests			(10,520)		(9,741)		(9,359)		(8,234)		(7,249)
Unconsolidated entities			15,983		20,787		18,250		19,560		26,496
Funds from operations		$	288,803	$	284,245	$	316,512	$	284,516	$	344,250
Average common shares outstanding:
	Basic		289,606		296,256		311,117		327,492		336,754
	Diluted		290,917		297,995		312,812		329,130		337,812
Per share data:
Net income attributable to
	common stockholders
	Basic	$	0.17	$	0.24	$	0.44	$	0.58	$	0.57
	Diluted		0.17		0.24		0.44		0.57		0.56
Funds from operations
	Basic	$	1.00	$	0.96	$	1.02	$	0.87	$	1.02
	Diluted		0.99		0.95		1.01		0.86		1.02

     The table below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Interest expense includes discontinued operations. Dollars are in thousands.

		Three Months Ended
		March 31,		June 30,		September 30,		December 31,		March 31,
EBITDA Reconciliations:		2014		2014		2014		2014		2015
Net income		$	65,200	$	87,854	$	152,771	$	206,474	$	209,422
Interest expense			120,956		121,099		118,435		120,707		121,080
Income tax expense (benefit)			2,260		1,569		(10,198)		5,101		(304)
Depreciation and amortization			233,318		214,449		200,970		195,393		188,829
EBITDA		$	421,734	$	424,971	$	461,978	$	527,675	$	519,027
Interest Coverage Ratio:
Interest expense		$	120,956	$	121,099	$	118,435	$	120,707	$	121,080
Non-cash interest expense			(330)		(1,649)		(547)		100		(119)
Capitalized interest			1,605		1,700		1,779		2,066		2,387
	Total interest		122,231		121,150		119,667		122,873		123,348
EBITDA		$	421,734	$	424,971	$	461,978	$	527,675	$	519,027
	Interest coverage ratio		3.45x		3.51x		3.86x		4.29x		4.21x
Fixed Charge Coverage Ratio:
Total interest		$	122,231	$	121,150	$	119,667	$	122,873	$	123,348
Secured debt principal payments			15,455		15,803		14,549		16,473		15,630
Preferred dividends			16,353		16,352		16,352		16,352		16,352
	Total fixed charges		154,039		153,305		150,568		155,698		155,330
EBITDA		$	421,734	$	424,971	$	461,978	$	527,675	$	519,027
	Fixed charge coverage ratio		2.74x		2.77x		3.07x		3.39x		3.34x

43

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Interest expense includes discontinued operations. Dollars are in thousands.

		Twelve Months Ended
Adjusted EBITDA		March 31,		June 30,		September 30,		December 31,		March 31,
Reconciliations:		2014		2014		2014		2014		2015
Net income		$	131,682	$	212,355	$	331,524	$	512,300	$	656,518
Interest expense			472,827		483,082		484,975		481,197		481,321
Income tax expense (benefit)			6,987		7,341		(5,934)		(1,267)		(3,832)
Depreciation and amortization			920,156		934,128		892,117		844,130		799,641
Stock-based compensation expense			17,336		29,320		29,635		32,075		33,462
Provision for loan losses			2,110		2,110		2,110		-		-
Loss (gain) on extinguishment of debt, net			(749)		(218)		6,542		9,558		25,108
Adjusted EBITDA		$	1,550,349	$	1,668,118	$	1,740,969	$	1,877,993	$	1,992,218
Adjusted Fixed Charge Coverage Ratio:
Interest expense		$	472,827	$	483,082	$	484,975	$	481,197	$	481,321
Capitalized interest			6,700		7,014		7,087		7,150		7,931
Non-cash interest expense			(880)		(1,292)		(2,790)		(2,427)		(2,215)
	Total interest		478,647		488,804		489,272		485,920		487,037
Adjusted EBITDA		$	1,550,349	$	1,668,118	$	1,740,969	$	1,877,993	$	1,992,218
	Adjusted interest coverage ratio		3.24x		3.41x		3.56x		3.86x		4.09x
Total interest		$	478,647	$	488,804	$	489,272	$	485,920	$	487,037
Secured debt principal payments			60,341		62,867		62,119		62,280		62,455
Preferred dividends			66,088		65,838		65,588		65,408		65,408
	Total fixed charges		605,076		617,509		616,979		613,608		614,900
Adjusted EBITDA		$	1,550,349	$	1,668,118	$	1,740,969	$	1,877,993	$	1,992,218
	Adjusted fixed charge coverage ratio		2.56x		2.70x		2.82x		3.06x		3.24x

44

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following tables reflect the reconciliation of NOI and SSCNOI to net income attributable to common stockholders, the most directly comparable U.S. GAAP measure, for the periods presented.  Dollars are in thousands.

			Three Months Ended
			March 31,		June 30,		September 30,		December 31,		March 31,
NOI Reconciliations:			2014		2014		2014		2014		2015
Total revenues:
	Triple-net		$	245,580	$	256,439	$	259,248	$	266,600	$	282,988
	Seniors housing operating			456,319		468,914		483,791		488,546		494,561
	Outpatient medical			99,893		101,017		104,378		112,144		116,606
	Non-segment/corporate			15		76		106		479		22
		Total revenues		801,807		826,446		847,523		867,769		894,177
Property operating expenses:
	Triple-net			243		447		41		-		-
	Seniors housing operating			308,184		310,029		320,895		327,200		338,507
	Outpatient medical			33,004		33,278		34,221		35,815		37,954
		Total property operating expenses		341,431		343,754		355,157		363,015		376,461
Net operating income:
	Triple-net			245,337		255,992		259,207		266,600		282,988
	Seniors housing operating			148,135		158,885		162,896		161,346		156,054
	Outpatient medical			66,889		67,739		70,157		76,329		78,652
	Non-segment/corporate			15		76		106		479		22
		NOI		460,376		482,692		492,366		504,754		517,716
Reconciling items:
	Interest expense			(120,833)		(121,065)		(118,435)		(120,707)		(121,080)
	Gain (loss) on derivatives, net			-		(351)		(49)		1,895		58,427
	Depreciation and amortization			(233,318)		(214,449)		(200,970)		(195,393)		(188,829)
	General and administrative			(32,865)		(51,660)		(30,803)		(27,616)		(35,138)
	Transaction costs			(952)		(7,040)		(13,554)		(47,991)		(48,554)
	Gain (loss) on extinguishment of debt, net			148		(531)		(2,692)		(6,484)		(15,401)
	Impairment of assets			-		-		-		-		(2,220)
	Other expenses			-		-		(10,262)		-		-
	Income tax benefit (expense)			(2,260)		(1,569)		10,198		(5,101)		304
	Income (loss) from unconsolidated entities			(5,556)		(11,516)		(2,632)		(7,722)		(12,648)
	Income (loss) from discontinued operations, net			460		6,675		-		-		-
	Gain (loss) on real estate dispositions, net			-		6,668		29,604		110,839		56,845
	Preferred dividends			(16,353)		(16,352)		(16,352)		(16,352)		(16,352)
	Loss (income) attributable to noncontrolling interests			1,175		327		(164)		(1,486)		(2,271)
				(410,354)		(410,863)		(356,111)		(316,118)		(326,917)
Net income (loss) attributable to common stockholders			$	50,022	$	71,829	$	136,255	$	188,636	$	190,799

45

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

					Three Months Ended
					March 31,		June 30,		September 30,		December 31,		March 31,
Same Store Cash NOI Reconciliations:					2014		2014		2014		2014		2015
Net operating income from continuing operations:
	Triple-net				$	245,337	$	255,992	$	259,207	$	266,600	$	282,988
	Seniors housing operating					148,135		158,885		162,896		161,346		156,054
	Outpatient medical					66,889		67,739		70,156		76,329		78,652
			Total			460,361		482,616		492,259		504,275		517,694
Adjustments:
	Triple-net:
		Non-cash NOI on same store properties				(9,277)		(15,622)		(16,638)		(16,496)		(18,520)
		NOI attributable to non same store properties				(35,320)		(36,884)		(38,265)		(44,482)		(57,243)
			Subtotal			(44,597)		(52,506)		(54,903)		(60,978)		(75,764)
	Seniors housing operating:
		Non-cash NOI on same store properties				(266)		(266)		(261)		(252)		(251)
		NOI attributable to non same store properties				117		1,705		2,432		5,386		9,034
			Subtotal			149		(1,439)		(2,171)		(5,134)		(8,783)
	Outpatient medical:
		Non-cash NOI on same store properties				(2,188)		(2,139)		(1,683)		(1,485)		(1,287)
		NOI attributable to non same store properties				(1,858)		(2,335)		(5,235)		(11,008)		(12,750)
			Subtotal			(4,046)		(4,474)		(6,917)		(12,494)		(14,037)
Same store cash net operating income:				Properties
	Triple-net			586		200,740		203,486		204,304		205,622		207,224
	Seniors housing operating			279		148,284		157,446		160,725		156,212		147,271
	Outpatient medical			191		62,843		63,265		63,239		63,835		64,615
			Total	1,056	$	411,867	$	424,197	$	428,268	$	425,669	$	419,110
Same Store Cash NOI Property Reconciliation:
	Total Properties			1,316
	Acquisitions			(214)
	Developments			(20)
	Held-for-sale			(13)
	Other(1)			(13)
		Same store properties		1,056
(1) Includes ten land parcels and three loans.

Other Disclosures

United States of America

Health Care Reimbursements

     Policy and legislative changes that increase or decrease government reimbursement impact our operators and tenants that participate in Medicare, Medicaid or other government programs.  The reimbursement methodologies applied to health care facilities continue to evolve.  To the extent that policy or legislative changes, or new reimbursement methodologies decrease government reimbursement to our operators and tenants, our revenue and operations may be indirectly adversely affected.

     Medicare Reimbursement and Physicians.  Until recently, the Centers for Medicare and Medicaid Services (“CMS”) annually adjusted the Medicare Physician Fee Schedule payment rates based on an update formula that included application of the Sustainable Growth Rate (“SGR”).  On April 1, 2014, President Obama signed into law the Protecting Access to Medicare Act of 2014, which

46

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

provided for a 0% update to the 2015 Medicare Physician Fee Schedule through March 31, 2015.  On November 13, 2014, CMS published the calendar year 2015 Physician Fee Schedule final rule, which, consistent with the Protecting Access to Medicare Act of 2014, called for a 0% update from January 1, 2015 through March 31, 2015 and a negative 21.2% update under the statutory SGR formula for April 1, 2015 through December 31, 2015.  However, on April 16, 2015, President Obama signed and enacted into law H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015, which, among other things:

·Repeals the SGR.

·Institutes a 0% update to the single conversion factor under the Medicare Physician Fee Schedule from January 1 through June 30, 2015, a 0.5% update for July 2015 through the end of 2019, and a 0% update for 2020 through 2025.  For 2026 and subsequent years, the update will be either 0.75% or 0.25%, depending in which Alternate Payment Model (“APM”) the physician participates. 

·Delays the Geographic Practice Cost Indices (“GPCI”) payment adjustment until January 1, 2018.

·Extends the therapy cap exceptions process through December 31, 2017.

·Imposes a market basket update of 1% for skilled nursing providers for FY 2018.

     Additionally, on April 6, 2015, CMS announced final 2016 payment rates for Medicare Advantage, with an expected average payment impact of 3.25%.  Changes in Medicare Advantage plan payments may indirectly affect our operators and tenants that contract with Medicare Advantage plans.

     CMS also issued several proposed rules which, if finalized, could impact our tenants and operators.  On April 15, 2015, CMS issued a proposed rule regarding FY 2016 Medicare payment rates for skilled nursing facilities (“SNFs”).  If finalized, CMS projects that aggregate payments to SNFs will increase by $500 million, or 1.4%, from payments in FY 2015.  On April 17, 2015, CMS also issued a proposed rule for the Hospital Inpatient Prospective Payment System and Long-Term Care Hospital (“LTCH”) Prospective Payment System that could increase payments to general acute care hospitals by 1.1% for FY 2016, if they participate in the Hospital Inpatient Quality Reporting Program and are meaningful electronic health record users.  For LTCHs, CMS projects that payments would decrease by 4.6%, or approximately $250 million, under the proposed rule. On April 23, 2015, CMS also issued a proposed rule regarding FY 2016 Medicare payment rates for inpatient rehabilitation facilities (“IRFs”).  If finalized, CMS projects that aggregate payments to IRFs will increase by $130 million, or 1.7%, from payments in FY 2015.

Other Health Care Initiatives

     Recent Quality Initiatives.  Recent government proposals have resulted in an increased emphasis by the government on the quality of care provided by providers.  For example, on February 27, 2015, CMS announced the establishment of a Health Care Payment Learning and Action Network as part of its plan to shift the Medicare program, and the healthcare system at large, toward paying providers based on quality, rather than the quantity of care they provide to patients.  Through the Learning and Action Network, CMS will work with private payers, employers, consumers, providers, states and state Medicaid programs, and other partners to expand alternative payment models into their programs.  To the extent this and similar measures impose additional obligations on our operators or tenants, or decrease the reimbursements that they receive, our revenues and operations may be indirectly adversely affected.

     The Department of Health and Human Services, Office of Inspector General (“OIG”) Recommendations Addressing SNF Billing.  In the OIG’s March 2015 Compendium of Priority Recommendations, a report that highlights the OIG’s previous recommendations for which corrective action has not been completed, the OIG cited its prior November 2012 report addressing questionable billing practices by SNFs.  The OIG recommended, among other things, changing the current method for determining how much therapy is needed to ensure appropriate payments, monitoring compliance with new therapy assessments, and improving accuracy of data submitted by SNFs.  If followed these reports and recommendations may impact our operators and tenants.

     Challenges to the Health Reform Laws.  Since the enactment of the Patient Protection and Affordable Care Act of 2010, as modified by the Health Care and Education Reconciliation Act of 2010 (collectively, the “Health Reform Laws”), there have been multiple attempts through legislative action and legal challenge to repeal or amend the Health Reform Laws, including the case that is currently pending before the U.S. Supreme Court, King v. Burwell, the outcome of which, depending on how the Supreme Court rules, could result in significant changes to the implementation of the Health Care Reform Laws.  We cannot predict whether any of these or future attempts to repeal or amend the Health Reform Laws will be successful, nor can we predict the impact that such a repeal or amendment would have on our operators or tenants and their ability to meet their obligations to us.

Canada

Licensing and Regulation

47

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Ontario. Retirement homes in Ontario are regulated under the Retirement Homes Act, 2010 (the “Act”).  A license is required to operate a retirement home.  Licenses must be applied for and are non-transferable.  Applications for licenses are directed to the Registrar of the Retirement Homes Regulatory Authority (“RHRA”). 

     The Act requires a report to the RHRA when any person has reasonable grounds to suspect abuse of a resident by anyone, or neglect of a resident by staff.  Following a report to the RHRA, there is a mandatory inspection carried out by the RHRA, which results in a report that is posted on the RHRA’s public website. The most recent report must also be posted in the subject home, and be readily available for review if requested thereafter.  The Registrar of the RHRA can receive complaints about a retirement home contravening a provision of the Act, and if such a complaint is received, it must be reviewed promptly.  The Registrar may ask the retirement home that is the subject of the complaint to provide information relevant to the complaint, and has the power to conduct an inspection, issue a written warning or take other action as prescribed in the regulations.

British Columbia.  The Community Care and Assisted Living Act, the Residential Care Regulation, and the Community Care and Assisted Living Regulation (together, the “B.C. Act”) regulate “community care facilities” (long-term care facilities) in substantially the same manner as retirement homes are regulated under the Ontario Act. The B.C. Act defines such a facility as premises used for the purpose of supervising vulnerable persons who require three or more prescribed services (from a list that includes regular assistance with activities of daily living; distribution of medication; management of cash resources; monitoring of food intake; structured behavior management and intervention; and psychosocial or physical rehabilitative therapy).

United Kingdom

Registration 

     In England, care home services are principally regulated by the Health and Social Care Act 2008 (the “Act”) and associated Regulations. The Act requires all persons carrying out “Regulated Activities” in England, and the managers of such persons, to be registered. Regulated Activities are defined in the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, as amended (the “2014 Regulations”), and include (among other activities):

·The provision of personal care for persons who, by reason of old age, illness or disability are unable to provide it for themselves, and which is provided in a place where those persons are living at the time the care is provided; and

·The provision of residential accommodation, together with nursing or personal care. 

     From April 1, 2015, the 2014 Regulations fully revoked the Health and Social Care Act 2008 (Regulated Activities) Regulations 2010 (the “2010 Regulations”) and while the 2014 Regulations introduce certain modifications with regard to service standards, the registration obligations under the Act remain.

Service Standards and Notification Obligations

     The 2014 Regulations aim to streamline the legal obligations in the 2010 Regulations, and replace them with a set of more broadly-phrased, legally binding “Fundamental Standards”. The 2014 Regulations list the standards that must be met when providing care services. The service providers’ legal obligations include:

·Care and treatment must be appropriate and reflect service user needs and preferences;

·Service users must be treated with dignity and respect;

·Care and treatment must only be provided with consent;

·Care and treatment must be provided in a safe way for service users;

·Service users must be protected from abuse and improper treatment;

·Service users nutritional and hydration needs must be met;

·All premises and equipment must be clean, secure, suitable and used properly;

·Complaints must be investigated and appropriate action taken;

·Systems and processes must be established to ensure compliance with fundamental standards;

·Sufficient numbers of suitably qualified, competent, skilled and experienced staff must be deployed;

·Persons employed must be of good character, having the necessary qualifications, skills and experience, and be able to perform the work for which they are employed;

·Health service bodies must be open and transparent with service users about their care and treatment. 

48

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     Failure to comply with certain provisions of the above Regulations is an offense, with a person guilty of the offense liable on summary conviction to a fine.  Monetary penalty notices may also be issued. The Regulations also include:

·Requirements around fit and proper persons being employed for the purposes of carrying of a regulated activity. Such persons must be of good character, have the qualifications, competence, skills and experience necessary and be able by reason of their health to perform their tasks. Recruitment procedures must also be established and effectively operated with certain specified information being available in relation to each person employed and registered where required; 

·A new “duty of candour” to notify and apologize to affected persons, in the event of certain incidents having actually or potentially led to the death of the service user, where the death relates directly to the incident rather than to the natural course of the service user's illness or underlying condition, or severe harm, moderate harm or prolonged psychological harm to the service user;

·A requirement for a service provider to display a performance assessment received as a rating of its performance by the Care Quality Commission (the “CQC”); and

·A requirement that registered persons have regard to guidance issued by the CQC and any code of practice from the Secretary of State in relation to prevention or control of health care associated infections.

     Under the Care Quality Commission (Registration) Regulations 2009 certain matters must be notified to the CQC, the government regulatory body overseeing the provision of nursing and other care services in England.  Failure to comply with notification obligations is an offense and a person guilty of an offense is liable on summary conviction to a fine of up to £2,500. 

Regulatory Oversight and Inspections

     The Act also sets out the powers and responsibilities of the CQC. Among other powers, the CQC administers the compulsory registration system and issues guidance to care service providers on how to comply with applicable standards set out in legislation. 

     The Care Act 2014 sets out certain provisions concerning (among others):

·The duty of a local authority to meet the needs of an adult for care and support and a carer’s needs where the registered care provider is unable to carry on a regulated activity because of business failure;

·The duty of the CQC to assess the financial sustainability of providers subject to its regulatory regime with a view to identifying any threats that such providers may face to their financial sustainability. Where the CQC identifies a significant risk to financial sustainability it can require the provider to develop a sustainability plan setting out the provider’s plan to mitigate or eliminate risk or require the provider to organize an independent review of the business with the costs being recovered from the provider;

·The CQC informing local authorities where a registered care provider is likely to become unable to carry on a regulated activity; and

·A new offense where certain registered care providers supply, publish or make available information that is false or misleading in a material respect, which can also apply to a director, manager or person purporting to act as such of a company.

Critical Accounting Policies

Our unaudited consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions.  Management considers an accounting estimate or assumption critical if:

·the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and

·the impact of the estimates and assumptions on financial condition or operating performance is material.

Management has discussed the development and selection of its critical accounting policies with the Audit Committee of the Board of Directors.  Management believes the current assumptions and other considerations used to estimate amounts reflected in our unaudited consolidated financial statements are appropriate and are not reasonably likely to change in the future.  However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change.  If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition.  Please refer to Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014 for further information regarding significant accounting policies that impact us.  There have been no material changes to these policies in 2015.

Cautionary Statement Regarding Forward-Looking Statements

    This Quarterly Report on Form 10-Q may contain “forward-looking” statements as defined in the Private Securities Litigation

49

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Reform Act of 1995. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. In particular, these forward-looking statements include, but are not limited to, those relating to the company’s opportunities to acquire, develop or sell properties; the company’s ability to close its anticipated acquisitions, investments or dispositions on currently anticipated terms, or within currently anticipated timeframes; the expected performance of the company’s operators/tenants and properties; the company’s expected occupancy rates; the company’s ability to declare and to make distributions to shareholders; the company’s investment and financing opportunities and plans; the company’s continued qualification as a real estate investment trust (“REIT”); the company’s ability to access capital markets or other sources of funds; and the company’s ability to meet its earnings guidance. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the company’s actual results to differ materially from the company’s expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care, seniors housing and life science industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; the company’s ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting the company’s properties; the company’s ability to re-lease space at similar rates as vacancies occur; the company’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting the company’s properties; changes in rules or practices governing the company’s financial reporting; the movement of U.S. and foreign currency exchange rates; the company’s ability to maintain its qualification as a REIT; and key management personnel recruitment and retention.  Other important factors are identified in the company’s Annual Report on Form 10-K for the year ended December 31, 2014, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, the company undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

     We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates. We seek to mitigate the underlying foreign currency exposures with gains and losses on derivative contracts hedging these exposures.  We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates and foreign currency exchange rates.

      We historically borrow on our primary unsecured credit facility to acquire, construct or make loans relating to health care and seniors housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under our primary unsecured credit facility.  We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.

      A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments’ change in fair value. The following table summarizes the analysis performed as of the dates indicated (in thousands):

50

	March 31, 2015				December 31, 2014
	Principal		Change in		Principal		Change in
	balance		fair value		balance		fair value
Senior unsecured notes	$	7,567,921	$	(513,398)	$	7,817,154	$	(547,358)
Secured debt		2,653,452		(84,794)		2,673,480		(93,580)
Totals	$	10,221,373	$	(598,192)	$	10,490,634	$	(640,938)

     Our variable rate debt, including our primary unsecured credit facility, is reflected at fair value. At March 31, 2015, we had $1,426,356,000 outstanding under our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $14,264,000.  At December 31, 2014, we had $983,783,000 outstanding under our variable rate debt.  Assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $9,838,000.

     We are subject to currency fluctuations that may, from time to time, affect our financial condition and results of operations. Increases or decreases in the value of the Canadian Dollar or Pounds Sterling relative to the U.S. Dollar impact the amount of net income we earn from our investments in Canada and the United Kingdom. Based solely on our results for the three months ended March 31, 2015, if these exchange rates were to increase or decrease by 100 basis points, our net income from these investments would decrease or increase, as applicable, by less than $1,000,000 annualized.  We seek to mitigate these underlying foreign currency exposures with non-U.S. denominated borrowings and gains and losses on derivative contracts hedging these exposures.  If we increase our international presence through investments in, or acquisitions or development of, seniors housing and health care properties outside the U.S., we may also decide to transact additional business or borrow funds in currencies other than U.S. Dollars, Canadian Dollars or Pounds Sterling. To illustrate the impact of changes in foreign currency markets, we performed a sensitivity analysis on our derivative portfolio whereby we modeled the change in net present values arising from a hypothetical 1% increase in foreign currency exchange rates to determine the instruments’ change in fair value.  The following table summarizes the results of the analysis performed (dollars in thousands):

	March 31, 2015				December 31, 2014
	Carrying		Change in		Carrying		Change in
	Value		fair value		Value		fair value
Foreign currency forward contracts(1)	$	60,700	$	4,889	$	54,247	$	4,242
Debt designated as hedges		1,756,610		13,000		1,851,189		13,000
Totals	$	1,817,310	$	17,889	$	1,905,436	$	17,242
(1) Amounts exclude cross currency hedge activity.

     For additional information regarding fair values of financial instruments, see “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” and Notes 11 and 16 to our unaudited consolidated financial statements.

Item 4. Controls and Procedures

     Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. No changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.  Legal Proceedings

51

     From time to time, there are various legal proceedings pending to which we are a party or to which some of our properties are subject arising in the normal course of business. We do not believe that the ultimate resolution of these proceedings will have a material adverse effect on our consolidated financial position or results of operations.

Item 1A. Risk Factors

     There have been no material changes from the risk factors identified under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities
Period	Total Number of Shares Purchased(1)	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
January 1, 2015 through January 31, 2015	58,241	$	83.04
February 1, 2015 through February 28, 2015	9,972		81.64
March 1, 2015 through March 31, 2015	289		75.59
Totals	68,502	$	82.80
(1) During the three months ended March 31, 2015, the company acquired shares of common stock held by employees who tendered owned shares to satisfy tax withholding obligations.
(2) No shares were purchased as part of publicly announced plans or programs.

Item 5. Other Information

None.

Item 6. Exhibits

3.1(a)         Certificate of Elimination of Junior Participating Preferred Stock, Series A, of the company (filed with the Securities and Exchange Commission as Exhibit 3.1(j) to the company’s Form 10-K filed February 20, 2015 (File No. 001-08923), and incorporated herein by reference thereto).

3.1(b)         Certificate of Elimination of 6% Series H Cumulative Convertible and Redeemable Preferred Stock of the company (filed with the Securities and Exchange Commission as Exhibit 3.1(k) to the company’s Form 10-K filed February 20, 2015 (File No. 001-08923), and incorporated herein by reference thereto).

10               Summary of Director Compensation (filed with the Securities and Exchange Commission as Exhibit 10.13 to the company’s Form 10-K filed February 20, 2015 (File No. 001-08923), and incorporated herein by reference thereto).*

12               Statement Regarding Computation of Ratio of Earnings to Fixed Charges and Ratio of Earnings to Combined Fixed Charges and Preferred Stock Dividends (Unaudited)

31.1            Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.

31.2            Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.

32.1            Certification pursuant to 18 U.S.C. Section 1350 by Chief Executive Officer.

32.2            Certification pursuant to 18 U.S.C. Section 1350 by Chief Financial Officer.

101.INS     XBRL Instance Document**

101.SCH   XBRL Taxonomy Extension Schema Document**

101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document**

101.LAB   XBRL Taxonomy Extension Label Linkbase Document**

101.PRE    XBRL Taxonomy Extension Presentation Linkbase Document**

101.DEF    XBRL Taxonomy Extension Definition Linkbase Document**

52

*

Management Contract or Compensatory Plan or Arrangement.

**

Attached as Exhibit 101 to this Quarterly Report on Form 10-Q are the following materials, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets at March 31, 2015 and December 31, 2014, (ii) the Consolidated Statements of Comprehensive Income for the three months ended March 31, 2015 and 2014, (iii) the Consolidated Statements of Equity for the three months ended March 31, 2015 and 2014, (iv) the Consolidated Statements of Cash Flows for the three months ended March 31, 2015 and 2014 and (v) the Notes to Unaudited Consolidated Financial Statements.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	HEALTH CARE REIT, INC.
Date: May 8, 2015	By:	/s/ THOMAS J. DEROSA
	Thomas J. DeRosa,
	Chief Executive Officer  (Principal Executive Officer)
Date: May 8, 2015	By:	/s/ SCOTT A. ESTES
	Scott A. Estes,
	Executive Vice President and Chief Financial Officer  (Principal Financial Officer)
Date: May 8, 2015	By:	/s/ PAUL D. NUNGESTER, JR.
	Paul D. Nungester, Jr.,
	Senior Vice President and Controller  (Principal Accounting Officer)

53

EX-12

 

EXHIBIT 12
STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES AND RATIO OF EARNINGS TO COMBINED FIXED CHARGES AND PREFERRED STOCK DIVIDENDS (UNAUDITED)
	Year Ended December 31,										Three Months Ended March 31,
(dollars in thousands)	2010		2011		2012		2013		2014		2014		2015
Earnings:
Pretax income from continuing operations before adjustment for income or loss from equity investees(1)	$	32,976	$	112,203	$	185,912	$	102,245	$	384,213	$	72,556	$	164,921
Fixed charges		134,905		290,240		359,947		460,918		485,762		122,108		123,348
Capitalized interest		(20,792)		(13,164)		(9,777)		(6,700)		(7,150)		(1,605)		(2,387)
Amortized premiums, discounts and capitalized expenses related to indebtedness		13,945		13,905		11,395		4,142		2,427		330		119
Noncontrolling interest in pre-tax income of subsidiaries that have not incurred fixed charges		(357)		4,894		2,415		6,770		(147)		1,175		(2,271)
Earnings	$	160,677	$	408,078	$	549,892	$	567,375	$	865,105	$	194,564	$	283,730
Fixed charges:
Interest expense(1)	$	128,058	$	290,981	$	361,565	$	458,360	$	481,039	$	120,833	$	121,080
Capitalized interest		20,792		13,164		9,777		6,700		7,150		1,605		2,387
Amortized premiums, discounts and capitalized expenses related to indebtedness		(13,945)		(13,905)		(11,395)		(4,142)		(2,427)		(330)		(119)
Fixed charges	$	134,905	$	290,240	$	359,947	$	460,918	$	485,762	$	122,108	$	123,348
Consolidated ratio of earnings to fixed charges		1.19		1.41		1.53		1.23		1.78		1.59		2.30
Earnings:
Pretax income from continuing operations before adjustment for income or loss from equity investees(1)	$	32,976	$	112,203	$	185,912	$	102,245	$	384,213	$	72,556	$	164,921
Fixed charges		134,905		290,240		359,947		460,918		485,762		122,108		123,348
Capitalized interest		(20,792)		(13,164)		(9,777)		(6,700)		(7,150)		(1,605)		(2,387)
Amortized premiums, discounts and capitalized expenses related to indebtedness		13,945		13,905		11,395		4,142		2,427		330		119
Noncontrolling interest in pre-tax income of subsidiaries that have not incurred fixed charges		(357)		4,894		2,415		6,770		(147)		1,175		(2,271)
Earnings	$	160,677	$	408,078	$	549,892	$	567,375	$	865,105	$	194,564	$	283,730
Fixed charges:
Interest expense(1)	$	128,058	$	290,981	$	361,565	$	458,360	$	481,039	$	120,833	$	121,080
Capitalized interest		20,792		13,164		9,777		6,700		7,150		1,605		2,387
Amortized premiums, discounts and capitalized expenses related to indebtedness		(13,945)		(13,905)		(11,395)		(4,142)		(2,427)		(330)		(119)
Fixed charges		134,905		290,240		359,947		460,918		485,762		122,108		123,348
Preferred stock dividends		21,645		60,502		69,129		66,336		65,408		16,353		16,352
Combined fixed charges and preferred stock dividends	$	156,550	$	350,742	$	429,076	$	527,254	$	551,170	$	138,461	$	139,700
Consolidated ratio of earnings to combined fixed charges and preferred stock dividends		1.03		1.16		1.28		1.08		1.57		1.41		2.03
(1) We have reclassified the income and expenses attributable to the properties sold prior to or held for sale at January 1, 2014 to discontinued operations.

EX-31.1

 

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Thomas J. DeRosa, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Health Care REIT, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2015

/s/ THOMAS J. DEROSA

Thomas J. DeRosa, 

Chief Executive Officer 

EX-31.2

 

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Scott A. Estes, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Health Care REIT, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2015

/s/ SCOTT A. ESTES

Scott A. Estes, 

Chief Financial Officer 

EX-32.1

 

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

          I, Thomas J. DeRosa, the Chief Executive Officer of Health Care REIT, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended March 31, 2015 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ THOMAS J. DEROSA

Thomas J. DeRosa, 

Chief Executive Officer

 Date: May 8, 2015

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

 

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

          I, Scott A. Estes, the Chief Financial Officer of Health Care REIT, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended March 31, 2015 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ SCOTT A. ESTES

Scott A. Estes, 

Chief Financial Officer

 Date: May 8, 2015 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Business (Details)	Mar. 31, 2015 Number properties
Business [Line Items]
Number of properties in diversified portfolio	1,316	[1]
Number of states in diversified portfolio	46
Controlling [Member]
Business [Line Items]
Number of properties in diversified portfolio	1,384

[1] (1)     Genesis Healthcare is in our triple-net segment. Sunrise Senior Living and Revera are in our seniors housing operating segment. Brookdale Senior Living and Benchmark Senior Living are in both our triple-net and seniors housing operating segments.

XML

Borrowings Under Credit Facilities and Related Items (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015 properties		Dec. 31, 2014	Mar. 31, 2014
Line Of Credit Facility [Line Items]
Unsecured line of credit arrangement	$ 2,500,000,000
Additional unsecured line of credit arrangement	1,000,000,000
Number of banks in consortium	28
Available to borrow in alternate currencies	500,000,000
Agent bank's prime rate of interest	1.103%
Interest Rate margin	0.925%
Annual facility fee for each bank based on commitment amount	0.15%
Debt instrument maturity date	Oct. 31, 2018
Balance outstanding at quarter end	410,000,000	[1]	0	562,000,000	[1]
Term Loan Interest Rate Margin	0.975%
HCN Term Loan	500,000,000
HCN Canadian Denomiated Term Loan	250,000,000
Borrowings under primary unsecured credit facilities, Carrying Value	410,000,000	[1]	0	562,000,000	[1]
Financial Stand by Letter Of Credit [Member]
Line Of Credit Facility [Line Items]
Balance outstanding at quarter end	65,335,000
Borrowings under primary unsecured credit facilities, Carrying Value	$ 65,335,000

[1] (1) As of March 31, 2015, letters of credit in the aggregate amount of $65,335,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Real Estate Loans Receivable (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Advances on real estate loans receivable:
Investments in new loans	$ 368,080,000	$ 1,203,000
Draws on existing loans	16,615,000	28,506,000
Net cash advances on real estate loans	384,695,000	29,709,000
Receipts on real estate loans receivable:
Loan payoffs	8,568,000	500,000
Principal payments on loans	7,933,000	10,146,000
Total receipts on real estate loans	16,501,000	10,646,000
Net advances (receipts) on real estate loans	368,194,000	19,063,000
Non Cash Decrease In Real Estate Loans Receivable	0
Change in balance due to foreign currency translation	(3,096,000)	192,000
Net change Real Estate Loans Receivable	365,098,000	19,255,000
Triple Net [Member]
Advances on real estate loans receivable:
Investments in new loans	368,080,000	1,203,000
Draws on existing loans	14,330,000	23,077,000
Net cash advances on real estate loans	382,410,000	24,280,000
Receipts on real estate loans receivable:
Loan payoffs	8,568,000	500,000
Principal payments on loans	7,933,000	10,127,000
Total receipts on real estate loans	16,501,000	10,627,000
Net advances (receipts) on real estate loans	365,909,000	13,653,000
Change in balance due to foreign currency translation	(3,096,000)	192,000
Net change Real Estate Loans Receivable	362,813,000	13,845,000
Outpatient Medical [Member]
Advances on real estate loans receivable:
Investments in new loans	0	0
Draws on existing loans	2,285,000	5,429,000
Net cash advances on real estate loans	2,285,000	5,429,000
Receipts on real estate loans receivable:
Loan payoffs	0	0
Principal payments on loans	0	19,000
Total receipts on real estate loans	0	19,000
Net advances (receipts) on real estate loans	2,285,000	5,410,000
Non Cash Decrease In Real Estate Loans Receivable	0
Change in balance due to foreign currency translation	0	0
Net change Real Estate Loans Receivable	$ 2,285,000	$ 5,410,000

XML

Disclosure about Fair Value of Financial Instruments (Details) (USD $)	Mar. 31, 2015		Dec. 31, 2014	Mar. 31, 2014		Dec. 31, 2013
Financial Assets:
Loans receivable, Carrying Amount	$ 745,267,000		$ 380,169,000
Available-for-sale equity investments, Carrying Amount	46,740,000		0
Available-for-sale equity investments, Fair Value	46,740,000	[1]	0
Cash and cash equivalents, Carrying Amount	202,273,000		473,726,000	185,928,000		158,780,000
Cash and cash equivalents, Fair Value	202,273,000		473,726,000
Foreign currency forward contract, asset	73,081,000		57,087,000
Financial Liabilities:
Borrowings under primary unsecured credit facilities, Carrying Value	410,000,000	[2]	0	562,000,000	[2]
Borrowings under primary unsecured credit facilities, Fair Value	410,000,000		0
Senior unsecured notes, Carrying Amount	7,518,196,000		7,766,251,000
Senior unsecured notes, Fair Value	8,378,885,000		8,613,702,000
Secured debt, Carrying Amount	3,010,971,000		2,977,713,000
Secured debt, Fair Value	2,993,308,000		3,053,067,000
Foreign currency forward contact, liability	410,000		1,495,000
Redeemable OP unitholder interests	47,147,000		46,722,000
Mortgage Loans on Real Estate [Member]
Financial Assets:
Loans receivable, Carrying Amount	554,731,000		188,651,000
Loans receivable, Fair value	577,232,000		194,935,000
Other Real Estate Loans Receivable [Member]
Financial Assets:
Loans receivable, Carrying Amount	190,536,000		191,518,000
Loans receivable, Fair value	$ 192,005,000		$ 195,375,000

[1] (1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.

[2] (1) As of March 31, 2015, letters of credit in the aggregate amount of $65,335,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Senior Unsecured Notes and Secured Debt (Details)	3 Months Ended		3 Months Ended								3 Months Ended
	Mar. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Mar. 31, 2015 Senior Unsecured Notes [Member] USD ($)		Mar. 31, 2015 Secured Debt [Member] USD ($)		Mar. 31, 2015 Canadian Denominated Unsecured Term Loan [Member] USD ($)	Mar. 31, 2015 Canadian Denominated Unsecured Term Loan [Member] CAD	Mar. 31, 2015 Canadian Denominated Unsecured Term Loan [Member] London Interbank Offered Rate (LIBOR) [Member]	Mar. 31, 2015 Unsecured Line of Credit Term Loan [Member] USD ($)	Mar. 31, 2015 UK Debt Due 2034 [Member] USD ($)	Mar. 31, 2015 UK Debt Due 2034 [Member] GBP (£)	Mar. 31, 2015 UK Debt Due 2028 [Member] USD ($)	Mar. 31, 2015 UK Debt Due 2028 [Member] GBP (£)	Mar. 31, 2015 Unsecured term credit facility [Member] USD ($)	Mar. 31, 2015 Unsecured term credit facility [Member] London Interbank Offered Rate (LIBOR) [Member]
Principal payments due on debt obligations
2015	$ 332,035,000		$ 0	[1],[2]	$ 332,035,000	[1],[3]
2016	1,193,223,000		700,000,000	[1],[2]	493,223,000	[1],[3]
2017	829,397,000		450,000,000	[1],[2]	379,397,000	[1],[3]
2018	894,394,000		450,000,000	[1],[2]	444,394,000	[1],[3]
2019	1,668,950,000		1,297,150,000	[1],[2],[4],[5]	371,800,000	[1],[3]
Thereafter	5,622,580,000		4,670,771,000	[1],[2],[6],[7]	951,809,000	[1],[3]
Totals	10,540,579,000		7,567,921,000	[1],[2]	2,972,658,000	[1],[3]
Senior Unsecured Notes and Secured Debt (Textual) [Abstract]
Notes, annual stated interest rates, Minimum			1.10%		1.00%
Notes, annual stated interest rates, Maximum			6.50%		7.90%
Interest rate											4.50%	4.50%	4.80%	4.80%
Senior unsecured notes issued amount											500,000,000	742,600,000	816,860,000	550,000,000
Senior unsecured notes	7,518,196,000	7,766,251,000					197,150,000	250,000,000		410,000,000					500,000,000
Secured debt	3,010,971,000	2,977,713,000
Carrying values of properties securing the debt					$ 5,349,988,000
Interest Rate margin	0.925%						2.00%	2.00%	0.975%						1.15%	0.975%
Debt Instrument, Issuance Date							Jul. 25, 2014	Jul. 25, 2014			Nov. 25, 2014	Nov. 25, 2014	Nov. 20, 2013	Nov. 20, 2013	Jul. 25, 2014
Debt instrument maturity date	Oct. 31, 2018						Oct. 31, 2018	Oct. 31, 2018			Nov. 24, 2034	Nov. 24, 2034	Nov. 20, 2028	Nov. 20, 2028	Oct. 31, 2018

[1] (1) Amounts represent principal amounts due and do not include unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.

[2] (2) Annual interest rates range from 1.1% to 6.5%.

[3] (3) Annual interest rates range from 1.0% to 7.9%. Carrying value of the properties securing the debt totaled $5,349,988,000 at March 31, 2015.

[4] (5) On July 25, 2014, we refinanced the funding on a $500,000,000 unsecured term credit facility. The loan matures on October 31, 2018 (with an option to extend for one additional year at our discretion) and bears interest at LIBOR plus 97.5 basis points (1.15% at March 31, 2015).

[5] (4) On July 25, 2014, we refinanced the funding on a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $197,150,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2015). The loan matures on October 31, 2018 (with an option to extend for an additional year at our discretion) and bears interest at the Canadian Dealer Offered Rate plus 97.5 basis points (2.0% at March 31, 2015).

[6] (6) On November 20, 2013, we completed the sale of £550,000,000 (approximately $816,860,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2015) of 4.8% senior unsecured notes due 2028.

[7] (7) On November 25, 2014, we completed the sale of £500,000,000 (approximately $742,600,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2015) of 4.5% senior unsecured notes due 2034.

XML

Dispositions, Assets Held for Sale and Discontinued Operations (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenues:
Rental income, discontinued	$ 0	$ 583,000
Expenses:
Interest expense, discontinued	0	123,000
Property operating expenses, discontinued	0	0
Provision for depreciation, discontinued	0	0
Expenses, discontinued	0	123,000
Income (loss) from discontinued operations, net		$ 460,000

XML

Senior Unsecured Notes and Secured Debt (Tables)

3 Months Ended

Mar. 31, 2015

Senior Unsecured Notes And Secured Debt (Tables) [Abstract]

Principal payments due on debt obligations

	Senior		Secured
	Unsecured Notes(1,2)		Debt (1,3)		Totals
2015	$	-	$	332,035	$	332,035
2016		700,000		493,223		1,193,223
2017		450,000		379,397		829,397
2018		450,000		444,394		894,394
2019(4,5)		1,297,150		371,800		1,668,950
Thereafter(6,7)		4,670,771		951,809		5,622,580
Totals	$	7,567,921	$	2,972,658	$	10,540,579
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(2) Annual interest rates range from 1.1% to 6.5%.
(3) Annual interest rates range from 1.0% to 7.9%. Carrying value of the properties securing the debt totaled $5,349,988,000 at March 31, 2015.
(4) On July 25, 2014, we refinanced the funding on a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $197,150,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2015). The loan matures on October 31, 2018 (with an option to extend for an additional year at our discretion) and bears interest at the Canadian Dealer Offered Rate plus 97.5 basis points (2.0% at March 31, 2015).
(5) On July 25, 2014, we refinanced the funding on a $500,000,000 unsecured term credit facility. The loan matures on October 31, 2018 (with an option to extend for one additional year at our discretion) and bears interest at LIBOR plus 97.5 basis points (1.15% at March 31, 2015).
(6) On November 20, 2013, we completed the sale of £550,000,000 (approximately $816,860,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2015) of 4.8% senior unsecured notes due 2028.
(7) On November 25, 2014, we completed the sale of £500,000,000 (approximately $742,600,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2015) of 4.5% senior unsecured notes due 2034.

Summary of senior unsecured note activity

	Three Months Ended
	March 31, 2015			March 31, 2014
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	7,817,154	4.385%	$	7,421,707	4.400%
Debt redeemed		(154,654)	3.000%		(1)	3.000%
Foreign currency		(94,579)	4.333%		(3,332)	3.486%
Ending balance	$	7,567,921	4.352%	$	7,418,374	4.400%

Secured debt principal activity

	Three Months Ended
		March 31, 2015		March 31, 2014
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	2,941,765	4.94%	$	3,010,711	5.10%
Debt issued		82,724	2.34%		10,690	3.54%
Debt assumed		205,897	3.98%		-	0.00%
Debt extinguished		(192,427)	4.02%		(114,084)	5.73%
Principal payments		(15,630)	5.01%		(15,455)	5.12%
Foreign currency		(49,672)	3.96%		(15,905)	3.86%
Ending balance	$	2,972,657	4.88%	$	2,875,957	5.08%

XML

Income Taxes and Distributions (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Income Taxes And Distributions (Textuals) [Abstract]
Deferred Tax Liabilities	$ 13,771,000	$ 12,451,000
Additional Income Taxes and Distributions (Textuals) [Abstract]
Unrecognized Tax Benefits	$ 857,000	$ 857,000
Percentage of Taxable income to be distributed to stockholders for federal tax purposes	90.00%
Percentage of capital gains excluded from taxable income distributed to shareholders	100.00%
Percentage of federal excise tax on real estate investment trusts that do not distribute income.	4.00%

XML

Senior Unsecured Notes and Secured Debt (Details 2) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
Secured debt principal activity
Secured debt issued	$ 82,724,000		$ 10,690,000
Secured debt extinguished	208,057,000		129,539,000
Excluding Fair Value Adjustments [Member]
Secured debt principal activity
Secured debt principal balance	2,972,657,000	2,941,765,000	2,875,957,000	3,010,711,000
Secured debt transferred	0
Secured debt issued	82,724,000		10,690,000
Secured debt assumed	205,897,000		0
Secured debt extinguished	(192,427,000)		(114,084,000)
Secured debt principal payments	(15,630,000)		(15,455,000)
Secured debt foreign currency	$ (49,672,000)		$ (15,905,000)
Secured debt principal balance average rate	0.0488	0.0494	0.0508	0.051
Secured debt principal transferred average rate	0		0
Secured debt principal issued average rate	0.0234		0.0354
Secured debt principal assumed average rate	0.0398		0
Secured debt principal extinguished average rate	0.0402		0.0573
Secured debt principal payment average rate	0.0501		0.0512
Secured debt principal foreign currency average rate	0.0396		0.0386

XML

Disclosure about Fair Value of Financial Instruments (Details 1) (USD $)	Mar. 31, 2015		Dec. 31, 2014
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments	$ 46,740,000	[1]	$ 0
Foreign currency forward contracts	72,671,000	[2]
Redeemable OP unitholder interests	47,147,000		46,722,000
Totals	166,558,000
Level 1 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Available-for-sale equity investments	46,740,000	[1]
Totals	46,740,000
Level 2 [Member]
The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis
Foreign currency forward contracts	72,671,000	[2]
Redeemable OP unitholder interests	47,147,000
Totals	$ 119,818,000

[1] (1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.

[2] (2) Please see Note 11 for additional information.

XML

Accounting Policies and Related Matters (Policies)

3 Months Ended

Mar. 31, 2015

Accounting Policies and Related Matters (Policies) [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the threemonths ended March 31, 2015 are not necessarily an indication of the results that may be expected for the year ending December 31, 2015. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.

New Accounting Standards

New Accounting Standards

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). The standard is a comprehensive new revenue recognition model that requires revenue to be recognized in a manner to depict the transfer of goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016, and early adoption is not permitted. In April 2015, the FASB proposed deferring the effective date by one year to December 15, 2017 for annual reporting periods beginning after that date, but early adoption is permitted. We are currently evaluating the impact that the standard will have on our consolidated financial statements and have not yet determined the method by which we will adopt the standard.

In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis” (“ASU 2015-02”), which makes certain changes to both the variable interest model and the voting model, including changes to (1) the identification of variable interests (fees paid to a decision maker or service provider), (2) the variable interest entity characteristics for a limited partnership or similar entity and (3) the primary beneficiary determination. ASU 2015-02 is effective beginning January 1, 2016. We are continuing to evaluate this guidance; however, we do not expect its adoption to have a significant impact on our consolidated financial statements.

In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs”(“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The recognition and measurement guidance for debt issuance costs are not affected. Upon adoption, we will apply the new guidance on a retrospective basis and adjust the balance sheet of each individual period presented to reflect the period-specific effects of applying the new guidance. The guidance is effective beginning January 1, 2016. We are continuing to evaluate this guidance; however, we do not expect its adoption to have a significant impact on our consolidated financial statements.

XML

Investments in Unconsolidated Entities (Summary of Investments in Unconsolidated Entities) (Details) (USD $)	Mar. 31, 2015		Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities	$ 715,468,000		$ 744,151,000
Triple Net [Member]
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities	31,276,000		31,511,000
Triple Net [Member] | Minimum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	10.00%	[1]	10.00%	[1]
Triple Net [Member] | Maximum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	49.00%	[1]	49.00%	[1]
Seniors Housing Facilities Operating [Member]
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities	509,743,000		539,147,000
Seniors Housing Facilities Operating [Member] | Minimum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	10.00%	[1]	10.00%	[1]
Seniors Housing Facilities Operating [Member] | Maximum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	50.00%	[1]	50.00%	[1]
Outpatient Medical [Member]
Schedule of Equity Method Investments [Line Items]
Investments in unconsolidated entities	$ 174,449,000		$ 173,493,000
Outpatient Medical [Member] | Minimum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	36.00%	[1]	36.00%	[1]
Outpatient Medical [Member] | Maximum [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	49.00%	[1]	49.00%	[1]

[1] (1) Excludes ownership of in-substance real estate.

XML

Real Estate Intangibles (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Intangible Assets:
Gross historical cost	$ 1,187,094,000	$ 1,135,936,000
Accumulated amortization	789,546,000	776,501,000
Net book value	397,548,000	359,435,000
Weighted-average amortization period in years	16 years 2 months	17 years 8 months
Intangible Liabilities:
Gross historical cost	99,224,000	99,027,000
Accumulated amortization	42,853,000	40,891,000
Net book value	56,371,000	58,136,000
Weighted-average amortization period in years	14 years 5 months	14 years 5 months
In place lease intangibles [Member]
Intangible Assets:
Gross historical cost	1,037,697,000	988,290,000
Above market tenant leases [Member]
Intangible Assets:
Gross historical cost	66,162,000	65,684,000
Below market ground leases [Member]
Intangible Assets:
Gross historical cost	62,426,000	62,426,000
Lease commissions [Member]
Intangible Assets:
Gross historical cost	20,809,000	19,536,000
Below market tenant leases [Member]
Intangible Liabilities:
Gross historical cost	91,365,000	91,168,000
Above market ground leases [Member]
Intangible Liabilities:
Gross historical cost	$ 7,859,000	$ 7,859,000

XML

Disclosure about Fair Value of Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2015

Disclosure about Fair Value of Financial Instruments (Tables) [Abstract]

Carrying amounts and estimated fair values of financial instruments

		March 31, 2015				December 31, 2014
		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
	Mortgage loans receivable	$	554,731	$	577,232	$	188,651	$	194,935
	Other real estate loans receivable		190,536		192,005		191,518		195,375
	Available-for-sale equity investments		46,740		46,740		-		-
	Cash and cash equivalents		202,273		202,273		473,726		473,726
	Foreign currency forward contracts		73,081		73,081		57,087		57,087
Financial liabilities:
	Borrowings under unsecured credit facilities	$	410,000	$	410,000	$	-	$	-
	Senior unsecured notes		7,518,196		8,378,885		7,766,251		8,613,702
	Secured debt		3,010,971		2,993,308		2,977,713		3,053,067
	Foreign currency forward contracts		410		410		1,495		1,495
Redeemable OP unitholder interests			47,147		47,147		46,722		46,722

The Market approach utilized to measure fair value of financial assets and liabilities on recurring basis

	Fair Value Measurements as of March 31, 2015
	Total		Level 1		Level 2		Level 3
Available-for-sale equity investments(1)	$	46,740	$	46,740	$	-	$	-
Foreign currency forward contracts, net(2)		72,671		-		72,671		-
Redeemable OP unitholder interests		47,147		-		47,147		-
Totals	$	166,558		46,740	$	119,818	$	-
(1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.
(2) Please see Note 11 for additional information.

XML

Credit Concentration (Details) (USD $)	3 Months Ended
	Mar. 31, 2015 properties		Mar. 31, 2014	Dec. 31, 2014
Concentration by investment:
Number of properties in diversified portfolio	1,316	[1]
Percent of NOI	100.00%	[1],[2]
Net Operating Income	$ 517,716,000	[1]	$ 460,376,000
Credit Concentration (Textual) [Abstract]
Percentage total investments with top five customers				49.00%
Genesis HealthCare [Member]
Concentration by investment:
Number of properties in diversified portfolio	180	[1]
Percent of NOI	17.00%	[1],[2]
Net Operating Income	87,277,000	[1]
Sunrise Senior Living [Member]
Concentration by investment:
Number of properties in diversified portfolio	143	[1],[3]
Percent of NOI	14.00%	[1],[2],[3]
Net Operating Income	71,268,000	[1],[3]
Brookdale [Member]
Concentration by investment:
Number of properties in diversified portfolio	146	[1]
Percent of NOI	8.00%	[1],[2]
Net Operating Income	42,092,000	[1]
Benchmark Senior Living [Member]
Concentration by investment:
Number of properties in diversified portfolio	49	[1]
Percent of NOI	4.00%	[1],[2]
Net Operating Income	21,726,000	[1]
Revera [Member]
Concentration by investment:
Number of properties in diversified portfolio	71	[1],[3]
Percent of NOI	4.00%	[1],[2],[3]
Net Operating Income	19,121,000	[1],[3]
Remaining Portfolio [Member]
Concentration by investment:
Number of properties in diversified portfolio	727	[1]
Percent of NOI	53.00%	[1],[2]
Net Operating Income	$ 276,232,000	[1]

[1] (1)     Genesis Healthcare is in our triple-net segment. Sunrise Senior Living and Revera are in our seniors housing operating segment. Brookdale Senior Living and Benchmark Senior Living are in both our triple-net and seniors housing operating segments.

[2] (2)     NOI with our top five relationships comprised 49% of total NOI for the year ending December 31, 2014

[3] (3)     Revera owns a controlling interest in Sunrise.

XML

Stockholder's Equity (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stockholders' Equity (Details) [Abstract]
Acquisitions of noncontrolling interests	$ 0	$ (1,175,000)

XML

Commitments and Contingencies (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015 Number	Dec. 31, 2014
Commitments and Contingencies (Textual) [Abstract]
Number of outstanding letters of credit	7
Letter of credit obligation	$ 10,769,000
Outstanding construction financings for leased properties	211,941,000	186,327,000
Additional financing to complete construction	355,231,000
Total contingent purchase obligations	59,856,000
Minimum part of economic life of the leased asset to be classified as capital lease	75.00%
Minimum net present value of the future minimum lease payments to be classified as capital lease.	90.00%
Operating lease obligations relating to certain ground leases	948,535,000
Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals	28,834,000
Capital Leases, Future Minimum Payments Due	$ 102,117,000

XML

Dispositions, Assets Held for Sale and Discontinued Operations (Details 2) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenues:
Rental income, disposed	$ 4,517,000	$ 28,243,000
Expenses:
Interest expense, disposed	1,303,000	7,644,000
Property operating expenses, disposed	14,000	673,000
Depreciation expense, disposed	133,000	8,236,000
Expenses, disposed	1,450,000	16,553,000
Income (loss) from disposed properties	$ 3,067,000	$ 11,690,000

XML

Real Property Acquisitions and Development

3 Months Ended

Mar. 31, 2015

Real Property Acquisitions and Development [Abstract]

Real Property Acquisitions and Development

3. Real Property Acquisitions and Development

The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets, liabilities and noncontrolling interests based upon their respective fair values in accordance with our accounting policies. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with property acquisitions, including due diligence costs, fees for legal and valuation services and termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs.

Triple-net Activity

		Three Months Ended
(In thousands)		March 31, 2015(1)			March 31, 2014
Land and land improvements			$	70,002		$	2,750
Buildings and improvements				537,014			30,693
Acquired lease intangibles				799			-
Receivables and other assets				7			-
	Total assets acquired			607,822			33,443
Accrued expenses and other liabilities				(732)			-
	Total liabilities assumed			(732)			-
Non-cash acquisition related activity				(357)			(657)
	Cash disbursed for acquisitions			606,733			32,786
Construction in progress additions				45,360			24,657
Less:	Capitalized interest			(1,756)			(1,170)
	Foreign currency translation			(642)			(14)
Cash disbursed for construction in progress				42,962			23,473
Capital improvements to existing properties				11,557			5,877
	Total cash invested in real property, net of cash acquired		$	661,252		$	62,136
(1) Includes acquisitions with an aggregate purchase price of $571,586,000 for which the allocation of the purchase price consideration is preliminary and subject to change.

Seniors Housing Operating Activity

Acquisitions of seniors housing operating properties are structured under RIDEA, which is described in Note 18. This structure results in the inclusion of all resident revenues and related property operating expenses from the operation of these qualified health care properties in our Consolidated Statements of Comprehensive Income. Certain of our subsidiaries’ functional currencies are the local currencies of their respective countries. See Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014for information regarding our foreign currency policies.

		Three Months Ended
(In thousands)		March 31, 2015(1)			March 31, 2014
Land and land improvements			$	86,184		$	2,100
Building and improvements				1,016,426			19,069
Acquired lease intangibles				62,838			1,331
Restricted cash				3,820			-
Receivables and other assets				23,014			-
	Total assets acquired(2)			1,192,282			22,500
Secured debt				(208,960)			-
Accrued expenses and other liabilities				(16,164)			(245)
	Total liabilities assumed			(225,124)			(245)
Noncontrolling interests				(83,194)			-
	Cash disbursed for acquisitions			883,964			22,255
Construction in progress additions				4,193			1,026
Less:	Capitalized interest			(394)			(50)
	Foreign currency translation			(1,472)			-
Cash disbursed for construction in progress				2,327			976
Capital improvements to existing properties				11,632			13,998
	Total cash invested in real property, net of cash acquired		$	897,923		$	37,229
(1) Includes acquisitions with an aggregate purchase price of $885,642,000 for which the allocation of the purchase price consideration is preliminary and subject to change.
(2) Excludes $1,677,000 and $245,000 of cash acquired during the three months ended March 31, 2015 and 2014, respectively.

Outpatient Medical Activity

		Three Months Ended
(In thousands)		March 31, 2015 (1)			March 31, 2014
Buildings and improvements			$	9,786	$	-
Acquired lease intangibles				511		-
	Total assets acquired			10,297		-
	Cash disbursed for acquisitions			10,297		-
Construction in progress additions				16,421		38,237
Less:	Capitalized interest			(237)		(385)
	Accruals(2)			(1,921)		(9,584)
Cash disbursed for construction in progress				14,263		28,268
Capital improvements to existing properties				6,639		7,531
	Total cash invested in real property		$	31,199	$	35,799
(1) Includes acquisitions with an aggregate purchase price of $10,297,000 for which the allocation of the purchase price consideration is preliminary and subject to change.
(2) Represents non-cash consideration accruals for amounts to be paid in future periods relating to properties that converted in the periods noted above.

Construction Activity

The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):

			Three Months Ended
			March 31, 2015			March 31, 2014
	Development projects:
		Triple-net		$	-		$	8,481
		Outpatient medical			16,592			42,799
		Total development projects			16,592			51,280
	Expansion projects				19,541			9,209
Total construction in progress conversions				$	36,133		$	60,489

XML

Stockholder's Equity (Details)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	25,875,000	25,875,000
Outstanding shares	25,875,000	25,875,000	25,875,000	26,108,236
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	351,237,849	329,487,615
Outstanding shares	350,471,798	328,790,066

XML

Real Estate Intangibles (Real Estate Intangible Maturity Schedule) (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Estimated Aggregate Amortization Expense For Acquired Lease Intangibles Expected To Be Recognized [Line Items]
Totals	$ 397,548,000	$ 359,435,000
Intangible Liability [Member]
Estimated Aggregate Amortization Expense For Acquired Lease Intangibles Expected To Be Recognized [Line Items]
2015	3,323,000
2016	8,176,000
2017	8,594,000
2018	8,500,000
2019	6,819,000
Thereafter	20,959,000
Totals	56,371,000
Intangible Asset [Member]
Estimated Aggregate Amortization Expense For Acquired Lease Intangibles Expected To Be Recognized [Line Items]
2015	72,406,000
2016	60,019,000
2017	37,369,000
2018	26,596,000
2019	23,289,000
Thereafter	177,869,000
Totals	$ 397,548,000

XML

Real Estate Loans Receivable (Tables)

3 Months Ended

Mar. 31, 2015

Real Estate Loans Receivable (Tables) [Abstract]

Summary of real estate loan activity

		Three Months Ended
		March 31, 2015						March 31, 2014
				Outpatient						Outpatient
		Triple-net		Medical		Totals		Triple-net		Medical		Totals
Advances on real estate loans receivable:
	Investments in new loans	$	368,080	$	-	$	368,080	$	1,203	$	-	$	1,203
	Draws on existing loans		14,330		2,285		16,615		23,077		5,429		28,506
	Net cash advances on real estate loans		382,410		2,285		384,695		24,280		5,429		29,709
Receipts on real estate loans receivable:
	Loan payoffs		8,568		-		8,568		500		-		500
	Principal payments on loans		7,933		-		7,933		10,127		19		10,146
	Net cash receipts on real estate loans		16,501		-		16,501		10,627		19		10,646
Net cash advances (receipts) on real estate loans			365,909		2,285		368,194		13,653		5,410		19,063
Change in balance due to foreign currency translation			(3,096)		-		(3,096)		192		-		192
Net change in real estate loans receivable		$	362,813	$	2,285	$	365,098	$	13,845	$	5,410	$	19,255

XML

Dispositions, Assets Held for Sale and Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2015

Dispositions, Assets Held for Sale and Discontinued Operations (Tables) [Abstract]

Summary of real property disposition activity

		Three Months Ended
		March 31, 2015			March 31, 2014
Real property dispositions:
	Triple-net		$	110,998		$	-
	Outpatient medical			9,422			-
	Total dispositions			120,420			-
Gain (loss) on sales of real property, net				56,845			-
Proceeds from real property sales			$	177,265		$	-

Reclassification impact as result of classifying properties as discontinued operations

			Three Months Ended
			March 31,
		2015		2014
Revenues:
	Rental income	$	-	$	583
Expenses:
	Interest expense		-		123
	Total expenses		-		123
Income (loss) from discontinued operations, net		$	-	$	460

Summary of disposed properties.

			Three Months Ended
			March 31,
		2015		2014
Revenues:
	Rental income	$	4,517	$	28,243
Expenses:
	Interest expense		1,303		7,644
	Property operating expenses		14		673
	Provision for depreciation		133		8,236
	Total expenses		1,450		16,553
Income (loss) from real estate dispositions, net		$	3,067	$	11,690

XML

Senior Unsecured Notes and Secured Debt (Details 1) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014	Dec. 31, 2013
Unsecured note issuances
Senior unsecured debt issued	$ 0	$ 0
Senior unsecured debt redeemed	(154,654,000)	(1,000)
Excluding Fair Value Adjustments [Member]
Unsecured note issuances
Senior unsecured debt balance	7,567,921,000	7,418,374,000	7,817,154,000	7,421,707,000
Senior unsecured debt issued	0	0
Senior unsecured debt extinguished	0
Senior unsecured debt redeemed	(154,654,000)	(1,000)
Senior unsecured debt foreign currency	$ (94,579,000)	$ (3,332,000)
Senior unsecured debt balance average rate	0.04352	0.044	0.04385	0.044
Senior unsecured debt issued average rate	0	0
Senior unsecured debt extinguished average rate	0	0
Senior unsecured debt redeemed average rate	0.03	0.03
Senior unsecured debt foreign currency average rate	0.04333	0.03486

XML

Real Estate Intangibles (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Real Estate Intangible Amortization [Abstract]
Rental income related to above/below market tenant leases, net	$ 206,000	$ (45,000)
Property operating expenses related to above/below market ground leases, net	(319,000)	(311,000)
Depreciation and amortization related to in place lease intangibles and lease commissions	$ 24,324,000	$ (79,393,000)

XML

Investments in Unconsolidated Entities (Tables)

3 Months Ended

Mar. 31, 2015

Investments In Unconsolidated Entities [Abstract]

Summary Of Investments In Unconsolidated Entities [Text Block]

	Percentage Ownership(1)	March 31, 2015		December 31, 2014
Triple-net	10% to 49%	$	31,276	$	31,511
Seniors housing operating	10% to 50%		509,743		539,147
Outpatient medical	36% to 49%		174,449		173,493
Total		$	715,468	$	744,151
(1) Excludes ownership of in-substance real estate.

XML

Credit Concentration (Tables)

3 Months Ended

Mar. 31, 2015

Customer Concentration (Tables) [Abstract]

Summary of credit concentration

		Number of	Total		Percent of
Concentration by relationship:(1)		Properties	NOI		NOI(2)
	Genesis Healthcare	180	$	87,277	17%
	Sunrise Senior Living(3)	143		71,268	14%
	Brookdale Senior Living	146		42,092	8%
	Benchmark Senior Living	49		21,726	4%
	Revera(3)	71		19,121	4%
	Remaining portfolio	727		276,232	53%
	Totals	1,316	$	517,716	100%

• Genesis Healthcare is in our triple-net segment. Sunrise Senior Living and Revera are in our seniors housing operating segment. Benchmark Senior Living and Brookdale Senior Living are in both our triple-net and seniors housing operating segments.
• NOI with our top five relationships comprised 49% of totalNOI for the year endingDecember 31, 2014.
• Revera owns a controlling interest in Sunrise.

XML

Accounting Policies and Related Matters

3 Months Ended

Mar. 31, 2015

Accounting Policies and Related Matters [Abstract]

Accounting Policies and Related Matters

2. Accounting Policies and Related Matters

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the threemonths ended March 31, 2015 are not necessarily an indication of the results that may be expected for the year ending December 31, 2015. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014.

New Accounting Standards

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). The standard is a comprehensive new revenue recognition model that requires revenue to be recognized in a manner to depict the transfer of goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for those goods or services. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016, and early adoption is not permitted. In April 2015, the FASB proposed deferring the effective date by one year to December 15, 2017 for annual reporting periods beginning after that date, but early adoption is permitted. We are currently evaluating the impact that the standard will have on our consolidated financial statements and have not yet determined the method by which we will adopt the standard.

In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810): Amendments to the Consolidation Analysis” (“ASU 2015-02”), which makes certain changes to both the variable interest model and the voting model, including changes to (1) the identification of variable interests (fees paid to a decision maker or service provider), (2) the variable interest entity characteristics for a limited partnership or similar entity and (3) the primary beneficiary determination. ASU 2015-02 is effective beginning January 1, 2016. We are continuing to evaluate this guidance; however, we do not expect its adoption to have a significant impact on our consolidated financial statements.

In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs”(“ASU 2015-03”), which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The recognition and measurement guidance for debt issuance costs are not affected. Upon adoption, we will apply the new guidance on a retrospective basis and adjust the balance sheet of each individual period presented to reflect the period-specific effects of applying the new guidance. The guidance is effective beginning January 1, 2016. We are continuing to evaluate this guidance; however, we do not expect its adoption to have a significant impact on our consolidated financial statements.

XML

Borrowings Under Credit Facilities and Related Items (Tables)

3 Months Ended

Mar. 31, 2015

Borrowings Under Credit Facilities and Related Items (Tables) [Abstract]

Aggregate borrowings under the unsecured line of credit arrangements

		Three Months Ended March 31,
		2015		2014
Balance outstanding at quarter end(1)		$	410,000	$	562,000
Maximum amount outstanding at any month end		$	430,000	$	562,000
Average amount outstanding (total of daily
	principal balances divided by days in period)	$	408,944	$	286,889
Weighted average interest rate (actual interest
	expense divided by average borrowings outstanding)		1.21%		1.34%
(1) As of March 31, 2015, letters of credit in the aggregate amount of $65,335,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Real Property Acquisitions and Development (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Triple Net [Member]
Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities
Land and land improvements	$ 70,002,000	[1]	$ 2,750,000
Buildings and improvements	537,014,000	[1]	30,693,000
Acquired lease intangibles	799,000
Receivables and other assets	7,000
Total assets acquired	607,822,000	[1]	33,443,000
Accrued expenses and other liabilities	(732,000)
Total liabilities assumed	(732,000)
Noncontrolling interests	0
Non-cash acquisition related activity	(357,000)	[1]	(657,000)
Cash disbursed for acquisitions	606,733,000	[1]	32,786,000
Construction in progress additions	45,360,000	[1]	24,657,000
Less: Capitalized Interest	(1,756,000)	[1]	(1,170,000)
Less: Foreign currency translation	(642,000)	[1]	(14,000)
Cash disbursed for construction in progress	42,962,000	[1]	23,473,000
Capital improvements to existing properties	11,557,000	[1]	5,877,000
Total cash invested in real property	661,252,000	[1]	62,136,000
Senior housing - operating [Member]
Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities
Land and land improvements	86,184,000	[2]	2,100,000
Buildings and improvements	1,016,426,000	[2]	19,069,000
Acquired lease intangibles	62,838,000	[2]	1,331,000
Acquired Construction in Progress	0	[2]
Restricted cash	3,820,000	[2]	0
Receivables and other assets	23,014,000	[2]	0
Total assets acquired	1,192,282,000	[2],[3]	22,500,000	[3]
Secured debt	(208,960,000)	[2]	0
Accrued expenses and other liabilities	(16,164,000)	[2]	(245,000)
Total liabilities assumed	(225,124,000)	[2]	(245,000)
Noncontrolling interests	(83,194,000)	[2]	0
Non-cash acquisition related activity	0	[2]	0
Cash disbursed for acquisitions	883,964,000	[2]	22,255,000
Construction in progress additions	4,193,000	[2]	1,026,000
Less: Capitalized Interest	(394,000)	[2]	(50,000)
Less: Foreign currency translation	(1,472,000)	[2]
Cash disbursed for construction in progress	2,327,000	[2]	976,000
Capital improvements to existing properties	11,632,000	[2]	13,998,000
Total cash invested in real property	897,923,000	[2]	37,229,000
Cash Acquired from Acquisition	1,677,000,000		8,476,000
Senior housing - operating [Member] | Preliminary [Member]
Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities
Total cash invested in real property	885,642,000,000
Outpatient Medical [Member]
Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities
Land and land improvements	0	[4]	0
Buildings and improvements	9,786,000	[4]	0
Acquired lease intangibles	511,000	[4]	0
Restricted cash			0
Receivables and other assets			0
Total assets acquired	10,297,000	[4]	0
Secured debt			0
Accrued expenses and other liabilities			0
Total liabilities assumed			0
Non-cash acquisition related activity			0
Cash disbursed for acquisitions	10,297,000	[4]	0
Construction in progress additions	16,421,000	[4]	38,237,000
Less: Capitalized Interest	(237,000)	[4]	(385,000)
Less: Accruals	(1,921,000)	[4],[5]	(9,584,000)	[5]
Cash disbursed for construction in progress	14,263,000	[4]	28,268,000
Capital improvements to existing properties	6,639,000	[4]	7,531,000
Total cash invested in real property	31,199,000	[4]	35,799,000
Outpatient Medical [Member] | Preliminary [Member]
Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities
Total cash invested in real property	$ 10,297,000

[1] (1) Includes acquisitions with an aggregate purchase price of $571,586,000 for which the allocation of the purchase price consideration is preliminary and subject to change.

[2] (1) Includes acquisitions with an aggregate purchase price of $885,642,000 for which the allocation of the purchase price consideration is preliminary and subject to change.

[3] (2) Excludes $1,677,000 and $245,000 of cash acquired during the three months ended March 31, 2015 and 2014, respectively.

[4] (1) Includes acquisitions with an aggregate purchase price of $10,297,000 for which the allocation of the purchase price consideration is preliminary and subject to change.

[5] (2) Represents non-cash consideration accruals for amounts to be paid in future periods relating to properties that converted in the periods noted above.

XML

Borrowings Under Credit Facilities and Related Items (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014		Dec. 31, 2014
Aggregate borrowings under the unsecured line of credit arrangements
Balance outstanding at quarter end	$ 410,000,000	[1]	$ 562,000,000	[1]	$ 0
Maximum amount outstanding at any month end	430,000,000		562,000,000
Average amount outstanding (total of daily principal balances divided by days in period)	$ 408,944,000		$ 286,889,000
Weighted average interest rate (actual interest expense divided by average borrowings outstanding)	1.21%		1.34%

[1] (1) As of March 31, 2015, letters of credit in the aggregate amount of $65,335,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Segment Reporting (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014	Dec. 31, 2014
Summary of information for reportable segments
Rental income	$ 379,587,000		$ 336,455,000
Resident fees and services	492,510,000		456,265,000
Interest income	16,994,000		8,594,000
Other income	5,086,000		493,000
Total revenues	894,177,000		801,807,000
Property operating expenses	376,461,000		341,431,000
Net Operating Income from Continuing Operations	517,716,000	[1]	460,376,000
Interest expense	121,080,000		120,833,000
Loss (gain) on derivatives, net	(58,427,000)	[2]
Depreciation and amortization	188,829,000		233,318,000
General and administrative	35,138,000		32,865,000
Transaction costs	48,554,000		952,000
Loss (gain) on extinguishment of debt, net	(15,401,000)		148,000
Provision for loan losses	0
Impairment of Asset	2,220,000
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	164,921,000		72,556,000
Income tax (expense) benefit	304,000		(2,260,000)
(Loss) income from unconsolidated entities	(12,648,000)		(5,556,000)
Income (loss) from continuing operations	152,577,000		64,740,000
Discontinued Operation, Amount of Other Income (Loss) from Disposition of Discontinued Operation, Net of Tax			460,000
Gain (loss) on real estate dispositions, net	56,845,000
Net income	209,422,000		65,200,000
Total assets	26,629,395,000			25,014,296,000
Percent Of Assets	1			1
Percent Of Revenues	1		1
Triple Net [Member]
Summary of information for reportable segments
Rental income	264,406,000		237,716,000
Resident fees and services	0		0
Interest income	14,699,000		7,720,000
Other income	3,883,000		144,000
Total revenues	282,988,000		245,580,000
Property operating expenses			243,000
Net Operating Income from Continuing Operations	282,988,000		245,337,000
Interest expense	10,027,000		9,115,000
Loss (gain) on derivatives, net	(58,427,000)		0
Depreciation and amortization	70,031,000		67,269,000
General and administrative	0		0
Transaction costs	36,172,000		275,000
Loss (gain) on extinguishment of debt, net	10,336,000		0
Provision for loan losses			0
Impairment of Asset	2,220,000
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	212,629,000		168,678,000
Income tax (expense) benefit	418,000		(355,000)
(Loss) income from unconsolidated entities	1,393,000		1,382,000
Income (loss) from continuing operations	214,440,000		169,705,000
Discontinued Operation, Amount of Other Income (Loss) from Disposition of Discontinued Operation, Net of Tax			460,000
Gain (loss) on real estate dispositions, net	54,097,000
Net income	268,537,000		170,165,000
Total assets	11,916,636,000
Senior housing - operating [Member]
Summary of information for reportable segments
Rental income	0		0
Resident fees and services	492,510,000		456,265,000
Interest income	1,031,000		0
Other income	1,020,000		54,000
Total revenues	494,561,000		456,319,000
Property operating expenses	338,507,000		308,184,000
Net Operating Income from Continuing Operations	156,054,000		148,135,000
Interest expense	34,458,000		27,479,000
Loss (gain) on derivatives, net	0		0
Depreciation and amortization	76,636,000		129,162,000
General and administrative	0		0
Transaction costs	12,042,000		630,000
Loss (gain) on extinguishment of debt, net	0		(148,000)
Other expenses	0
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	32,918,000		(8,988,000)
Income tax (expense) benefit	(533,000)		(1,643,000)
(Loss) income from unconsolidated entities	(15,073,000)		(7,961,000)
Income (loss) from continuing operations	17,312,000		(18,592,000)
Net income	17,312,000		(18,592,000)
Total assets	10,208,763,000
Outpatient Medical [Member]
Summary of information for reportable segments
Rental income	115,181,000		98,739,000
Resident fees and services	0		0
Interest income	1,264,000		874,000
Other income	161,000		280,000
Total revenues	116,606,000		99,893,000
Property operating expenses	37,954,000		33,004,000
Net Operating Income from Continuing Operations	78,652,000		66,889,000
Interest expense	7,625,000		9,383,000
Loss (gain) on derivatives, net	0		0
Depreciation and amortization	42,162,000		36,887,000
General and administrative	0		0
Transaction costs	341,000		47,000
Loss (gain) on extinguishment of debt, net	0
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	28,524,000		20,572,000
Income tax (expense) benefit	466,000		(262,000)
(Loss) income from unconsolidated entities	1,032,000		1,023,000
Income (loss) from continuing operations	30,022,000		21,333,000
Gain (loss) on real estate dispositions, net	2,749,000
Net income	32,771,000		21,333,000
Total assets	4,444,058,000
Non Segment Corporate [Member]
Summary of information for reportable segments
Rental income	0		0
Resident fees and services	0		0
Interest income	0		0
Other income	22,000		15,000
Total revenues	22,000		15,000
Property operating expenses	0		0
Net Operating Income from Continuing Operations	22,000		15,000
Interest expense	68,970,000		74,856,000
Loss (gain) on derivatives, net	0		0
Depreciation and amortization	0		0
General and administrative	35,138,000		32,865,000
Transaction costs	0		0
Loss (gain) on extinguishment of debt, net	5,064,000		0
Income (loss) from continuing operations before income taxes and income from unconsolidated entities	(109,150,000)		(107,706,000)
Income tax (expense) benefit	(48,000)		0
(Loss) income from unconsolidated entities	0		0
Income (loss) from continuing operations	(109,198,000)		(107,706,000)
Net income	(109,198,000)		(107,706,000)
Total assets	59,938,000
International [Member]
Summary of information for reportable segments
Total revenues	149,041,000		126,708,000
Total assets	4,748,464,000			4,285,819,000
Percent Of Assets	0.178			0.171
Percent Of Revenues	0.167		0.158
United States [Member]
Summary of information for reportable segments
Total revenues	745,136,000		675,099,000
Total assets	$ 21,880,931,000			$ 20,728,477,000
Percent Of Assets	0.822			0.829
Percent Of Revenues	0.833		0.842

[1] (1)     Genesis Healthcare is in our triple-net segment. Sunrise Senior Living and Revera are in our seniors housing operating segment. Brookdale Senior Living and Benchmark Senior Living are in both our triple-net and seniors housing operating segments.

[2] (1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.

XML

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2015		Dec. 31, 2014
Real property owned:
Land and land improvements	$ 2,160,886,000		$ 2,046,541,000
Buildings and improvements	23,192,154,000		21,799,313,000
Acquired lease intangibles	1,187,094,000		1,135,936,000
Real property held for sale, net of accumulated depreciation	234,829,000		323,818,000
Construction in progress	211,941,000		186,327,000
Gross real property owned	26,986,904,000		25,491,935,000
Less accumulated depreciation and amortization	(3,186,424,000)		(3,020,908,000)
Net real property owned	23,800,480,000		22,471,027,000
Real estate loans receivable:
Real estate loans receivable	745,267,000		380,169,000
Less allowance for losses on loans receivable	0
Net real estate investments	24,545,747,000		22,851,196,000
Other assets:
Investments in unconsolidated entities	715,468,000		744,151,000
Goodwill	68,321,000		68,321,000
Deferred loan expenses	63,378,000		69,282,000
Cash and cash equivalents	202,273,000		473,726,000
Restricted cash	85,177,000		79,697,000
Straight-line rent receivable	307,050,000		279,806,000
Receivables and other assets	641,981,000		448,117,000
Total other assets	2,083,648,000		2,163,100,000
Total assets	26,629,395,000		25,014,296,000
Liabilities:
Borrowings under primary unsecured credit facilities, Carrying Value	410,000,000	[1]	0
Senior unsecured notes	7,518,196,000		7,766,251,000
Secured debt	3,010,971,000		2,977,713,000
Capital lease obligations	75,622,000		84,049,000
Accrued expenses and other liabilities	604,149,000		626,825,000
Total liabilities	11,618,938,000		11,454,838,000
Redeemable noncontrolling interests	92,508,000		86,409,000
Equity:
Preferred stock	1,006,250,000		1,006,250,000
Common stock	350,434,000		328,835,000
Capital in excess of par value	16,218,794,000		14,740,712,000
Treasury stock	(41,373,000)		(35,241,000)
Cumulative net income	3,049,173,000		2,842,022,000
Cumulative Dividends	(5,924,844,000)		(5,635,923,000)
Accumulated other comprehensive income (loss)	(107,496,000)		(77,009,000)
Other equity	4,449,000		5,507,000
Total Health Care REIT, Inc. stockholders' equity	14,555,387,000		13,175,153,000
Noncontrolling interests	362,562,000		297,896,000
Total equity	14,917,949,000		13,473,049,000
Total liabilities and equity	$ 26,629,395,000		$ 25,014,296,000

[1] (1) As of March 31, 2015, letters of credit in the aggregate amount of $65,335,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Dispositions, Assets Held for Sale and Discontinued Operations (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Real property dispositions:
Total dispositions	$ 120,420,000	$ 0
Net loss (gain) on sales of properties	(56,845,000)	0
Noncash disposition activity		0
Real property held for sale, net of accumulated depreciation	234,829,000		323,818,000
Proceeds from sales of real property	177,265,000	0
Gain (loss) on sales of properties, net	56,845,000
Escrow Deposits Related To Property Sales	19,493,000,000
Triple Net [Member]
Real property dispositions:
Total dispositions	110,998,000	0
Net loss (gain) on sales of properties	6,411,000
Real property held for sale, net of accumulated depreciation	18,502,000
Outpatient Medical [Member]
Real property dispositions:
Total dispositions	$ 9,422,000	$ 0

XML

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Operating activities
Net income (loss)	$ 209,422,000		$ 65,200,000
Adjustments to reconcile net income to net cash provided from (used in) operating activities:
Depreciation and amortization	188,829,000		233,318,000
Other amortization expenses	1,320,000		1,672,000
Provision for loan losses	0
Asset Impairment Charges	2,220,000
Stock-based compensation expense	9,054,000		7,667,000
Loss (gain) on derivatives, net	(58,427,000)		0
Loss (gain) on extinguishment of debt, net	15,401,000		(148,000)
Income from unconsolidated entities	12,648,000		5,556,000
Rental income in excess of cash received	(27,244,000)		(15,323,000)
Amortization related to above (below) market leases, net	113,000		266,000
Net loss (gain) on sales of properties	(56,845,000)		0
Distributions by unconsolidated entities	172,000		4,560,000
Increase (decrease) in accrued expenses and other liabilities	(47,489,000)		(25,532,000)
Decrease (increase) in receivables and other assets	(22,992,000)		(18,575,000)
Net cash provided from (used in) operating activities	226,182,000		258,661,000
Investing activities
Cash disbursed for acquisitions	(1,500,994,000)		(55,041,000)
Cash disbursed for capital improvements to existing properties	(29,828,000)		(27,406,000)
Cash disbursed for construction in progress	(59,552,000)		(52,717,000)
Capitalized interest	(2,387,000)		(1,605,000)
Investment in real estate loans receivable	(384,695,000)		(29,709,000)
Other investments, net of payments	(102,126,000)		1,787,000
Principal collected on real estate loans receivable	16,501,000		10,646,000
Contributions to unconsolidated entities	(83,964,000)		(214,832,000)
Distributions by unconsolidated entities	89,195,000		12,462,000
Proceeds from (payments on) derivatives investing	72,477,000		0
Decrease (increase) in restricted cash	(1,660,000)		5,024,000
Proceeds from sales of real property	177,265,000		0
Net cash provided from (used in) investing activities	(1,809,768,000)		(351,391,000)
Financing activities
Net increase (decrease) under unsecured lines of credit arrangements	410,000,000		432,000,000
Proceeds from issuance of senior unsecured notes	0		0
Payments to extinguish senior unsecured notes	(154,654,000)		(1,000)
Secured debt issued	82,724,000		10,690,000
Payments on secured debt	(208,057,000)		(129,539,000)
Net proceeds from the issuance of common stock	1,489,547,000		63,755,000
Decrease (increase) in deferred loan expenses	(4,485,000)		(2,284,000)
Contributions by noncontrolling interests	2,514,000	[1]	778,000	[1]
Distributions to noncontrolling interests	(7,417,000)	[1]	(7,386,000)	[1]
Acquisitions of noncontrolling interests	0		(1,175,000)
Cash distributions to stockholders	(288,921,000)		(247,154,000)
Other financing activities	(8,428,000)		(87,000)
Net cash provided from (used in) financing activities	1,312,823,000		119,597,000
Effect of foreign currency translation on cash and cash equivalents	(690,000)		281,000
Increase (decrease) in cash and cash equivalents	(271,453,000)		27,148,000
Cash and cash equivalents at beginning of period	473,726,000		158,780,000
Cash and cash equivalents at end of period	202,273,000		185,928,000
Supplemental cash flow information:
Interest paid	134,737,000		126,302,000
Income taxes paid	$ 2,942,000		$ 10,064,000

[1] (1) Includes amounts attributable to redeemable noncontrolling interests.

XML

Derivative Instruments (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Derivative [Line Items]
Loss (Gain) on option exercise	$ (58,427,000)	[1]
Interest Rate Swap [Member]
Derivative [Line Items]
Gain (loss) recognized in OCI			(3,000)
Gain (loss) on interest rate swaps recalssified from AOCI into income (effective portion)	(465,939)		(443,000)
Foreign Exchange Contract [Member]
Derivative [Line Items]
Gain (loss) on forward exchange contracts recognized in income.	2,746,740
Gain on Release of cumulative translation adjustment related to net investment hedge of an equity investment	$ 184,051,097		$ 18,489,000

[1] (1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.

XML

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2015

Stockholders' Equity (Tables) [Abstract]

Summary of stockholder's equity capital accounts

	March 31, 2015	December 31, 2014
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	25,875,000	25,875,000
Outstanding shares	25,875,000	25,875,000
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	351,237,849	329,487,615
Outstanding shares	350,471,798	328,790,066

Summary of preferred stock activity

	Three Months Ended
	March 31, 2015		March 31, 2014
		Weighted Avg.		Weighted Avg.
	Shares	Dividend Rate	Shares	Dividend Rate
Beginning balance	25,875,000	6.500%	26,108,236	6.496%
Shares converted	-	0.000%	(233,236)	6.000%
Ending balance	25,875,000	6.500%	25,875,000	6.500%

Summary of common stock issuances

	Shares Issued		Average Price		Gross Proceeds		Net Proceeds
2014 Dividend reinvestment plan issuances	1,143,397	$	55.71	$	63,703	$	63,703
2014 Option exercises	1,155		45.02		52		52
2014 Senior note conversions	1				-		-
2014 Preferred stock conversions	233,236				-		-
2014 Totals	1,377,789			$	63,755	$	63,755
February 2015 public issuance	19,550,000	$	75.50	$	1,476,025	$	1,423,935
2015 Dividend reinvestment plan issuances	766,488		76.38		58,547		58,547
2015 Option exercises	149,788		47.17		7,065		7,065
2015 Stock incentive plans, net of forfeitures	166,815				-		-
2015 Senior note conversions	1,048,641				-		-
2015 Totals	21,681,732			$	1,541,637	$	1,489,547

Summary of dividend payments

	Three Months Ended
	March 31, 2015				March 31, 2014
	Per Share		Amount		Per Share		Amount
Common Stock	$	0.8250	$	272,569	$	0.7950	$	230,801
Series H Preferred Stock		-		-		0.0079		1
Series I Preferred Stock		0.8125		11,680		0.8125		11,680
Series J Preferred Stock		0.4064		4,672		0.4064		4,672
Totals			$	288,921			$	247,154

Summary of accumulated other comprehensive income/(loss)

		Unrecognized gains (losses) related to:
		Foreign Currency Translation		Available for Sale Securities		Actuarial Losses		Cash Flow Hedges		Total
Balance at December 31, 2014	$	(74,770)	$	-	$	(1,589)	$	(650)	$	(77,009)
Other comprehensive income before reclassification adjustments		(16,641)		(11,687)		-		(2,625)		(30,953)
Reclassification amount to net income		-		-		-		466 (1)		466
Net current-period other comprehensive income		(16,641)		(11,687)		-		(2,159)		(30,487)
Balance at March 31, 2015	$	(91,411)	$	(11,687)	$	(1,589)	$	(2,809)	$	(107,496)
Balance at December 31, 2013	$	(17,631)	$	(389)	$	(1,452)	$	(5,059)	$	(24,531)
Other comprehensive income before reclassification adjustments		(1,877)		549		-		(3)		(1,331)
Reclassification amount to net income		-		-		-		443 (1)		443
Net current-period other comprehensive income		(1,877)		549		-		440		(888)
Balance at March 31, 2014	$	(19,508)	$	160	$	(1,452)	$	(4,619)	$	(25,419)
(1) Please see note 11 for additional information.

XML

Stockholder's Equity (Details 4)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
Stockholders' Equity [Line Items]
Preferred stock conversions	0		(233,236)
Preferred Stock, Shares Outstanding	25,875,000	25,875,000	25,875,000	26,108,236
Preferred stock balance weighted average rate	0.065	0.065	0.065	0.06496
Preferred stock balance issued weighted average rate	0		0
Preferred stock balance redeemed weighted average rate	0		0
Preferred stock converted weighted average rate	0		0.06

XML

Disclosure about Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2015

Disclosure About Fair Value of Financial Instruments [Abstract]

Disclosure about Fair Value of Financial Instruments

16. Disclosure about Fair Value of Financial Instruments

U.S. GAAP provides authoritative guidance for measuring and disclosing fair value measurements of assets and liabilities. The guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014 for additional information.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.

Mortgage Loans and Other Real Estate Loans Receivable — The fair value of mortgage loans and other real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.

Cash and Cash Equivalents — The carrying amount approximates fair value.

Available-for-sale Equity Investments — Available-for-sale equity investments are recorded at their fair valuebased on Level 1 publicly available trading prices.

Borrowings Under Primary Unsecured Credit Facility — The carrying amount of the primary unsecured credit facility approximates fair value because the borrowings are interest rate adjustable.

Senior Unsecured Notes — The fair value of the fixed rate senior unsecured notes payable was estimated based on Level 1 publicly available trading prices.The carrying amount of variable rate senior unsecured notes payable approximates fair value because the borrowings are interest rate adjustable.

Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable.

Foreign Currency Forward Contracts— Foreign currency forward contracts are recorded in other assets or other liabilities on the balance sheet at fair market value. Fair market value is determined using Level 2 inputs by estimating the future value of the currency pair based on existing exchange rates, comprised of current spot and traded forward points, and calculating a present valueof the net amount using a discount factor based on observable traded interest rates.

Redeemable OP Unitholder Interests — The fair value of our redeemable unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, oneshare of our common stock per unit, subject to adjustment in certain circumstances.

The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):

		March 31, 2015				December 31, 2014
		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Financial assets:
	Mortgage loans receivable	$	554,731	$	577,232	$	188,651	$	194,935
	Other real estate loans receivable		190,536		192,005		191,518		195,375
	Available-for-sale equity investments		46,740		46,740		-		-
	Cash and cash equivalents		202,273		202,273		473,726		473,726
	Foreign currency forward contracts		73,081		73,081		57,087		57,087
Financial liabilities:
	Borrowings under unsecured credit facilities	$	410,000	$	410,000	$	-	$	-
	Senior unsecured notes		7,518,196		8,378,885		7,766,251		8,613,702
	Secured debt		3,010,971		2,993,308		2,977,713		3,053,067
	Foreign currency forward contracts		410		410		1,495		1,495
Redeemable OP unitholder interests			47,147		47,147		46,722		46,722

Items Measured at Fair Value on a Recurring Basis

The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):

	Fair Value Measurements as of March 31, 2015
	Total		Level 1		Level 2		Level 3
Available-for-sale equity investments(1)	$	46,740	$	46,740	$	-	$	-
Foreign currency forward contracts, net(2)		72,671		-		72,671		-
Redeemable OP unitholder interests		47,147		-		47,147		-
Totals	$	166,558		46,740	$	119,818	$	-
(1) Unrealized gains or losses on equity investments are recorded in accumulated other comprehensive income (loss) at each measurement date.
(2) Please see Note 11 for additional information.

Items Measured at Fair Value on a Nonrecurring Basis

In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis. As these assets and liabilities are not measured at fair value on a recurring basis, they are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired/assumed in business combinations (see Note 3) and asset impairments (if applicable, see Note 5 for impairments of real property and Note 6 for impairments of loans receivable). We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally reside within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of secured debt assumed in business combinations using current interest rates at which similar borrowings could be obtained on the transaction date.

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2015

Earnings Per Share (Tables) [Abstract]

Computation of basic and diluted earnings per share

		Three Months Ended
		March 31,
		2015		2014
Numerator for basic and diluted earnings
	per share - net income (loss) attributable
	to common stockholders	$	190,799	$	50,022
Denominator for basic earnings per
	share - weighted average shares		336,754		289,606
Effect of dilutive securities:
	Employee stock options		200		148
	Non-vested restricted shares		416		540
	Convertible senior unsecured notes		442		623
Dilutive potential common shares			1,058		1,311
Denominator for diluted earnings per
	share - adjusted weighted average shares		337,812		290,917
Basic earnings per share		$	0.57	$	0.17
Diluted earnings per share		$	0.56	$	0.17

XML

Income Taxes and Distributions

3 Months Ended

Mar. 31, 2015

Income Taxes And Distributions [Abstract]

Income Taxes And Distributions

18. Income Taxes and Distributions

We elected to be taxed as a REIT commencing with our first taxable year.To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of current year taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes.

Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.”  A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years. 

Income tax expense reflected in the financial statements primarily represents U.S. federal and state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and all of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. The company reflects current and deferred tax liabilities for any such withholding taxes incurred as a result of this holding company structure in its consolidated financial statements.

The income tax benefit for the three month periods ended March 31, 2015 and 2014 is due primarily to operating income or losses at our TRS entities. Net deferred tax liabilities with respect to our TRS entities totaled $13,771,000 and $12,451,000 as of March 31, 2015 and December 31, 2014, respectively, and related primarily to differences between the financial reporting and tax bases of fixed and intangible assets.

Generally, given current statutes of limitations, we are subject to audit by the Internal Revenue Service (“IRS”) for the year ended December 31, 2011 and subsequent years and by state taxing authorities for the year ended December 31, 2010 and subsequent years.  The company and its subsidiaries are also subject to audit by the Canada Revenue Agency and provincial authorities generally for periods subsequent to our initial investments in Canada made in May 2012, by HM Revenue & Customs for periods subsequent to our initial investments in the United Kingdom made in August 2012 and by Luxembourg taxing authorities generally for periods subsequent to our establishment of certain Luxembourg-based subsidiaries during 2014.

      The balance of our unrecognized tax benefits as of March 31, 2015 and December 31, 2014 was $857,000. The unrecognized tax benefits and related penalties, as currently accrued for, have an immaterial impact on the effective tax rate to the extent that they would be recognized.

XML

Stock Incentive Plans (Details Textual) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock Incentive Plans [Line Items]
Number of common stock authorized for Long-Term Incentive Plan	6,200,000
Stock-based compensation expense	$ 9,054,000	$ 7,667,000
Maximum [Member]
Stock Incentive Plans [Line Items]
Vesting period	5 years
Minimum [Member]
Stock Incentive Plans [Line Items]
Vesting period	3 years
Employee Stock Option [Member] | Employee Stock Option [Member]
Stock Incentive Plans [Line Items]
Vesting period	10 years
Employee Stock Option [Member] | Employee Stock Option [Member] | Director [Member]
Stock Incentive Plans [Line Items]
Vesting period	3 years
Employee Stock Option [Member] | Employee Stock Option [Member] | Officer [Member]
Stock Incentive Plans [Line Items]
Vesting period	5 years

XML

Business

3 Months Ended

Mar. 31, 2015

Business [Abstract]

Business

1. Business

     Health Care REIT, Inc., an S&P 500 company with headquarters in Toledo, Ohio, is an equity real estate investment trust (“REIT”) that invests in seniors housing and health care real estate. Our full service platform offers property management and development services to our customers. As of March 31, 2015, our diversified portfolio consisted of 1,384 properties in 46 states, the United Kingdom, and Canada. Founded in 1970, we were the first real estate investment trust to invest exclusively in health care facilities.

XML

Consolidated Statements of Income (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Revenues:
Rental income	$ 379,587,000		$ 336,455,000
Resident fees and services	492,510,000		456,265,000
Interest income	16,994,000		8,594,000
Other income	5,086,000		493,000
Total revenues	894,177,000		801,807,000
Expenses:
Interest expense	121,080,000		120,833,000
Property operating expenses	376,461,000		341,431,000
Depreciation and amortization	188,829,000		233,318,000
General and administrative	35,138,000		32,865,000
Transaction costs	48,554,000		952,000
Loss (gain) on derivatives, net	(58,427,000)	[1]
Loss (gain) on extinguishment of debt, net	(15,401,000)		148,000
Provision for loan losses	0
Impairment of Asset	2,220,000
Total expenses	729,256,000		729,251,000
Income (loss) from continuing operations before income taxes and income from unconsolidated entities, total	164,921,000		72,556,000
Income tax (expense) benefit	304,000		(2,260,000)
(Loss) income from unconsolidated entities	(12,648,000)		(5,556,000)
Income from continuing operations	152,577,000		64,740,000
Discontinued operations:
Gain (loss) on sales of properties, net	56,845,000
Income (loss) from discontinued operations, net			460,000
Gain (loss) on real estate dispositions, net	56,845,000
Net income	209,422,000		65,200,000
Less: Preferred stock dividends	16,352,000		16,353,000
Less: Net income (loss) attributable to noncontrolling interests	2,271,000	[2]	(1,175,000)	[2]
Net income (loss) attributable to common stockholders	$ 190,799,000		$ 50,022,000
Average number of common shares outstanding:
Basic	336,754		289,606
Diluted	337,812		290,917
Basic:
Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions	$ 0.57		$ 0.17
Discontinued operations, net	$ 0
Net income (loss) attributable to common stockholders, total	$ 0.57		$ 0.17
Diluted:
Income (loss) from continuing operations attributable to common stockholders, including real estate dispositions	$ 0.56		$ 0.17
Discontinued operations, net	$ 0
Net income (loss) attributable to common stockholders, total	$ 0.56		$ 0.17
Dividends declared and paid per common share	$ 0.825		$ 0.795

[1] (1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.

[2] (1) Includes amounts attributable to redeemable noncontrolling interests.

XML

Derivative Instruments

3 Months Ended

Mar. 31, 2015

Summary of Derivative Instruments [Abstract]

Derivative Instruments

11. Derivative Instruments

We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We may elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to manage the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. In addition, non-U.S. investments expose us to the potential losses associated with adverse changes in foreign currency to U.S. Dollar exchange rates. We may elect to manage this risk through the use of forward contracts and issuing debt in foreign currencies.

Interest Rate Swap Contracts and Foreign Currency Forward Contracts Designated as Cash Flow Hedges

For instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”), and reclassified into earnings in the same period, or periods, during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings. Approximately $5,363,000 of losses, which are included in accumulated other comprehensive income (“AOCI”), are expected to be reclassified into earnings in the next 12 months.

Foreign Currency Hedges

For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI. During the three months ended March 31, 2015, we settled certain net investment hedges generating cash proceeds of $72,477,000.  The balance of the cumulative translation adjustment will be reclassified to earnings when the hedged investment is sold or substantially liquidated.

The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands):

		March 31, 2015		December 31, 2014
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	1,175,000	$	900,000
Denominated in Pounds Sterling	£	350,000	£	350,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges
Denominated in U.S. Dollars	$	57,000	$	57,000
Denominated in Canadian Dollars	$	55,000	$	58,000
Denominated in Pounds Sterling	£	42,000	£	40,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	3,000	$	12,000

The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):

		Three Months Ended
		March 31,
	Location		2015		2014
Gain (loss) on interest rate swap recognized in OCI (effective portion)	OCI	$	-	$	(3)
Gain (loss) on interest rate swaps reclassified from AOCI into income (effective portion)	Interest expense		(466)		(443)
Gain (loss) on forward exchange contracts recognized in income	Interest expense		2,747		-
Loss (gain) on option exercise(1)	Loss (gain) on derivatives, net		(58,427)		-
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		184,051		18,489
(1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.

XML

Document and Entity Information (USD $)	3 Months Ended
	Mar. 31, 2015	May 01, 2015	Jun. 30, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	HEALTH CARE REIT INC /DE/
Entity Central Index Key	0000766704
Document Type	10-Q
Document Period End date	Mar. 31, 2015
Amendment Flag	false
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 19,277,423,332
Entity Common Stock Shares Outstanding		350,626,627

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2015

Commitments and Contingencies [Abstract]

Commitments and Contingencies

12. Commitments and Contingencies

At March 31, 2015, we had sevenoutstanding letter of credit obligations totaling $77,057,000 and expiring between 2015 and 2018. At March 31, 2015, we had outstanding construction in progress of $211,941,000 and were committed to providing additional funds of approximately $355,231,000to complete construction. Purchase obligations include contingent purchase obligations totaling $59,856,000. These contingent purchase obligations relate to unfunded capital improvement obligations and contingent obligations on acquisitions. Rents due from the tenant are increased to reflect the additional investment in the property.

     We evaluate our leases for operating versus capital lease treatment in accordance with Accounting Standards Codification (“ASC”) Topic 840 “Leases.”  A lease is classified as a capital lease if it provides for transfer of ownership of the leased asset at the end of the lease term, contains a bargain purchase option, has a lease term greater than 75% of the economic life of the leased asset, or if the net present value of the future minimum lease payments are in excess of 90% of the fair value of the leased asset. Certain leases contain bargain purchase options and have been classified as capital leases. AtMarch 31, 2015, we had operating lease obligations of $948,535,000 relating to certain ground leases and company office space and capital lease obligations of $102,117,000 relating primarily to certain investment properties. Regarding ground leases, we have sublease agreements with certain of our operators that require the operators to reimburse us for our monthly operating lease obligations. At March 31, 2015, aggregate future minimum rentals to be received under these noncancelable subleases totaled $28,834,000.

XML

Consolidated Statements of Comprehensive Income (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income	$ 209,422,000		$ 65,200,000
Other comprehensive income (loss):
Unrecognized gain (loss) on equity investments	(11,687,000)		549,000
Unrecognized gain (loss) on cash flow hedges	(2,159,000)		440,000
Reclassification adjustment realized in net income	0		0
Unrecognized actuarial gain/(loss)	0		0
Unrecognized gain (loss) on foreign currency translation	(29,197,000)		(9,889,000)
Total other comprehensive income (loss)	(43,043,000)		(8,900,000)
Total comprehensive income (loss), total	166,379,000		56,300,000
Total comprehensive income (loss) attributable to noncontrolling interests	(10,285,000)	[1]	(9,187,000)	[1]
Comprehensive income (loss) attributable to controlling interests	$ 176,664,000		$ 65,487,000

[1] (1) Includes amounts attributable to redeemable noncontrolling interests.

XML

Real Estate Loans Receivable

3 Months Ended

Mar. 31, 2015

Real Estate Loans Receivable [Abstract]

Real Estate Loans Receivable

6. Real Estate Loans Receivable

     The following is a summary of our real estate loan activity for the periods presented (in thousands):

		Three Months Ended
		March 31, 2015						March 31, 2014
				Outpatient						Outpatient
		Triple-net		Medical		Totals		Triple-net		Medical		Totals
Advances on real estate loans receivable:
	Investments in new loans	$	368,080	$	-	$	368,080	$	1,203	$	-	$	1,203
	Draws on existing loans		14,330		2,285		16,615		23,077		5,429		28,506
	Net cash advances on real estate loans		382,410		2,285		384,695		24,280		5,429		29,709
Receipts on real estate loans receivable:
	Loan payoffs		8,568		-		8,568		500		-		500
	Principal payments on loans		7,933		-		7,933		10,127		19		10,146
	Net cash receipts on real estate loans		16,501		-		16,501		10,627		19		10,646
Net cash advances (receipts) on real estate loans			365,909		2,285		368,194		13,653		5,410		19,063
Change in balance due to foreign currency translation			(3,096)		-		(3,096)		192		-		192
Net change in real estate loans receivable		$	362,813	$	2,285	$	365,098	$	13,845	$	5,410	$	19,255

We recorded no provision for loan losses during the three months ended March 31, 2015. At March 31, 2015, we had real estate loans with outstanding balances of $21,000,000on non-accrual status with an allowance for loan losses of $0.

XML

Dispositions, Assets Held for Sale and Discontinued Operations

3 Months Ended

Mar. 31, 2015

Disclosure Dispositions, Assets Held for Sale and Discontinued Operations [Abstract]

Dispositions, Assets Held for Sale and Discontinued Operations

5. Dispositions, Assets Held for Sale and Discontinued Operations

We periodically sell properties for various reasons, including favorable market conditions or the exercise of tenant purchase options. Of our total sales proceeds, $19,493,000 was deposited in an Internal Revenue Code Section 1031 exchange escrow account with a qualified intermediary. The following is a summary of our real property disposition activity for the periods presented (in thousands):

		Three Months Ended
		March 31, 2015			March 31, 2014
Real property dispositions:
	Triple-net		$	110,998		$	-
	Outpatient medical			9,422			-
	Total dispositions			120,420			-
Gain (loss) on sales of real property, net				56,845			-
Proceeds from real property sales			$	177,265		$	-

Dispositions and Assets Held for Sale

Pursuant to our adoption of ASU No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity” (“ASU 2014-08”), operating results attributable to properties sold subsequent to or classified as held for sale after January 1, 2014 and which do not meet the definition of discontinued operations are no longer reclassified on our Consolidated Statements of Comprehensive Income. The following represents the activity related to these properties for the periods presented (in thousands):

			Three Months Ended
			March 31,
		2015		2014
Revenues:
	Rental income	$	4,517	$	28,243
Expenses:
	Interest expense		1,303		7,644
	Property operating expenses		14		673
	Provision for depreciation		133		8,236
	Total expenses		1,450		16,553
Income (loss) from real estate dispositions, net		$	3,067	$	11,690

Discontinued Operations

We have reclassified the income and expenses attributable to all properties sold prior to or held for sale at January 1, 2014 to discontinued operations in accordance with ASU 2014-08. The following illustrates the reclassification impact as reported in our Consolidated Statements of Comprehensive Income as a result of classifying these properties as discontinued operations for the periods presented (in thousands):

			Three Months Ended
			March 31,
		2015		2014
Revenues:
	Rental income	$	-	$	583
Expenses:
	Interest expense		-		123
	Total expenses		-		123
Income (loss) from discontinued operations, net		$	-	$	460

XML

Segment Reporting

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment Reporting

17. Segment Reporting

We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our four operating segments: triple-net, seniors housing operating, outpatient medical and life science. During the quarter ended March 31, 2015, we changed the names of our seniors housing triple-net segment to triple-net and our medical facilities segment to outpatient medical.

Our triple-net properties include long-term/post-acute care facilities, hospitals, assisted living facilities, independent living/continuing care retirement communities, care homes (United Kingdom), independent support living facilities (Canada), care homes with nursing (United Kingdom) and combinations thereof. Under the triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our seniors housing operating properties include the seniors housing communities referenced above that are owned and/or operated through RIDEA structures (see Notes 3 and 18).

Our outpatient medical properties include medical office buildings and life science buildings which are aggregated into our outpatient medical reportable segment. Our medical office buildings are typically leased to multiple tenants and generally require a certain level of property management. Our life science investment represents an investment in an unconsolidated entity (see Note 7).

We evaluate performance based upon NOI by segment. We define NOI as total revenues, including tenant reimbursements, less property level operating expenses. We believe NOI provides investors relevant and useful information because it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.

Non-segment revenue consists mainly of interest income on non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. There are no intersegment sales or transfers.

     Summary information for the reportable segments is as follows for the periods presented (in thousands):

Three Months Ended March 31, 2015:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	264,406	$	-	$	115,181	$	-	$	379,587
Resident fees and services		-		492,510		-		-		492,510
Interest income		14,699		1,031		1,264		-		16,994
Other income		3,883		1,020		161		22		5,086
Total revenues		282,988		494,561		116,606		22		894,177
Property operating expenses		-		338,507		37,954		-		376,461
Net operating income from continuing operations		282,988		156,054		78,652		22		517,716
Reconciling items:
Interest expense		10,027		34,458		7,625		68,970		121,080
Loss (gain) on derivatives, net		(58,427)		-		-		-		(58,427)
Depreciation and amortization		70,031		76,636		42,162		-		188,829
General and administrative		-		-		-		35,138		35,138
Transaction costs		36,172		12,042		341		-		48,555
Loss (gain) on extinguishment of debt, net		10,336		-		-		5,064		15,400
Impairment of assets		2,220		-		-		-		2,220
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		212,629		32,918		28,524		(109,150)		164,921
Income tax expense		418		(533)		466		(48)		303
(Loss) income from unconsolidated entities		1,393		(15,073)		1,032		-		(12,648)
Income (loss) from continuing operations		214,440		17,312		30,022		(109,198)		152,576
Gain (loss) on real estate dispositions, net		54,097		-		2,749		-		56,846
Net income (loss)	$	268,537	$	17,312	$	32,771	$	(109,198)	$	209,422
Total assets	$	11,916,636	$	10,208,763	$	4,444,058	$	59,938	$	26,629,395

Three Months Ended March 31, 2014:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	237,716	$	-	$	98,739	$	-	$	336,455
Resident fees and services		-		456,265		-		-		456,265
Interest income		7,720		-		874		-		8,594
Other income		144		54		280		15		493
Total revenues		245,580		456,319		99,893		15		801,807
Property operating expenses		243		308,184		33,004		-		341,431
Net operating income from continuing operations		245,337		148,135		66,889		15		460,376
Reconciling items:
Interest expense		9,115		27,479		9,383		74,856		120,833
Depreciation and amortization		67,269		129,162		36,887		-		233,318
General and administrative		-		-		-		32,865		32,865
Transaction costs		275		630		47		-		952
Loss (gain) on extinguishment of debt, net		-		(148)		-		-		(148)
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		168,678		(8,988)		20,572		(107,706)		72,556
Income tax expense		(355)		(1,643)		(262)		-		(2,260)
(Loss) income from unconsolidated entities		1,382		(7,961)		1,023		-		(5,556)
Income (loss) from continuing operations		169,705		(18,592)		21,333		(107,706)		64,740
Income (loss) from discontinued operations		460		-		-		-		460
Net income (loss)	$	170,165	$	(18,592)	$	21,333	$	(107,706)	$	65,200

		Three Months Ended
		March 31, 2015			March 31, 2014
Revenues:		Amount	%		Amount	%
United States	$	745,136	83.3%	$	675,099	84.2%
International		149,041	16.7%		126,708	15.8%
Total	$	894,177	100.0%	$	801,807	100.0%
		As of
		March 31, 2015			December 31, 2014
Assets:		Amount	%		Amount	%
United States	$	21,880,931	82.2%	$	20,728,477	82.9%
International		4,748,464	17.8%		4,285,819	17.1%
Total	$	26,629,395	100.0%	$	25,014,296	100.0%

XML

Stockholders' Equity

3 Months Ended

Mar. 31, 2015

Stockholders' Equity [Abstract]

Stockholders' Equity

13. Stockholders’ Equity

     The following is a summary of our stockholders’ equity capital accounts as of the dates indicated:

	March 31, 2015	December 31, 2014
Preferred Stock:
Authorized shares	50,000,000	50,000,000
Issued shares	25,875,000	25,875,000
Outstanding shares	25,875,000	25,875,000
Common Stock, $1.00 par value:
Authorized shares	700,000,000	700,000,000
Issued shares	351,237,849	329,487,615
Outstanding shares	350,471,798	328,790,066

Preferred Stock. The following is a summary of our preferred stock activity during the periods indicated:

	Three Months Ended
	March 31, 2015		March 31, 2014
		Weighted Avg.		Weighted Avg.
	Shares	Dividend Rate	Shares	Dividend Rate
Beginning balance	25,875,000	6.500%	26,108,236	6.496%
Shares converted	-	0.000%	(233,236)	6.000%
Ending balance	25,875,000	6.500%	25,875,000	6.500%

Common Stock. The following is a summary of our common stock issuances during the three months ended March 31, 2015 and 2014 (dollars in thousands, except per share amounts):

	Shares Issued		Average Price		Gross Proceeds		Net Proceeds
2014 Dividend reinvestment plan issuances	1,143,397	$	55.71	$	63,703	$	63,703
2014 Option exercises	1,155		45.02		52		52
2014 Senior note conversions	1				-		-
2014 Preferred stock conversions	233,236				-		-
2014 Totals	1,377,789			$	63,755	$	63,755
February 2015 public issuance	19,550,000	$	75.50	$	1,476,025	$	1,423,935
2015 Dividend reinvestment plan issuances	766,488		76.38		58,547		58,547
2015 Option exercises	149,788		47.17		7,065		7,065
2015 Stock incentive plans, net of forfeitures	166,815				-		-
2015 Senior note conversions	1,048,641				-		-
2015 Totals	21,681,732			$	1,541,637	$	1,489,547

Dividends. The increase in dividends is primarily attributable to increases in our common shares outstanding as described above and an increase in common dividends per share. The following is a summary of our dividend payments (in thousands, except per share amounts):

	Three Months Ended
	March 31, 2015				March 31, 2014
	Per Share		Amount		Per Share		Amount
Common Stock	$	0.8250	$	272,569	$	0.7950	$	230,801
Series H Preferred Stock		-		-		0.0079		1
Series I Preferred Stock		0.8125		11,680		0.8125		11,680
Series J Preferred Stock		0.4064		4,672		0.4064		4,672
Totals			$	288,921			$	247,154

Accumulated Other Comprehensive Income. The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):

		Unrecognized gains (losses) related to:
		Foreign Currency Translation		Available for Sale Securities		Actuarial Losses		Cash Flow Hedges		Total
Balance at December 31, 2014	$	(74,770)	$	-	$	(1,589)	$	(650)	$	(77,009)
Other comprehensive income before reclassification adjustments		(16,641)		(11,687)		-		(2,625)		(30,953)
Reclassification amount to net income		-		-		-		466 (1)		466
Net current-period other comprehensive income		(16,641)		(11,687)		-		(2,159)		(30,487)
Balance at March 31, 2015	$	(91,411)	$	(11,687)	$	(1,589)	$	(2,809)	$	(107,496)
Balance at December 31, 2013	$	(17,631)	$	(389)	$	(1,452)	$	(5,059)	$	(24,531)
Other comprehensive income before reclassification adjustments		(1,877)		549		-		(3)		(1,331)
Reclassification amount to net income		-		-		-		443 (1)		443
Net current-period other comprehensive income		(1,877)		549		-		440		(888)
Balance at March 31, 2014	$	(19,508)	$	160	$	(1,452)	$	(4,619)	$	(25,419)
(1) Please see note 11 for additional information.

XML

Borrowings Under Credit Facilities and Related Items

3 Months Ended

Mar. 31, 2015

Borrowings Under Credit Facilities and Related Items [Abstract]

Borrowings Under Credit Facilities and Related Items

9. Borrowings Under Credit Facilities and Related Items

     At March 31, 2015, we had aprimary unsecured credit facility with a consortium of 28 banks that includes a $2,500,000,000 unsecured revolving credit facility, a $500,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $500,000,000 unsecured term credit facility by up to an additional $1,000,000,000 and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000. The primary unsecured credit facility also allows us to borrow up to $500,000,000 in alternate currencies (none outstanding at March 31, 2015). Borrowings under the unsecured revolving credit facilityare subject to interest payable at the applicable margin over LIBOR interest rate (1.103% atMarch 31, 2015). The applicable margin is based on certain of our debt ratings and was0.925% atMarch 31, 2015. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on certain of our debt ratings and was 0.15% at March 31, 2015. The primary unsecured credit facility is scheduled to expire October 31, 2018 and can be extended for an additional year at our option.

     The following information relates to aggregate borrowings under the unsecured revolving credit facilityfor the periods presented (dollars in thousands):

		Three Months Ended March 31,
		2015		2014
Balance outstanding at quarter end(1)		$	410,000	$	562,000
Maximum amount outstanding at any month end		$	430,000	$	562,000
Average amount outstanding (total of daily
	principal balances divided by days in period)	$	408,944	$	286,889
Weighted average interest rate (actual interest
	expense divided by average borrowings outstanding)		1.21%		1.34%
(1) As of March 31, 2015, letters of credit in the aggregate amount of $65,335,000 have been issued, which reduces the borrowing capacity on the unsecured revolving credit facility.

XML

Derivative Instruments (Textual) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Derivative Instruments [Abstract]
Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months 2	$ 5,363,000
Derivative Cash Received On Hedge	$ 72,477,000

XML

Investments in Unconsolidated Entities

3 Months Ended

Mar. 31, 2015

Investments In Unconsolidated Entities [Abstract]

Equity Method Investments Disclosure [Text Block]

7. Investments in Unconsolidated Entities

We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. The results of operations for these properties have been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands):

	Percentage Ownership(1)	March 31, 2015		December 31, 2014
Triple-net	10% to 49%	$	31,276	$	31,511
Seniors housing operating	10% to 50%		509,743		539,147
Outpatient medical	36% to 49%		174,449		173,493
Total		$	715,468	$	744,151
(1) Excludes ownership of in-substance real estate.

At March 31, 2015, the aggregate unamortized basis difference of our joint venture investments of $169,696,000 is primarily attributable to appreciation of the underlying properties and transaction costs. This difference will be amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.

XML

Credit Concentration

3 Months Ended

Mar. 31, 2015

Customer Concentration [Abstract]

Credit Concentration

8. Credit Concentration

We use net operating income from continuing operations (“NOI”) as our credit concentration metric. See Note 17 for additional information and reconciliation. The following table summarizes certain information about our credit concentration as of March 31, 2015, excluding our share of NOI in unconsolidated entities (dollars in thousands):

		Number of	Total		Percent of
Concentration by relationship:(1)		Properties	NOI		NOI(2)
	Genesis Healthcare	180	$	87,277	17%
	Sunrise Senior Living(3)	143		71,268	14%
	Brookdale Senior Living	146		42,092	8%
	Benchmark Senior Living	49		21,726	4%
	Revera(3)	71		19,121	4%
	Remaining portfolio	727		276,232	53%
	Totals	1,316	$	517,716	100%

• Genesis Healthcare is in our triple-net segment. Sunrise Senior Living and Revera are in our seniors housing operating segment. Benchmark Senior Living and Brookdale Senior Living are in both our triple-net and seniors housing operating segments.
• NOI with our top five relationships comprised 49% of totalNOI for the year endingDecember 31, 2014.
• Revera owns a controlling interest in Sunrise.

XML

Senior Unsecured Notes and Secured Debt

3 Months Ended

Mar. 31, 2015

Senior Unsecured Notes and Secured Debt [Abstract]

Senior Unsecured Notes and Secured Debt

10. Senior Unsecured Notes and Secured Debt

We may repurchase, redeem or refinance convertible and non-convertible senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The non-convertible senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of (1) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (2) any “make-whole” amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.At March 31, 2015, the annual principal payments due on these debt obligations were as follows (in thousands):

	Senior		Secured
	Unsecured Notes(1,2)		Debt (1,3)		Totals
2015	$	-	$	332,035	$	332,035
2016		700,000		493,223		1,193,223
2017		450,000		379,397		829,397
2018		450,000		444,394		894,394
2019(4,5)		1,297,150		371,800		1,668,950
Thereafter(6,7)		4,670,771		951,809		5,622,580
Totals	$	7,567,921	$	2,972,658	$	10,540,579
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(2) Annual interest rates range from 1.1% to 6.5%.
(3) Annual interest rates range from 1.0% to 7.9%. Carrying value of the properties securing the debt totaled $5,349,988,000 at March 31, 2015.
(4) On July 25, 2014, we refinanced the funding on a $250,000,000 Canadian-denominated unsecured term credit facility (approximately $197,150,000 based on the Canadian/U.S. Dollar exchange rate on March 31, 2015). The loan matures on October 31, 2018 (with an option to extend for an additional year at our discretion) and bears interest at the Canadian Dealer Offered Rate plus 97.5 basis points (2.0% at March 31, 2015).
(5) On July 25, 2014, we refinanced the funding on a $500,000,000 unsecured term credit facility. The loan matures on October 31, 2018 (with an option to extend for one additional year at our discretion) and bears interest at LIBOR plus 97.5 basis points (1.15% at March 31, 2015).
(6) On November 20, 2013, we completed the sale of £550,000,000 (approximately $816,860,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2015) of 4.8% senior unsecured notes due 2028.
(7) On November 25, 2014, we completed the sale of £500,000,000 (approximately $742,600,000 based on the Sterling/U.S. Dollar exchange rate in effect on March 31, 2015) of 4.5% senior unsecured notes due 2034.

The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):

	Three Months Ended
	March 31, 2015			March 31, 2014
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	7,817,154	4.385%	$	7,421,707	4.400%
Debt redeemed		(154,654)	3.000%		(1)	3.000%
Foreign currency		(94,579)	4.333%		(3,332)	3.486%
Ending balance	$	7,567,921	4.352%	$	7,418,374	4.400%

The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands):

	Three Months Ended
		March 31, 2015		March 31, 2014
			Weighted Avg.			Weighted Avg.
	Amount		Interest Rate	Amount		Interest Rate
Beginning balance	$	2,941,765	4.94%	$	3,010,711	5.10%
Debt issued		82,724	2.34%		10,690	3.54%
Debt assumed		205,897	3.98%		-	0.00%
Debt extinguished		(192,427)	4.02%		(114,084)	5.73%
Principal payments		(15,630)	5.01%		(15,455)	5.12%
Foreign currency		(49,672)	3.96%		(15,905)	3.86%
Ending balance	$	2,972,657	4.88%	$	2,875,957	5.08%

Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintaincertain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of March 31, 2015, we were in compliance with all of the covenants under our debt agreements.

XML

Stockholder's Equity (Details 2) (USD $)	Mar. 31, 2015		Dec. 31, 2014	Mar. 31, 2014		Dec. 31, 2013
Summary of accumulated other comprehensive income/(loss) [Line Items]
Unrecognized losses on cash flow hedges	$ (2,809,000)		$ (650,000)	$ (4,619,000)		$ (5,059,000)
Unrecognized losses on equity investments	(11,687,000)		0	160,000		(389,000)
Unrecognized gains (losses) on foreign currency translation	(91,411,000)		(74,770,000)	(19,508,000)		(17,631,000)
Unrecognized actuarial losses	(1,589,000)		(1,589,000)	(1,452,000)		(1,452,000)
Totals	(107,496,000)		(77,009,000)	(25,419,000)		(24,531,000)
Other comprehensive income before reclassification adjustments
Summary of accumulated other comprehensive income/(loss) [Line Items]
Unrecognized losses on cash flow hedges	(2,625,000)			(3,000)
Unrecognized losses on equity investments	(11,687,000)			549,000
Unrecognized gains (losses) on foreign currency translation	(16,641,000)			(1,877,000)
Unrecognized actuarial losses	0			0
Totals	(30,953,000)			(1,331,000)
Reclassification amount to net income
Summary of accumulated other comprehensive income/(loss) [Line Items]
Unrecognized losses on cash flow hedges	466,000	[1]		443,000	[1]
Unrecognized losses on equity investments	0			0
Unrecognized gains (losses) on foreign currency translation	0	[1]		0
Unrecognized actuarial losses	0			0
Totals	466,000			443,000
Net current period other comprehensive income
Summary of accumulated other comprehensive income/(loss) [Line Items]
Unrecognized losses on cash flow hedges	(2,159,000)			440,000
Unrecognized losses on equity investments	(11,687,000)			549,000
Unrecognized gains (losses) on foreign currency translation	(16,641,000)			(1,877,000)
Unrecognized actuarial losses	0			0
Totals	$ (30,487,000)			$ (888,000)

[1] (1) Please see note 11 for additional information.

XML

Stockholder's Equity (Details 5) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Summary of dividend payments
Dividends declared and paid per common share	$ 0.825	$ 0.795
Common stock cash dividends	$ 272,569,000	$ 230,801,000
Total dividends paid	288,921,000	247,154,000
Series H Preferred Stock [Member]
Summary of dividend payments
Dividends declared and paid per preferred share		$ 0.0079
Preferred stock cash dividends		1,000
Series I Preferred Stock [Member]
Summary of dividend payments
Dividends declared and paid per preferred share	$ 0.8125	$ 0.8125
Preferred stock cash dividends	11,680,000	11,680,000
Series J Preferred Stock [Member]
Summary of dividend payments
Dividends declared and paid per preferred share	$ 0.4064	$ 0.4064
Preferred stock cash dividends	$ 4,672,000	$ 4,672,000

XML

Stockholder's Equity (Details 1) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Summary of common stock issuances
Dividend reinvestment plan issuances, Shares Issued	766,488	1,143,397
Dividend reinvestment plan issuances, Average Price	$ 76.38	$ 55.71
Dividend reinvestment plan issuances, Net Proceeds	58,547,000	63,703,000
Dividend reinvestment plan issuances, Gross Proceeds	58,547,000	63,703,000
Option exercises, Shares	149,788	1,155
Option exercises, Average Price	47.17	45.02
Option exercises, Gross Proceeds	7,065,000	52,000
Option exercises, Net Proceeds	7,065,000	52,000
Stock incentive plans, net of forfeitures, Shares Issued	166,815
Issuance of Common Stock, Shares	21,681,732	1,377,789
Preferred stock conversions	0	(233,236)
Senior note conversions	1,048,641	1
Equity issued in acquisition of noncontrolling interest		233,236
Gross Proceeds From Issuance of Common Stock	1,541,637,000	63,755,000
Net proceeds from the issuance of common stock	1,489,547,000	63,755,000
February 2015 Public Issuance [Member]
Summary of common stock issuances
Public issuance, Shares Issued	19,550,000
Public issuance, Average Price	$ 75.5
Public issuance, Gross Proceeds	1,476,025,000
Public issuance, Net Proceeds	$ 1,423,935,000

XML

Derivative Instruments (Tables)

3 Months Ended

Mar. 31, 2015

Derivative Instruments (Tables) [Abstract]

Impact of derivative instruments on the statement of operations and OCI

		March 31, 2015		December 31, 2014
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	1,175,000	$	900,000
Denominated in Pounds Sterling	£	350,000	£	350,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges
Denominated in U.S. Dollars	$	57,000	$	57,000
Denominated in Canadian Dollars	$	55,000	$	58,000
Denominated in Pounds Sterling	£	42,000	£	40,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	3,000	$	12,000

		Three Months Ended
		March 31,
	Location		2015		2014
Gain (loss) on interest rate swap recognized in OCI (effective portion)	OCI	$	-	$	(3)
Gain (loss) on interest rate swaps reclassified from AOCI into income (effective portion)	Interest expense		(466)		(443)
Gain (loss) on forward exchange contracts recognized in income	Interest expense		2,747		-
Loss (gain) on option exercise(1)	Loss (gain) on derivatives, net		(58,427)		-
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		184,051		18,489
(1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.

XML

Investments in Unconsolidated Entities (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]
(Loss) income from unconsolidated entities	$ (12,648,000)	$ (5,556,000)
Investments in unconsolidated entities	715,468,000		744,151,000
Unamortized Investment In Joint Venture Primarily Attributable To Real Estate And Related Intangible Assets	166,699,000,000
Triple Net [Member]
Schedule of Equity Method Investments [Line Items]
(Loss) income from unconsolidated entities	1,393,000	1,382,000
Senior housing - operating [Member]
Schedule of Equity Method Investments [Line Items]
(Loss) income from unconsolidated entities	(15,073,000)	(7,961,000)
Outpatient Medical [Member]
Schedule of Equity Method Investments [Line Items]
(Loss) income from unconsolidated entities	$ 1,032,000	$ 1,023,000

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings Per Share

15. Earnings Per Share

     The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

		Three Months Ended
		March 31,
		2015		2014
Numerator for basic and diluted earnings
	per share - net income (loss) attributable
	to common stockholders	$	190,799	$	50,022
Denominator for basic earnings per
	share - weighted average shares		336,754		289,606
Effect of dilutive securities:
	Employee stock options		200		148
	Non-vested restricted shares		416		540
	Convertible senior unsecured notes		442		623
Dilutive potential common shares			1,058		1,311
Denominator for diluted earnings per
	share - adjusted weighted average shares		337,812		290,917
Basic earnings per share		$	0.57	$	0.17
Diluted earnings per share		$	0.56	$	0.17

The Series I Cumulative Convertible Perpetual Preferred Stock was not included in the calculations as the effect of conversions into common stock was anti-dilutive.

XML

Real Property Acquisitions and Development (Tables)

3 Months Ended

Mar. 31, 2015

Real property acquisitions and development [Line Items]

Estimated Fair Value of Allocated Purchase Price of Asset and Liabilities

Triple-net Activity

		Three Months Ended
(In thousands)		March 31, 2015(1)			March 31, 2014
Land and land improvements			$	70,002		$	2,750
Buildings and improvements				537,014			30,693
Acquired lease intangibles				799			-
Receivables and other assets				7			-
	Total assets acquired			607,822			33,443
Accrued expenses and other liabilities				(732)			-
	Total liabilities assumed			(732)			-
Non-cash acquisition related activity				(357)			(657)
	Cash disbursed for acquisitions			606,733			32,786
Construction in progress additions				45,360			24,657
Less:	Capitalized interest			(1,756)			(1,170)
	Foreign currency translation			(642)			(14)
Cash disbursed for construction in progress				42,962			23,473
Capital improvements to existing properties				11,557			5,877
	Total cash invested in real property, net of cash acquired		$	661,252		$	62,136
(1) Includes acquisitions with an aggregate purchase price of $571,586,000 for which the allocation of the purchase price consideration is preliminary and subject to change.

Seniors Housing Operating Activity

		Three Months Ended
(In thousands)		March 31, 2015(1)			March 31, 2014
Land and land improvements			$	86,184		$	2,100
Building and improvements				1,016,426			19,069
Acquired lease intangibles				62,838			1,331
Restricted cash				3,820			-
Receivables and other assets				23,014			-
	Total assets acquired(2)			1,192,282			22,500
Secured debt				(208,960)			-
Accrued expenses and other liabilities				(16,164)			(245)
	Total liabilities assumed			(225,124)			(245)
Noncontrolling interests				(83,194)			-
	Cash disbursed for acquisitions			883,964			22,255
Construction in progress additions				4,193			1,026
Less:	Capitalized interest			(394)			(50)
	Foreign currency translation			(1,472)			-
Cash disbursed for construction in progress				2,327			976
Capital improvements to existing properties				11,632			13,998
	Total cash invested in real property, net of cash acquired		$	897,923		$	37,229
(1) Includes acquisitions with an aggregate purchase price of $885,642,000 for which the allocation of the purchase price consideration is preliminary and subject to change.
(2) Excludes $1,677,000 and $245,000 of cash acquired during the three months ended March 31, 2015 and 2014, respectively.

Outpatient Medical Activity

		Three Months Ended
(In thousands)		March 31, 2015 (1)			March 31, 2014
Buildings and improvements			$	9,786	$	-
Acquired lease intangibles				511		-
	Total assets acquired			10,297		-
	Cash disbursed for acquisitions			10,297		-
Construction in progress additions				16,421		38,237
Less:	Capitalized interest			(237)		(385)
	Accruals(2)			(1,921)		(9,584)
Cash disbursed for construction in progress				14,263		28,268
Capital improvements to existing properties				6,639		7,531
	Total cash invested in real property		$	31,199	$	35,799
(1) Includes acquisitions with an aggregate purchase price of $10,297,000 for which the allocation of the purchase price consideration is preliminary and subject to change.
(2) Represents non-cash consideration accruals for amounts to be paid in future periods relating to properties that converted in the periods noted above.

Summary of construction projects placed into service and generating revenues

			Three Months Ended
			March 31, 2015			March 31, 2014
	Development projects:
		Triple-net		$	-		$	8,481
		Outpatient medical			16,592			42,799
		Total development projects			16,592			51,280
	Expansion projects				19,541			9,209
Total construction in progress conversions				$	36,133		$	60,489

XML

Real Estate Loans Receivable (Textuals) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Real Estate Loans Receivable (Textual) [Abstract]
Provision for loan losses	$ 0
Allowance for loan losses	0
Real estate loans with outstanding balances	$ 21,000,000,000

XML

Real Property Acquisitions and Development (Details 2) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Development projects:
Total development projects	$ 16,592,000	$ 51,280,000
Expansion projects	19,541,000	9,209,000
Total construction in progress conversions	36,133,000	60,489,000
Outpatient Medical [Member]
Development projects:
Total development projects	16,592,000	42,799,000
Triple Net [Member]
Development projects:
Total development projects	$ 0	$ 8,481,000

XML

Consolidated Statements of Equity (Unaudited) (USD $)	Total	Preferred Stock	Common Stock	Capital in Excess of Par Value	Treasury Stock	Cumulative Net Income	Cumulative Dividends	Accumulated Other Comprehensive Income (Loss)	Other Equity	Noncontrolling Interests
Balances at beginning of period at Dec. 31, 2013	$ 11,756,331,000	$ 1,017,361,000	$ 289,461,000	$ 12,418,520,000	$ (21,263,000)	$ 2,329,869,000	$ (4,600,854,000)	$ (24,531,000)	$ 6,020,000	$ 341,748,000
Comprehensive income:
Net income (loss)	65,393,000					66,375,000				(982,000)
Other comprehensive income	(8,900,000)							(888,000)		(8,012,000)
Total comprehensive income	56,493,000
Net change in noncontrolling interests	(7,096,000)			(2,713,000)						(4,383,000)
Amounts related to issuance of common stock from dividend reinvestment and stock incentive plans, net of forfeitures	63,919,000		1,397,000	67,725,000	(5,191,000)				(12,000)
Proceeds from issuance of common stock	0		0	0
Conversion of preferred stock		(11,111,000)	233,000	10,878,000
Equity component of convertible debt	0
Option compensation expense	233,000								233,000
Cash dividends paid:
Common stock cash dividends	(230,801,000)						(230,801,000)
Preferred stock cash dividends	(16,353,000)						(16,353,000)
Balances at end of period at Mar. 31, 2014	11,622,726,000	1,006,250,000	291,091,000	12,494,410,000	(26,454,000)	2,396,244,000	(4,848,008,000)	(25,419,000)	6,241,000	328,371,000
Balances at beginning of period at Dec. 31, 2014	13,473,049,000	1,006,250,000	328,835,000	14,740,712,000	(35,241,000)	2,842,022,000	(5,635,923,000)	(77,009,000)	5,507,000	297,896,000
Comprehensive income:
Net income (loss)	209,076,000					207,151,000				1,925,000
Other comprehensive income	(43,043,000)							(30,487,000)		(12,556,000)
Total comprehensive income	166,033,000
Net change in noncontrolling interests	70,757,000			(4,540,000)						75,297,000
Amounts related to issuance of common stock from dividend reinvestment and stock incentive plans, net of forfeitures	67,236,000		1,001,000	73,642,000	(6,132,000)				(1,275,000)
Proceeds from issuance of common stock	1,423,935,000		19,550,000	1,404,385,000
Conversion of preferred stock	0
Equity component of convertible debt	5,643,000		1,048,000	4,595,000
Option compensation expense	217,000								217,000
Cash dividends paid:
Common stock cash dividends	(272,569,000)						(272,569,000)
Preferred stock cash dividends	(16,352,000)						(16,352,000)
Balances at end of period at Mar. 31, 2015	$ 14,917,949,000	$ 1,006,250,000	$ 350,434,000	$ 16,218,794,000	$ (41,373,000)	$ 3,049,173,000	$ (5,924,844,000)	$ (107,496,000)	$ 4,449,000	$ 362,562,000

XML

Real Estate Intangibles

3 Months Ended

Mar. 31, 2015

Real Estate Intangibles [Abstract]

Real Estate Intangibles

4. Real Estate Intangibles

     The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):

		March 31, 2015		December 31, 2014
Assets:
	In place lease intangibles	$	1,037,697	$	988,290
	Above market tenant leases		66,162		65,684
	Below market ground leases		62,426		62,426
	Lease commissions		20,809		19,536
	Gross historical cost		1,187,094		1,135,936
	Accumulated amortization		(789,546)		(776,501)
	Net book value	$	397,548	$	359,435
	Weighted-average amortization period in years		16.2		17.7
Liabilities:
	Below market tenant leases	$	91,365	$	91,168
	Above market ground leases		7,859		7,859
	Gross historical cost		99,224		99,027
	Accumulated amortization		(42,853)		(40,891)
	Net book value	$	56,371	$	58,136
	Weighted-average amortization period in years		14.4		14.4

The following is a summary of real estate intangible amortization for the periods presented (in thousands):

	Three Months Ended
	March 31,
	2015		2014
Rental income related to above/below market tenant leases, net	$	206	$	(45)
Property operating expenses related to above/below market ground leases, net		(319)		(311)
Depreciation and amortization related to in place lease intangibles and lease commissions		(24,324)		(79,393)

     The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):

		Assets		Liabilities
2015	$	72,406	$	$3,323
2016		60,019		8,176
2017		37,369		8,594
2018		26,596		8,500
2019		23,289		6,819
Thereafter		177,869		20,959
Total	$	397,548	$	56,371

XML

Derivative Instrument (Notional Table) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | USD
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	$ 57,000,000	$ 57,000,000
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | CAD
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	55,000,000	58,000,000
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | GBP
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	42,000,000	40,000,000
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | CAD
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	1,175,000,000	900,000,000
Notional Amount Of Nonderivative Instruments	250,000,000	250,000,000
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | GBP
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	350,000,000	350,000,000
Notional Amount Of Nonderivative Instruments	1,050,000,000	1,050,000,000
Not Designated as Hedging Instrument [Member] | CAD
Derivatives Fair Value [Line Items]
Derivative, Notional Amount	$ 3,000,000	$ 12,000,000

XML

Earnings Per Share (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Computation of basic and diluted earnings per share
Numerator for basic and diluted earnings per share - net income (loss) attributable to common stockholders	$ 190,799,000	$ 50,022,000
Denominator for basic earnings per share - weighted average shares	336,754	289,606
Effect of dilutive securities:
Employee stock options	200,000	148,000
Non-vested restricted shares	416,000	540,000
Convertible senior unsecured notes	442,000	623,000
Dilutive potential common shares	1,058,000	1,311,000
Denominator for diluted earnings per share - adjusted weighted average shares	337,812	290,917
Basic earnings per share	$ 0.57	$ 0.17
Diluted earnings per share	$ 0.56	$ 0.17

XML

Real Estate Intangibles (Tables)

3 Months Ended

Mar. 31, 2015

Real Estate Intangibles (Tables) [Abstract]

Summary of real estate intangibles excluding those classified as held for sale

		March 31, 2015		December 31, 2014
Assets:
	In place lease intangibles	$	1,037,697	$	988,290
	Above market tenant leases		66,162		65,684
	Below market ground leases		62,426		62,426
	Lease commissions		20,809		19,536
	Gross historical cost		1,187,094		1,135,936
	Accumulated amortization		(789,546)		(776,501)
	Net book value	$	397,548	$	359,435
	Weighted-average amortization period in years		16.2		17.7
Liabilities:
	Below market tenant leases	$	91,365	$	91,168
	Above market ground leases		7,859		7,859
	Gross historical cost		99,224		99,027
	Accumulated amortization		(42,853)		(40,891)
	Net book value	$	56,371	$	58,136
	Weighted-average amortization period in years		14.4		14.4

Schedule of Real Estate Intangible Amortization

	Three Months Ended
	March 31,
	2015		2014
Rental income related to above/below market tenant leases, net	$	206	$	(45)
Property operating expenses related to above/below market ground leases, net		(319)		(311)
Depreciation and amortization related to in place lease intangibles and lease commissions		(24,324)		(79,393)

Schedule of the future estimated aggregate amortization of intangible assets and liabilities

		Assets		Liabilities
2015	$	72,406	$	$3,323
2016		60,019		8,176
2017		37,369		8,594
2018		26,596		8,500
2019		23,289		6,819
Thereafter		177,869		20,959
Total	$	397,548	$	56,371

XML

Subsequent Events (Details) (USD $)	1 Months Ended	3 Months Ended
	Oct. 31, 2014	Mar. 31, 2015 properties
Subsequent Events Details [Abstract]
Number of banks in consortium		28
Line of Credit Facility, Maximum Borrowing Capacity		$ 2,500,000,000
Interest Rate margin		0.925%
Facility Fee as Percentage of commitment fee		0.15%
Line of Credit Facility Maximum Borrowing Capacity Additional		1,000,000,000
Available In Alternate Currencies		$ 500,000,000
Term Loan Interest Rate Margin	1.15%
Debt instrument maturity date		Oct. 31, 2018

XML

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2015

Segment Reporting (Tables) [Abstract]

Summary of information for reportable segments

Three Months Ended March 31, 2015:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	264,406	$	-	$	115,181	$	-	$	379,587
Resident fees and services		-		492,510		-		-		492,510
Interest income		14,699		1,031		1,264		-		16,994
Other income		3,883		1,020		161		22		5,086
Total revenues		282,988		494,561		116,606		22		894,177
Property operating expenses		-		338,507		37,954		-		376,461
Net operating income from continuing operations		282,988		156,054		78,652		22		517,716
Reconciling items:
Interest expense		10,027		34,458		7,625		68,970		121,080
Loss (gain) on derivatives, net		(58,427)		-		-		-		(58,427)
Depreciation and amortization		70,031		76,636		42,162		-		188,829
General and administrative		-		-		-		35,138		35,138
Transaction costs		36,172		12,042		341		-		48,555
Loss (gain) on extinguishment of debt, net		10,336		-		-		5,064		15,400
Impairment of assets		2,220		-		-		-		2,220
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		212,629		32,918		28,524		(109,150)		164,921
Income tax expense		418		(533)		466		(48)		303
(Loss) income from unconsolidated entities		1,393		(15,073)		1,032		-		(12,648)
Income (loss) from continuing operations		214,440		17,312		30,022		(109,198)		152,576
Gain (loss) on real estate dispositions, net		54,097		-		2,749		-		56,846
Net income (loss)	$	268,537	$	17,312	$	32,771	$	(109,198)	$	209,422
Total assets	$	11,916,636	$	10,208,763	$	4,444,058	$	59,938	$	26,629,395

Three Months Ended March 31, 2014:		Triple-net		Seniors Housing Operating		Outpatient Medical		Non-segment / Corporate		Total
Rental income	$	237,716	$	-	$	98,739	$	-	$	336,455
Resident fees and services		-		456,265		-		-		456,265
Interest income		7,720		-		874		-		8,594
Other income		144		54		280		15		493
Total revenues		245,580		456,319		99,893		15		801,807
Property operating expenses		243		308,184		33,004		-		341,431
Net operating income from continuing operations		245,337		148,135		66,889		15		460,376
Reconciling items:
Interest expense		9,115		27,479		9,383		74,856		120,833
Depreciation and amortization		67,269		129,162		36,887		-		233,318
General and administrative		-		-		-		32,865		32,865
Transaction costs		275		630		47		-		952
Loss (gain) on extinguishment of debt, net		-		(148)		-		-		(148)
Income (loss) from continuing operations before income taxes and income from unconsolidated entities		168,678		(8,988)		20,572		(107,706)		72,556
Income tax expense		(355)		(1,643)		(262)		-		(2,260)
(Loss) income from unconsolidated entities		1,382		(7,961)		1,023		-		(5,556)
Income (loss) from continuing operations		169,705		(18,592)		21,333		(107,706)		64,740
Income (loss) from discontinued operations		460		-		-		-		460
Net income (loss)	$	170,165	$	(18,592)	$	21,333	$	(107,706)	$	65,200

		Three Months Ended
		March 31, 2015			March 31, 2014
Revenues:		Amount	%		Amount	%
United States	$	745,136	83.3%	$	675,099	84.2%
International		149,041	16.7%		126,708	15.8%
Total	$	894,177	100.0%	$	801,807	100.0%
		As of
		March 31, 2015			December 31, 2014
Assets:		Amount	%		Amount	%
United States	$	21,880,931	82.2%	$	20,728,477	82.9%
International		4,748,464	17.8%		4,285,819	17.1%
Total	$	26,629,395	100.0%	$	25,014,296	100.0%

XML

Stock Incentive Plans

3 Months Ended

Mar. 31, 2015

Stock Incentive Plans [Abstract]

Stock Incentive Plans

14. Stock Incentive Plans

Our Amended and Restated 2005 Long-Term Incentive Plan (“2005 Plan”) authorizes up to 6,200,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. The 2005 Plan replaced the 1995 Stock Incentive Plan (“1995 Plan”) and the Stock Plan for Non-Employee Directors. The options granted to officers and key employees under the 1995 Plan vested through 2010 and expire ten years from the date of grant. Our non-employee directors, officers and key employees are eligible to participate in the 2005 Plan. The 2005 Plan allows for the issuance of, among other things, stock options, restricted stock, deferred stock units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years. Options expire ten years from the date of grant. Stock-based compensation expense totaled $9,054,000 for the three months ended March 31, 2015 and $7,667,000for the same period in 2014.